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ABSTRACT 
 
The onset of lactation in dairy cows is characterized by high output of methylated 
compounds in milk when sources of methyl group are in short supply. Methionine (MET) and 
choline (CHOL) are key methyl donors and their availability during this time may be limiting for 
milk production, hepatic lipid metabolism, and immune function. Supplementing rumen-
protected MET and CHOL may improve overall performance and health of transition cows. 
Physiological and molecular mechanisms for methyl donor supplementation benefits are 
unknown. Objectives were to evaluate performance, immunometabolic status, liver function, and 
the underlying mechanisms in response to MET and CHOL supplementation. Eighty-one 
multiparous Holstein cows were used in a randomized complete block design with 2×2 factorial 
arrangement of MET (Smartamine M, Adisseo NA) and CHOL (ReaShure, Balchem Inc.) level 
(with or without). Treatments were control (CON), no MET or CHO; CON+MET (SMA); 
CON+CHO (REA); and CON+MET+CHO (MIX). From −50 d to −21 d before expected 
calving, all cows received the same diet (1.40 Mcal/kg DM). From −21 d to calving, cows 
received the same close up diet (1.52 Mcal/kg DM) and were assigned randomly to treatments 
(CON, SMA, REA, or MIX). From calving to 30 DIM, cows were on the same postpartal diet 
(1.71 Mcal/kg DM) and continued to receive the same treatments through 30 DIM. MET 
supplementation was adjusted daily at 0.08% DM of diet and CHOL was supplemented at 60 
g/cow/d. Blood (-10, 4, 8, 20, and 30 d) and liver (-10, 7, 21, and 30 d) samples were harvested 
for biomarker and molecular analyses. Incidence of clinical ketosis and retained placenta tended 
to be lower in MET-supplemented cows. MET supplementation led to greater DMI during close-
up (P = 0.01) and first 30 d postpartum (P = 0.02). Milk yield (P = 0.03) and milk protein % (P < 
0.01) also were greater in MET- compared with CHOL-supplemented cows. The greater overall 
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plasma albumin concentration (P = 0.04), blood neutrophil phagocytosis capacity (P = 0.01), and 
neutrophil oxidative burst (P = 0.03) in MET-supplemented cows underscored a better liver 
function and immune status. In addition, the greater concentrations of hepatic reduced and total 
(P = 0.01) glutathione indicated a lower degree of oxidative stress in cows fed MET compared 
with CHOL. MET-supplemented cows had greater (0.38 vs. 0.27; SEM = 0.05; P = 0.02) 
methionine adenosyltransferase 1A (MAT1A) and phosphatidylethanolamine methyltransferase 
(PEMT) expression (0.74 vs. 0.58; SEM = 0.08; P = 0.05). Greater (0.93 vs. 0.74; SEM = 0.05; P 
= 0.01) S-adenosylhomocysteine hydrolase (SAHH) and CBS (1.16 vs. 1.02; SEM = 0.07; P = 
0.04) as well as lower (23.4 vs. 29.7 nmol product h-1 mg protein-1; SEM = 2.9; P = 0.04) MTR 
activity were also detected in MET but not CHOL-supplemented cows. Although greater (1.07 
vs. 0.93; SEM = 0.05; P = 0.01) expression of betaine aldehyde dehydrogenase (BADH) was 
observed in response to CHOL supplementation, expression of (BHMT) and MTR and BHMT 
enzyme activity did not change (P > 0.05). Furthermore, overall MTR enzyme activity was lower 
(23.5 vs. 29.6 nmol product h-1 mg protein-1; SEM = 2.9; P = 0.05) in CHOL cows. In terms of 
AA profile, MET supplementation led to greater (P < 0.01) circulating methionine and 
proportion of methionine in the essential AA pool, total AA, and total sulfur-containing 
compounds. Lysine in total AA also tends to be greater (P = 0.08) in these cows, indicating a 
better overall AA profile. Sulfur-containing compounds (cystathionine, cystine, homocystine, 
and taurine) also were greater (P < 0.05) in MET-supplemented cows, indicating an enriched 
sulfur-containing compound pool due to enhanced transsulfuration activity. Circulating essential 
AA (P = 0.06) and total AA (P = 0.03) concentrations were greater in MET cows due to greater 
lysine, arginine, tryptophan, threonine, proline, asparagine, alanine, and citrulline. In contrast, 
tryptophan and cystine were greater. Plasma 3-methylhistidine concentration was lower (P = 
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0.02) in response to CHOL, suggesting less tissue protein mobilization in these cows. Overall, 
results indicate that MET supplementation improves performance of transition cows through a 
combination of better immunometabolic status, plasma AA profile, and a reduction in oxidative 
stress; insufficient regeneration of MET may be one reason for the lack of effect with 
supplemental CHOL.  
Key words: Methionine, choline, transition cow, inflammation, oxidative stress 
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CHAPTER 1 
LITERATURE REVIEW 
 
 
INTRODUCTION 
Modern dairy cows have been selected over generations to maximize milk yield, thereby 
creating a nutrient highway from the daily ration to sustain milk production (Tamminga et al., 
1997). From a metabolic, physiologic, and immunologic standpoint the periparturient or 
transition period, defined as 3 weeks before to 3 weeks after parturition, is the most stressful 
period in the lactation cycle (Drackley, 1999). During this time, dairy cows experience the 
highest incidence of displaced abomasum, retained placenta, and ketosis. Although many cows 
are able to meet the adaptive changes, health problem such as displacement of abomasum, 
retained placenta, ketosis, and fatty liver, occur to nearly one in two cows underscores the 
fragility of the system during the transition period (Loor et al., 2013a). 
In fact, requirements for energy, protein as well as many minerals double overnight as 
cows go through parturition and commence lactation. As the nutrient demand is unable to be met 
through feed intake alone due to the rate of dry matter intake is slower than output for milk 
production, the onset of lactation in dairy cows is characterized by a severe negative balance of 
energy, metabolizable protein (MP), and limiting AA. These negative changes render dairy cows 
in a state of immune-suppression, which leads to increased susceptibility to metabolic disorders 
(Drackley, 1999, Ingvartsen, 2006). Therefore, energy consumption and availability of MP and 
limiting AA (e.g. methionine) may be determinant factors for the success of the transition period. 
Owing to the fact that methyl donors are required for the synthesis of key compounds 
such as phosphatidylcholine and carnitine in tissues (Pinotti et al., 2002), a negative methyl 
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donor balance also may be an important challenge for the transition dairy cow. In fact, milk from 
dairy cows is high in methylated compounds and levels of these compounds secreted into milk 
are maintained even at the cost of depleting liver tissue reserves (Pinotti et al., 2002). Due to 
extensive microbial degradation in the rumen, dietary availability of key methyl donors [(e.g., 
Met (MET) and choline (CHOL)] is limited (Sharma and Erdman, 1989, Girard and Matte, 
2005). Consequently, the increased mobilization of body protein in dairy cows during this period 
may serve, at least in part, to compensate for the shortfall in methyl groups required by 
mammary gland and liver (Komaragiri and Erdman, 1997). Supplementing rumen-protected 
methyl donors may help fulfill the daily methyl group requirement, and possibly improve the 
overall production and health of dairy cows during the transition period (Zom et al., 2011, Osorio 
et al., 2013, Osorio et al., 2014b). 
Therefore, our general hypothesis was that supplementing rumen-protected MET and/or 
CHOL to transition dairy cows improve overall health and lactation performance by improving 
liver function and alleviating inflammation and oxidative stress. These effects are controlled at 
the molecular level by cross-talk of gene expression, enzyme activity, and substrate availability.  
 
Transition period 
The transition period is the most challenging stage in the lactation cycle when most 
metabolic disorders and infectious diseases occur (Drackley, 1999). The importance of the 
transition from late pregnancy to lactation in health, productivity, and profitability has been 
underscored by intense interest in nutrition and management of dairy cows over the past 20 years 
(Drackley, 1999).  
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From parturition through peak lactation, mobilization of body reserves, e.g. skeletal 
muscle or adipose tissue, is often observed and occurs in response to the metabolic burden 
elicited by the onset of lactation, i.e. the need of the mammary gland to uptake glucose and other 
nutrients in support of milk component synthesis. Although considered “normal” adaptations, a 
period of stress accompanies the well-established physiological adaptations starting during the 
peripartal period through peak lactation. An important driver of the metabolic stress induced by 
the sudden onset of milk production is the lag in dry matter intake (DMI) that is not achieved 
until after peak lactation (Drackley, 1999). In light of such changes, the metabolism of dairy 
cows changes drastically which contribute greatly to the incidences of metabolic diseases 
occurred in the peripartal period. A summary of key metabolic changes and adaptations are 
presented below. 
 
Protein and AA metabolism 
The amount of MP flowing to the intestine from both dietary and microbial source are 
often diminished by lower DMI around calving. The increased demand for fetal development 
prepartum and the inability of cows to consume sufficient protein, greatly contributes to negative 
protein/amino acid balance, especially when the onset of lactation greatly increases the 
mammary gland demand for AA (Bell et al., 2000). It has been estimated that during the first 
week of lactation cows are 600g/d in negative MP balance. The inability of dairy cows to 
produce sufficient MP to meet mammary and extra-mammary AA requirement during the first 2 
weeks of lactation promotes active mobilization of tissue protein (Bell et al., 2000, van der Drift 
et al., 2012). In fact, continuous synthesis and breakdown of proteins characterizes the process of 
body protein metabolism (Bergen, 2008). Previous studies with dairy cattle proposed that AA 
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profiles in serum are affected by a multitude of events such as skeletal muscle catabolism (Bell et 
al., 2000, Korhonen et al., 2002), dietary AA profile (Polan et al., 1991), liver gluconeogenesis, 
and gastrointestinal absorption (Meijer et al., 1995a). More recent data from a large number of 
studies revealed that the uptake of total non-essential amino acids by the liver was substantially 
greater in the peripaturient period (Kuhla et al., 2011, Larsen and Kristensen, 2013). It has also 
been suggested that the liver may take up more AA from the circulation during the periparturient 
period for production of APP (Kurpad, 2006).  
The importance of balancing AA has been denoted by Schwab (2012). Lysine and Met 
have been identified as the two most limiting AA for lactating dairy cows in North America 
(NRC, 2001b). Thus, by supplementing the most limiting AA such as Lys and Met, AA 
requirements are being met with lower concentrations of dietary protein.  
 
Lipid Metabolism 
After calving, the total energy intake by dairy cows are usually less than energy 
requirements, even in healthy cows (Bell et al., 2000). To make up for the negative energy 
balance, long chain fatty acids are mobilized from adipose tissue and released to the circulation 
as non-esterified fatty acids (NEFA). As a result, NEFA concentration in blood commonly 
increase after calving and reflects the degree of adipose tissue mobilization (Pullen et al., 1990).  
As liver is the most important site for removal of NEFA from circulation, over 
mobilization of lipids from adipose tissue leads to increased liver NEFA uptake and increased 
triglycerides (TAG) accumulation (Drackley, 1999). Subsequently, NEFA have several fates 
including secretion in bile, oxidization to CO2, partial oxidation to ketone bodies, storage in the 
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liver as TAG, or secretion as lipoproteins (Emery et al., 1992). The low capacity of ruminant 
liver to synthesize and secrete very-low density lipoproteins (VLDL) for TAG export from liver 
renders dairy cows susceptible to increased TAG accumulation (Kleppe et al., 1988). Therefore, 
excessive liver NEFA uptake give rise to fatty liver. Production of ketone bodies also increases 
in negative energy balance and carbohydrate insufficiency in the liver after calving, which can 
result in ketosis. It has been reported that ad libitum feeding of high-energy diets during dry 
period increased esterification and decreased oxidation capacity in liver at 1 d post-calving, 
which favors deposition of TAG in liver (Litherland et al., 2011).  
Factors regulating disposition of NEFA between oxidation and esterification in liver of 
dairy cows remains to be investigated. Studies in nonruminants have suggested that the primary 
site of control seems to be at the entry of NEFA into the mitochondria, under the regulation of 
the enzyme carnitine palmitoyltransferase (CPT-1). However, little has changed both for activity 
of CPT-1 and its sensitivity to the key inhibitor molecule malonyl-CoA during the transition 
period (Dann et al., 2006). The peroxisomal fatty acid–oxidation system is an auxiliary pathway 
for fatty acid oxidation and increases in peroxisomal fatty acid–oxidation capacity in the liver 
may help the liver to cope with the large influx of NEFA from body fat mobilization (Grum et 
al., 1996, Grum et al., 2002). 
Fat infiltration impairs the liver’s ability to detoxify ammonia (Strang et al., 1998) as well 
as endotoxin (Andersen et al., 1996). Severe fatty liver disrupt normal liver functions, which can 
result in fatty liver syndrome, or clinical fatty liver (Morrow, 1976). Although fat infiltration per 
se does not lead to liver failure (Rehage, 1996), it may be a contributing factor at least in some 
circumstances. Therefore, maintaining liver function is crucial for dairy cows to ensure a smooth 
transition. 
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Methionine Metabolism 
Methionine in vivo is mainly metabolized through the methionine cycle and the 
transsulfuration pathway, which share the first three steps (Finkelstein, 2003). The first step of 
methionine metabolism converts methionine to S-adenosyl Methionine (SAM). This step is 
catalyzed by methionine adenosyltransferase (MAT) and activates the methyl group on the sulfur 
atom of SAM. The activated methyl group on SAM is used for methylating numerous kinds of 
molecules including other methyl group donors such as choline. Upon cleavage of activated 
methyl group from the sulfur atom, SAM becomes S-adenosyl Homocysteine (SAH), which is 
subsequently converted to homocysteine. After the initial 3 common steps of the methionine 
cycle, homocysteine can either irreversibly enter the transsulfuration pathway to form other 
sulfur containing amino acids or converted back to methionine by accepting a methyl group from 
5-methylenetetrahydrofolate or from betaine (Finkelstein, 2003). Although the methionine cycle 
is present in every tissue, transsulfuration only occurs in the liver, kidney, small intestine, and 
pancreas (Finkelstein, 1998). It has been estimated that 60% of homocysteine is metabolized by 
transsulfuration in the liver (Ulrey et al., 2005). Additionally, the liver is the only organ that 
possesses the isoenzyme of MAT that catalyzes the synthesis of SAM in response to increased 
availability of methionine (Finkelstein, 2003).  
The importance of Met as one of the most-limiting AA for milk yield and components 
can also be associated with Met helping alleviate the increased demand for methylated 
compounds with the onset of lactation (Preynat et al., 2009a). Increased Met bioavailability in 
cows supplemented with rumen-protected Met (Graulet et al., 2005) is likely to increase entry of 
Met into the 1-carbon metabolism cycle in liver where it is initially converted into S-
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adenosylmethionine (SAM), the major biological methyl-donor (Martinov et al., 2010b). Part of 
the mechanism elicited by supplemental Met in postpartal dairy cows is driven by changes in 
gene expression for key enzymes in the Met cycle. An end-result of such effect is more 
availability of enzyme protein that could help enhance the flux through the pathway leading to 
synthesis of several important intermediate metabolites (e.g. SAM, glutathione, taurine, PC). 
 
Choline Metabolism 
Dietary choline is absorbed from the small intestine and can be accumulated by all tissues 
of the body (Sweet et al., 2001). Upon uptake by various tissues, choline can be acetylated, 
oxidized or phosphorylated (Zeisel, 1990). Only a small portion of dietary choline is acetylated 
into neurotransmitter acetylcholine. Choline acetyltransferase in the terminals of cholinergic 
neurons are responsible for the reaction (White and Cavallito, 1970). Major choline metabolism 
takes place in the liver, and of all the possible fates of choline, formulating PC is the major 
pathway of dietary choline, and phosphorylation of choline is the first step for PC synthesis 
(Pelech and Vance, 1984). However, when synthesis of PC is saturated, choline can be 
irreversibly oxidized to betaine (Zeisel, 2006). Betaine can then participate in the methionine 
cycle and produce methionine by donating methyl groups acquired from choline to homocysteine 
(Zeisel, 1990). As for in vivo synthesis, choline can only be derived from de novo synthesis of 
PC through sequential methylation of phosphatidylethanolamine using the methyl group from 
SAM (Vance et al., 1997).     
It is well established that choline plays an important role in liver lipid transport (Zeisel, 
1990). Rats challenged with diets deficient in choline and methionine develops fatty liver and 
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such effect can be reversed upon resupplementation of choline (Hebbard and George, 2011). As 
VLDL is responsible for exporting triglycerides out of the liver and PC is an indispensable 
component for VLDL, choline deficiency leads to decreased synthesis of VLDL and thus 
triglycerides are accumulated in the cytosol of liver cells, which eventually induce the onset of 
fatty liver (Cole et al., 2012). 
 
Interrelated Metabolism of Methionine and Choline  
The direct interrelated metabolism of methionine and choline happens in the de novo 
synthesis of choline. During de novo synthesis of PC, phosphatidylethanolamine has to be 
sequentially methylated. As the global methyl donor, SAM is responsible for providing the 
methyl groups for sequential methylation and thus interacts with choline (Vance et al., 1997). 
In the methionine cycle, choline and methionine metabolism interact when converting 
homocysteine to methionine (Wong and Thompson, 1972b). Upon receiving a methyl group 
from betaine or 5-methylenetetrahydrofolate, methionine is regenerated from homocysteine. 
Although betaine acts as the direct methyl group donor for remethylation of homocysteine, 
betaine acquired the methyl group from choline through irreversible oxidation (Li and Vance, 
2008a). Therefore, choline is connected to methionine metabolism through betaine. As major 
methyl donors, both choline and methionine contribute to the methyl group pool of one carbon 
metabolism. Deficiency in one or more of the methyl group donors result in compensatory 
changes in others (Selhub et al., 1991). For example, feeding choline deficient diets to rodents 
not only decreased tissue concentrations of choline, but methionine level in tissue is also 
decreased (Zeisel et al., 1989). Although the irreversible reaction from choline to betaine makes 
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it impossible for choline to be formed directly from methionine through the methionine cycle, 
the compensatory changes in methionine may be beneficial for sparing choline for other 
important functions of choline, such as synthesis of VLDL. In terms of transition dairy cows, it 
has been debated whether supplementing one methyl donor is enough to satisfy the requirement 
of another. In the case of MET and CHO, it has yet to be determined the quantity of MET 
utilized to generate required CHO and vice versa during the peripartal period. More importantly, 
how much the flux from MET to CHO and vice versa serve to alleviate immunometabolic stress 
in peripartal dairy cow remains unknown. 
 
Methionine cycle enzyme assays and kinetics 
Kinetic studies on key enzymes in the Methionine cycle in rats revealed that the Km of 
CBS for Hcy is estimated at 4.8 mmol/L and for serine at 2.0 to 3.0 mmol/L (Taoka et al., 1999). 
MTR and BHMT, which use Hcy as substrate for remethylation back to methionine, has an 
estimated Km of 1.7 µmol/L and 106 µmol/L, respectively (Yamada et al., 1997). Therefore, at 
low concentrations of Hcy, remethylation of Hcy to methionine would be favored whereas at 
high concentrations, the transulfuration pathway would be activated to remove excess Hcy. 
These results suggest an important role of measuring key enzyme activities in the methionine 
cycle as an indication of flux and, more specifically, remethylation or transulfuration pathway 
especially in response to deficiency or over consumption of methyl group-containing nutrients.  
To our knowledge, kinetics of the methionine cycle enzymes in ruminants are unknown. 
However, several studies have determined the developmental activity of these enzymes in sheep 
(Radcliffe and Egan, 1974, Xue and Snoswell, 1986) and growing steers in response to abomasal 
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methionine supplementation (Lambert et al., 2002). It is important to note that compared with 
rats, sheep have lowered activity of key enzymes in the one carbon metabolism pathway. In 
response to abomasal supplementation of methionine, MTR activity was reduced but not CBS. 
To our knowledge, activity of key enzymes in one carbon metabolism have not been determined 
in dairy cows.  
 
Assessing oxidative stress status with pro- and anti-oxidants 
Oxidative stress is defined as the serious imbalance between oxidants and antioxidants, 
and has been proven to exert pleiotropic act-ions in a large number of tissues and cells in 
monogastric animals (Sies, 1985). In the context of the transition dairy cows, hepatic uptake of 
oxygen increased significantly around parturition for production of energy through oxidation 
(Reynolds, 2003). Consequently, production of reactive oxygen species (ROS), including oxygen 
ions, free radicals and lipid hydroperoxides, were greatly augmented. Although cellular 
antioxidants such as glutathione were capable of neutralizing ROS and prevent cellular damage, 
depletion of such antioxidants lead to ROS accumulation which give rise to substantial tissue 
damage and induce inflammatory responses (Sordillo and Aitken, 2009). As a result, oxidative 
stress contribute greatly to dysfunctional host immune and inflammatory response upon 
increased metabolic stress e.g. the transition period (Sordillo et al., 2009). Therefore, oxidative 
stress is associated with the increase in susceptibility of transition dairy cows to various health 
disorders (Bernabucci et al., 2005, Castillo et al., 2005), suggesting the imbalance between ROS 
production and neutralizing capacity of antioxidant in tissues and blood is the driving force of 
oxidative stress-related damage.  
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Pro-oxidants as biomarkers of oxidative stress 
The term ”pro-oxidant” refers to all reactive, free radical-containing molecules capable of 
inducing oxidative stress either by generation of ROS or by inhibiting antioxidant systems 
(Rahal et al., 2014). The increase in pro-oxidant levels is usually associated with increased risk 
of oxidative stress and therefore may be used as biomarkers. Because ROS concentration is an 
indicator of free radical production (Miller et al., 1993, Sugino, 2006), and when in excess can 
compromise cell function through damaging cellular lipid, protein, and DNA, it has been widely 
adopted as a biomarker for oxidative stress in non-ruminants (Fukui et al., 2011, Leufkens et al., 
2012, Jansen et al., 2013) and ruminants (Bernabucci et al., 2002, 2005, Celi et al., 2010). In fact, 
the level of ROS is now considered as the gold standard for assessing total oxidative status (Celi, 
2010). Bionaz et al. (2007) observed a correlation between paraoxonase (PON) and ROM during 
the first 2 weeks of lactation, indicating that lower PON levels led to a reduction of anti-
oxidative protection during the early postpartum period (Bionaz et al., 2007). The fact that ROM 
level has been reported to decrease close to calving and was positively associated with NEFA 
and BHBA suggest it could be a comparative biomarker for oxidative stress at least during the 
transition period (Bernabucci et al., 2005). 
Other pro-oxidants, oxidized protein products, and biomarkers of lipid peroxidation also 
have been considered as useful biomarkers of oxidative stress (Georgieva, 2005). However, the 
complexity of the assays required for their measurement have limited their use as oxidative stress 
biomarkers in the transition period.  
 
Antioxidants as biomarkers of oxidative stress 
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Antioxidants are defined as substances with the ability to significantly inhibit or delay the 
oxidative process at low concentrations. Endogenous and exogenous antioxidants are used to 
protect tissues or cells by neutralizing free radicals and maintaining redox balance (Sies, 1991, 
Valko et al., 2007). Enzymatic and non-enzymatic molecules within the cytoplasm and various 
cell organelles constitute the two major parts of endogenous antioxidant defenses (Celi, 2010).  
In humans, several ubiquitous primary antioxidant enzymes of significance, including 
superoxide dismutase (SOD), catalase, glutathione peroxidase (GSH-Px), malondialdehyde 
(MDA) and glutathione reductase (GR) are well known biomarkers of oxidative stress (Saikat 
and Raja, 2011). In dairy cows, the activity and concentration of these enzymes were also 
reported to be altered around parturition. For instance, GSH-Px activity was greater after calving 
(Sordillo et al., 2007), and erythrocyte SOD activity increased before calving and it decreased to 
prepartum levels one week after parturition (Bernabucci et al., 2005). However, the accumulation 
of lipid peroxides despite elevated GSH-Px suggested that elevated GSH-Px may not be 
sufficient to prevent oxidative damage. Therefore, caution must be taken when interpreting the 
results of enzyme biomarkers in the context of oxidative stress. 
By directly interacting with ROS and free radicals, small molecular-weight non-
enzymatic antioxidants (e.g., GSH, taurine, NADPH, thioredoxin, vitamins E and C, and trace 
metals, such as selenium) also work as scavengers (Young and Woodside, 2001). Of these redox 
pairs, the GSH-to-GSSG ratio is thought to be one of most abundant redox buffering systems in 
mammalian species (Ďuračková, 2007). As the most abundant non-protein thiol in the cell, 
glutathione (GSH) is a powerful antioxidant that is highly-abundant in the cytosol (1-11 mM), 
nuclei (3-15 mM), as well as mitochondria (5-11 mM) (Saikat and Raja, 2011). The critical role 
of GSH in maintaining the redox state of proteins essential for DNA repair and expression in the 
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nucleus, detoxifying foreign compounds in the cytosol, and protecting mitochondrial DNA 
damage are well-established (de la Asuncion et al., 1996, Saikat and Raja, 2011). In fact, GSH 
has been used as a biomarker in various oxidative stress-related diseases (Romeu et al., 2010, 
Vetrani et al., 2013, Saharan and Mandal, 2014). 
In the context of the transition period, dairy cows are likely to endure oxidative stress and 
changes in GSH levels are expected. Plasma thiol levels (representing GSH) have been reported 
to peak at -4 d relative to calving and decrease to baseline levels after parturition (Bernabucci et 
al., 2005). Using assays specific for measuring GSH, it was reported that oxidized GSH (GSSG) 
concentration in blood increased while the GSH:GSSG ratio was markedly decreased at calving 
(Sordillo et al., 2007). In the liver, GSH concentration in the transition period was also shown to 
decrease after parturition and did not return to prepartum levels at least until 21 d postpartum 
(Osorio et al., 2014b). Considering the amplifying effect from both the decrease in GSH and 
increase in GSSG upon oxidative stress, measuring both GSH and GSSG level and calculating 
the GSH: GSSG ratio may be a more sensitive biomarker of oxidative stress. If measuring both 
GSH and GSSG is not an option, in light of these results, changes in GSH from prepartum to 
postpartum could still serve as a suitable biomarker for evaluating oxidative stress in the 
transition dairy cow. 
Taurine (2-aminoethylsulphonic acid) is a semi-essential sulfur containing amino acid 
present in almost all tissues. Although taurine accounts for only 3% of the free amino acid pool 
in plasma, it accounts for 25%, 50%, 53%, and 19%, respectively, of this pool in liver, kidney, 
muscle, and brain (Brosnan and Brosnan, 2006). Apart for its well-known role in bile formation, 
osmoregulation, and neuromodulation (Ripps and Shen, 2012), taurine also acts as a 
cytoprotetant through alleviating oxidative stress.  Mammalian neutrophils and monocytes are 
 14 
high in taurine, which binds to excess hypochlorous acid produced from oxidative burst and 
protects cells from oxidative stress damage (Schaffer et al., 2009). Although taurine is not 
capable of scavenging ROS directly, it enhances other cellular antioxidant functions such as 
GSH and inhibits ROS production by stabilizing the electron transport chain in mitochondria 
(Schaffer et al., 2009, Jong et al., 2012). 
Due to the limitation of reliable ELISA kits for measuring taurine concentration, data on 
the concentration or change in concentration of taurine during the peripartal period are not 
available. However, considering taurine is a precursor of GSH and can help maintain GSH levels 
even during oxidative stress (Roy and Sil, 2012), a higher taurine concentration may be 
indicative of an elevated state of oxidative stress during the transition period. 
 
Liver function during the transition period: links with oxidative stress and inflammation 
It has been recognized in the last decade that the peripartal dairy cow experiences a state 
of reduced liver function coupled with increased inflammation and oxidative stress (Bionaz et 
al., 2007, Trevisi et al., 2012a). Bilirubin, glutamic-oxaloacetic transaminase (GOT), γ-
glutamyltransferase (GGT) along with albumin and paraoxonase (PON) are commonly-used 
biomarkers of liver status around calving (Bertoni et al., 2008). While the liver is responsible for 
clearance of bilirubin (Bertoni et al., 2008), higher GOT and GGT are related to liver cell 
damage (e.g. lysis and necrosis).   
The peripartal inflammatory response is characterized by an increase in the production of 
positive acute-phase proteins (posAPP) such as haptoglobin and serum amyloid A (SAA), and a 
concomitant decrease in the production of negative APP (negAPP) such as albumin (Bertoni et 
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al., 2008). At the level of liver, the well-established triggers of these responses are the pro-
inflammatory cytokines IL-6, IL-1, and TNF-α (Kindt et al., 2007).  
The fact that albumin is classified as a negAPP implies that hepatic production (the main 
site in the body) is commonly reduced during the onset of inflammation (Bertoni et al., 2008). 
Concentrations of ceruloplasmin and SAA are likely to increase during inflammatory episodes 
such as those occurring in the peripartal period (Ceciliani et al., 2012b).  
 During the transition period cows will normally experience an increase in adipose tissue 
lipolysis due to changes in hormones such as insulin (decrease) and growth hormone (increase), 
and consequently blood non-esterified fatty acid (NEFA) concentrations increase. Once NEFAs 
reach the liver these can be oxidized to provide energy to the liver, partially oxidized to produce 
ketone bodies, or esterified to triglyceride (TAG). A major organelle within hepatocytes where 
NEFA oxidation takes place is the mitochondria, and carnitine is essential for transport of NEFA 
from cytosol into mitochondria for subsequent β-oxidation (Drackley, 1999). Carnitine is derived 
endogenously from trimethyllysine (TML), in turn TML supply is driven by turnover of proteins 
containing Lys and Met, where Lys serves as the backbone while Met is the methyl donor for 
TML synthesis (Carlson et al., 2007).  
 
Immune function and immune response 
It is well known that the transition dairy cow is regarded as an immune-compromised 
animal, characterized by inflammatory conditions such as infectious disease and metabolic 
disorders that often result in pro-inflammatory cytokine release (Mallard et al., 1998, Bertoni et 
al., 2008). The decreased ability of the immune system to respond to infectious challenges is 
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likely responsible for the high incidences of environmental mastitis as well as metritis. Although 
the reasons for the impaired immune functions are not well understood, it has been suggested 
that a negative energy or protein balance may be a major contributing factor (Goff and Horst, 
1997). In particular, inadequate supply of metabolizable protein has been related to impaired 
function of the immune system (Houdijk et al., 2001). It has also been shown that 
supplementation of rumen-protected methionine reduces oxidative stress and benefits blood 
neutrophil function (Osorio et al., 2013). These findings correlated well with the common 
observation that cows that seem to be the most stressed by nutrition and environmental factors 
are the most likely to have health problems during the transition period. 
 
Phagocytosis and Oxidative Burst 
Phagocytosis is defined as the engulfment and degradation of large solid particles, 
usually over 0.5 μm in diameter, by phagocytic cells. As the first line of defense from pathogens, 
phagocytosis is evolutionary conserved and an essential part of innate immunity. Upon 
activation, phagocytes remove not only invading pathogens but also apoptotic cells or cell debris 
through internalizing these particles (Gaipl et al., 2004). Following internalization, these 
specialized leukocytes can facilitate host immunity by signaling to lymphocytes and promote 
inflammatory cytokine production via antigen presentation to T-lymphocytes (Pfeifer et al., 
1993). Owing to their capability of rapidly and efficiently ingesting invading pathogens at the 
sites of inflammation, neutrophils and macrophages are referred to as professional phagocytes. 
Although monocytes have lower phagocytic capabilities, they were also included as professional 
phagocytes as precursor of macrophages (Rabinovitch, 1995).  
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When exposed to stimuli such as invading microorganisms, oxygen uptake increased 
markedly in professional phagocytes. Although the magnitude of oxygen consumption is 
dependent on the stimulus used, the uptake of oxygen is usually more than 50-fold higher 
compared with the unstimulated state. Subsequently, large quantities of superoxide and hydrogen 
peroxide were generated and meanwhile large amounts of glucose were metabolized through 
hexose monophosphate shunt. These reactive oxygen species as well as lysosomal enzyme 
released by activated leukocytes assume the bactericidal role. Such series of changes in 
phagocytes are known as respiratory/oxidative burst. Similar to phagocytes, products from 
oxidative burst activation are also well known important mediators of host reactions. For 
instance, products derived from NADPH oxidase are key components of microbicidal system. 
The pathogen killing ability of macrophages is also closely correlated with oxygen metabolism 
(Murray and Cohn, 1980).    
As direct measurements of immune response, phagocytosis and oxidative burst 
capabilities of professional phagocytes can be quantified upon pathogen challenge. In fact, 
commercial kits are available for determination of phagocytic and oxidative burst capabilities in 
leukocytes. Results from multiple studies have shown that the ability of professional phagocytes 
to conduct phagocytosis and oxidative burst declines with age (Horn et al., 2014) or exposure to 
stress factors such as hyperoxia (Wang et al., 2015) and oxidative stress (Amer and Fibach, 
2005). Considering the oxidative stress status during the peripartal period reviewed above, 
bovine leukocytes are likely to have compromised phagocytic and oxidative burst capabilities. 
 
Hepatic oxidation theory 
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Non-ruminant research have suggested that elevated hepatic oxidation and generation of 
ATP can terminate a meal through signals from liver to brain via afferents in the vagus nerve 
(Langhans et al., 1985, Tordoff et al., 1991, Berthoud, 2004). Such control of food intake is 
referred to as Hepatic Oxidation Theory (Allen et al., 2009). As reviewed above, dairy cows 
enter a lipolytic state around parturition which was characterized by increased hepatic NEFA 
uptake and oxidation as well as a shortage of gluconeogenic precursors. As a result, insufficient 
intermediates for the TCA cycle lead to accumulation of acetyl-CoA. In agreement with hepatic 
oxidation theory, propionate infusion decreased dry matter intake by 20% in lactating dairy cows 
(Stocks and Allen, 2012). As propionate infusion provided the TCA cycle intermediates, the 
hypophagic effect of propionate infusion likely originates from oxidation of accumulated acetyl-
CoA, which leads to a dramatic increase in ATP production. Similarly, increasing hepatic fatty 
acid oxidation also lead to decreased feed intake in early lactating dairy cows (Allen et al., 
2009). Such results support a negative relationship between hepatic oxidation and dry matter 
intake in early lactating dairy cows. Considering hepatic oxidation lead to intracellular acetyl-
CoA build up, monitoring the hepatic acetyl-CoA pool may help elucidate the efficacy of dry 
matter intake during the transition period. 
 
Short-chain acyl CoA: links with AA catabolism 
It is well known that AA catabolism normally account for only a small portion of the 
body’s energy production. However, increased catabolism of AA through oxidation can be 
expected in times of severe negative energy balance e.g. the transition period. Although different 
AAs have distinct catabolic pathways, their catabolism converge to form only five products, all 
of which enter the TCA cycle where they were diverted to gluconeogenesis, ketogenesis or 
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complete oxidation to CO2. In fact, ten AAs ultimately broke down to yield acetyl-CoA, four into 
succinyl-CoA, two into fumarate, and two into oxaloacetate. Therefore, 14 out of 20 AAs enter 
the TCA cycle for oxidation through short-chain acyl CoA. It is also noteworthy that isoleucine, 
threonine, methionine, and valine are precursors of propionyl-CoA and methylmalonyl-CoA, 
which subsequently enter the TCA cycle via succinyl-CoA. This metabolic pathway has high 
flux level in ruminants for gluconeogenesis due to large amounts of propionate formed during 
ruminal fermentation (Aschenbach et al., 2010). Considering the critical roles of acetyl-CoA, 
succinyl-CoA, propionyl-CoA, and methylmalonyl-CoA in energy metabolism, monitoring 
hepatic short chain acyl-CoAs may provide insight into AA catabolism related energy 
metabolism during the transition period. 
 
Link between liver functionality index (LFI) and AA concentrations in transition period 
Using changes in plasma concentrations of albumin, cholesterol, and bilirubin, the liver 
functionality index (LFI) characterizes the extent of the inflammatory response and helps to 
predict its likely consequences on health and well-being of the cow (Bertoni and Trevisi, 2013b). 
A low LFI (LLFI) value is indicative of a pronounced inflammatory response, suggestive of a 
more difficult transition from gestation to lactation while a high LFI (HLFI) is suggestive of a 
smooth transition (Trevisi et al., 2012b). Previous work utilizing blood and milk samples has 
confirmed the usefulness of this approach to assess the severity of the immune and inflammatory 
status (Trevisi et al., 2010a). 
In terms of AA during the transition period, it is well known that the needs of the fetus 
pre-partum and the needs of the mammary gland post-partum increase greatly the demand for 
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AA but the supplies of metabolizable protein and essential AA (EAA) are limiting around 
calving (Bell et al., 2000). Therefore, “better” AA plasma profiles could serve as indicators of a 
successful adaptation during the transition period. Recent results have established that HLFI 
cows have greater plasma concentrations of Val, Thr, Ile, EAA, and branched-chain AA 
compared with LLFI cows without marked differences in dry matter intake (Zhou Z, 2016). 
Because there are very few published data on AA profiles around parturition, these data seem to 
indicate a biologically important linkage between liver function and systemic AA concentrations. 
Therefore, in the medium-to-long term additional research on AA and their biological roles 
beyond milk synthesis could help better define their potential use as biomarkers of health and 
disease. 
 
Uncover adaptations during the transition period with omics approach 
Omics is a suffix signifying the measurement of entire level of biological molecules, 
which encompasses a variety of high-throughput technologies to study the genome, proteome, 
and metabolome of the experimental unit. Along with bioinformatics, omics enhance 
understanding of the complex biological interactions in cells and tissues at the gene, protein, and 
metabolite level (Loor et al., 2015). Although the field of omics is ever expanding, 
transcriptomics, epigenomics, proteomics, and metabolomics are well-established research tools 
for nutritional research. 
In terms of dairy cows, results from both our group and others have confirmed the 
alterations on the transcriptome level (Ji et al., 2012, Osorio et al., 2014a, Li et al., 2016) as well 
as metabolome (Sun et al., 2015) level in response to nutritional interventions. For instance, 
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microarray analysis from our group revealed a greater overall subclinical inflammatory-like 
condition in feed-restricted cows compared with overfed cows (Shahzad et al., 2014). 
Metabolomics profiling of rumen fluid, milk, serum, and urine from lactating cows fed high- vs. 
low-quality diets suggest higher N loss and low N utilization efficiency in response to low 
quality diet (Sun et al., 2015).  
As mentioned above, high producing dairy cows undergo complex adaptations as the cow 
approaches parturition and enters lactation. Although nutritional interventions such as peripartal 
methionine supplementation was shown to help achieve a successful transition (Osorio et al., 
2013), integration of functional genomics technology with measurement of metabolism may help 
uncover the underlying key mechanisms.  
 
Summary 
The transition period is considered the most challenging phase during the lactation cycle 
(Drackley, 1999). The increased nutritional requirements and decreased DMI greatly contribute 
to the well-known metabolism related disorders during this period. Apart from the negative 
energy balance, negative metabolizable protein balance, and negative methyl donor balance have 
also been shown to closely associate with oxidative stress, inflammation, and compromised liver 
function in transition dairy cows.  
Rumen-protected methionine is expected to improve transition dairy cow performance as 
it can spare essential AAs, stimulate sulfur containing antioxidant synthesis, and provide 
backbone for gluconeogenesis. Rumen-protected choline has also been suggested to alleviate 
fatty liver during the transition period by enhancing TAG export. However, peripartal methyl 
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donor supplementation in the form of methionine and choline have yielded inconsistent effects 
on transition dairy cow performance and health (Erdman and Sharma, 1991, Hartwell et al., 
2000, Pinotti et al., 2003, Piepenbrink et al., 2004, Guretzky et al., 2006, Ordway et al., 2009, 
Preynat et al., 2009b, Osorio et al., 2013). In addition, as methyl donors, methionine and choline 
metabolism are closely interrelated, the flux from methionine to choline and vice versa during 
the transition period remains unknown.  
Our general hypothesis was that supplementing rumen-protected methionine and/or 
choline to peripartal dairy cows will improve overall lactation performance by enhancing liver 
function and antioxidant capacity, and decreasing the inflammatory response. Such effects were 
realized through changes in transcriptome and metabolome. The overall objective of this 
dissertation was to evaluate the performance parameters, blood and liver biomarkers, and 
transcriptomics and metabolomics alterations on dairy cows supplemented with methionine and 
choline during the transition period. 
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CHAPTER 2 
BETTER POSTPARTAL PERFORMANCE IN DAIRY COWS SUPPLEMENTED WITH 
RUMEN-PROTECTED METHIONINE THAN CHOLINE DURING THE PERIPARTAL 
PERIOD 
- Journal of dairy science, 2016, 99(11):8716-8732. 
INTRODUCTION 
During the transition from pregnancy to lactation (“transition period”), dairy cattle enter a 
period of negative energy and MP balance as a result of increased metabolic demand by the 
mammary gland and the low DMI (Drackley, 1999). Owing to the fact that methyl donors are 
required for the synthesis of key compounds such as phosphatidylcholine (PC) and carnitine in 
tissues (Pinotti et al., 2002), a negative methyl donor balance also may be an important challenge 
for the transition dairy cow. In fact, milk from dairy cows is high in methylated compounds and 
levels of these compounds secreted into milk are maintained even at the cost of depleting liver 
tissue reserves (Pinotti et al., 2002).  
Due to extensive microbial degradation in the rumen, dietary availability of key methyl 
donors [(e.g., Met (MET) and choline (CHOL)] is limited (Sharma and Erdman, 1989, Girard 
and Matte, 2005). Consequently, the increased mobilization of body protein in dairy cows during 
this period may serve, at least in part, to compensate for the shortfall in methyl groups required 
by mammary gland and liver (Komaragiri and Erdman, 1997). Supplementing rumen-protected 
methyl donors may help fulfill the daily methyl group requirement, and possibly improve the 
overall production and health of dairy cows during the transition period (Zom et al., 2011, Osorio 
et al., 2013, Osorio et al., 2014c).  
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Both MET and CHOL are key methyl donors in mammals and their availability is 
important for various biological functions. For instance, MET together with Lys are the two 
most-limiting AA for milk synthesis in lactating cows (NRC, 2001b). Being the only essential 
sulfur-containing AA, MET acts as the precursor for other sulfur-containing AA such as Cys, 
homocysteine and taurine (Brosnan and Brosnan, 2006).  It has been estimated in lactating goats 
that as much as 28% of absorbed MET could be used for CHOL synthesis (Emmanuel and 
Kennelly, 1984). Hence, it is thought that rumen-protected CHOL supplementation could spare 
MET to help cows achieve better overall performance (Hartwell et al., 2000, Pinotti, 2012). 
Current recommendations for duodenal supply of Lys and MET to maximize milk protein 
content and yield in established lactation are 7.2 and 2.4% of MP, respectively (NRC, 2001b). 
More recent work demonstrated a benefit of supplementing rumen-protected MET to achieve a 
Lys:Met ratio close to 2.8:1 during the peripartal period in terms of production performance 
(Osorio et al., 2013).  
Oxidative stress status during the peripartal period also was influenced by increased MET 
availability due to the fact that it serves as a substrate for glutathione synthesis, the most-
abundant natural antioxidant produced within cells (Martinov et al., 2010a, Osorio et al., 2014c). 
Furthermore, as a lipotropic agent, MET is directly involved in very low density lipoprotein 
(VLDL) synthesis via the generation of S-adenosylmethionine (SAM), the most important 
methyl donor (Martinov et al., 2010a). In turn, SAM can be used to methylate 
phosphatidylethanolamine (PE) to generate PC, which is essential for VLDL synthesis 
(Auboiron et al., 1995). In the context of VLDL synthesis and liver lipid metabolism, CHOL-
containing nutrients (mainly in the form of PC) are indispensable for the synthesis and release of 
chylomicrons and VLDL (Pinotti et al., 2002). Thus, supplementation of rumen-protected MET 
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and/or CHOL (Zom et al., 2011) may increase hepatic triacylglycerol (TAG) export and 
consequently decrease lipidosis.  
To date, the reported effects of rumen-protected MET and/or CHOL supplementation on 
dairy cow performance have been inconsistent. Although previous studies from our group and 
others have observed beneficial effects of MET (Chen et al., 2011, Osorio et al., 2013) or CHOL 
(Pinotti et al., 2003, Zom et al., 2011) supplementation, other studies did not detect significant 
improvements on peripartal production performance with MET (Socha et al., 2005, Ordway et 
al., 2009, Preynat et al., 2009b) or CHOL (Guretzky et al., 2006, Leiva et al., 2015) 
supplementation. In particular, data demonstrating whether CHOL alone or in combination with 
MET provide equal or different benefits to cows are limited. Our general hypothesis was that 
supplementation of rumen protected MET or CHOL improves overall health and lactation 
performance during the peripartal period. The objective of this study was to evaluate the impact 
of feeding a commercially-available rumen protected MET or CHOL products alone and in 
combination on transition cow performance and health.  
MATERIALS AND METHODS 
Experimental Design and Dietary Treatments 
 All procedures for this study (protocol 13023) were approved by the Institutional Animal 
Care and Use Committee (IACUC) of the University of Illinois. The experiment was conducted 
as randomized, complete, unbalanced block design with 2×2 factorial arrangement of MET 
(Smartamine M, Adisseo NA) and CHOL (ReaShure, Balchem Inc) inclusion (with or without). 
A total of 88 cows were blocked according to expected calving date. Each block had 12 cows 
(except for the last block). Cows within each block were balanced for parity, previous lactation 
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milk yield, and BCS before the close-up. A complete data set was obtained from 81 cows 
receiving a basal control (CON) diet (n = 20) with no MET or CHOL supplementation; CON 
plus MET (SMA, n = 21) at a rate of 0.08% of DM; CON+CHOL (REA, n = 20) at 60 g/d; or 
CON+MET+CHOL (MIX, n = 20). Dosage of MET was based on Osorio et al. (2013), whereas 
CHOL was supplied following manufacturer’s recommendations. All cows received the same 
far-off diet (1.40 Mcal NEL/kg of DM, 10.2% RDP, and 4.1% RUP) from -50 to -23 d before 
expected calving, the same close-up diet (1.52 Mcal NEL/kg of DM, 9.1% RDP, and 5.4% RUP) 
from -21d to expected calving, and the same lactation diet from calving (1.71 Mcal NEL/kg of 
DM, 9.7% RDP, and 7.5% RUP) through 30 DIM (Table 2.1).  
The MET and CHOL supplements were both top-dressed from -21 ± 2 to 30 DIM once 
daily at the AM feeding using approximately 50 g of ground corn as carrier. The TMR DM for 
the close-up and lactation diets was measured weekly for estimation of daily TMR DM offered. 
Supplementation of SMA (0.08% DM of TMR offered) was calculated daily for each cow. 
Smartamine M was supplied as small beads containing a minimum of 75% DL-Met, physically 
protected by a pH sensitive coating, which is considered to have a Met bioavailability of 80% 
(Graulet et al., 2005); therefore, per 10 g of Smartamine, the cows received 6 g of metabolizable 
MET. The ReaShure supplement is reported to contain 28.8% choline chloride and is protected 
by microencapsulation. The product is considered to have CHOL bioavailability of 72% (Benoit 
et al., 2009); therefore, per 60 g of ReaShure, the cows received 12.4 g of metabolizable choline 
chloride. To our knowledge, neither Smartamine M nor ReaShure have specific characteristics 
that may affect palatability of diets.  
Animal Management 
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All cows were enrolled in the experiment from late July 2013 to mid-October 2014, with 
an average temperature of 12.2 ± 11.1 C (Illinois State Water Survey; 
http://www.isws.illinois.edu/atmos/statecli/cuweather/index.htm). Dry cows were housed in a 
ventilated enclosed barn during the dry period and fed individually once daily at 0630 h using an 
individual gate system (American Calan Inc., Northwood, NH). Cows had access to sand-bedded 
free stalls until 3 d before expected parturition, when they were moved to individual maternity 
pens bedded with straw until parturition. On average, cows remained in the maternity pen for 
3.69 ± 3.61 days. After parturition, cows were housed in a tie-stall barn and were fed a common 
lactation diet once daily in the AM (Table 2.1) and milked 3 times daily at approximately 6:00, 
14:00, and 22:00. At 30 DIM, cows returned to the farm herd. Feed offered was adjusted daily to 
achieve 10% refusals.  
 Body weight was measured weekly before the mid-day milking for each cow at the same 
time after the morning feeding. A BCS (scale 1 = thin to 5 = obese, with quarter-point 
increments) was assigned to each cow weekly by 2 individuals and the average score was used 
for statistical analysis. Intake of DM was recorded daily. Milk yield was recorded daily during 
the first 30 DIM. Milk composition was analyzed, while ECM and energy balance (EB) were 
calculated from calving to 30 DIM.  
General cow housing and health-care conform to approved standard operating procedures 
for the University of Illinois Dairy cattle research Unit. Attending veterinarians from the 
University of Illinois Veterinary College of Medicine conducted diagnosis and, when needed, 
performed treatment for displaced abomasum (DA), ketosis (via urine test), endometritis, and 
other health problems. Per IACUC guidelines, cows only were removed from the experiment 
when failing to recover from a clinical disorder after treatment or surgery (e.g. feed intake less 
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than 80% of pre-diagnosis within 2 d after DA surgery). A total of 2, 0, 2, and 3 cows were 
removed from the study in the CON, SMA, REA and MIX groups, respectively (Table 2.2). All 
data from the cows removed were not included in the statistical analysis. 
Feed and Milk Samples  
 Dry matter of individual feed ingredients was determined weekly and rations were 
adjusted accordingly to maintain DM ratios of ingredients in the TMR. Weekly samples of 
ingredients and TMR were frozen at -20 C and composited monthly for analysis of DM, CP, 
NDF, ADF, Ca, P, K, and Mg by standard wet chemistry techniques at a commercial laboratory 
(Dairy One, Ithaca, NY; http://dairyone.com/wp-content/uploads/2014/02/Forage-Lab-
Analytical-Procedures.pdf). The values for NEL, RUP, RDP, Lys, and Met also were predicted 
using the NRC (2001) model with actual DMI, BW, BCS, milk production, and milk 
composition as inputs. Analytical values from individual feed ingredients (alfalfa silage, alfalfa 
hay, brewer grains, corn silage, cottonseeds, expeller soybean meal, wheat straw) were used to 
adjust the default values in the model. Consecutive morning, midday, and evening milk samples 
were taken weekly until 30 DIM. Composite milk samples were prepared in proportion to milk 
yield at each milking, preserved (800 Broad Spectrum Microtabs II; D & F Control Systems Inc., 
San Ramon, CA), and analyzed for contents of fat, protein, lactose, SNF, MUN, and SCC by 
mid-infrared procedures (Chemists, 1995) in a commercial laboratory (Dairy Lab Services, 
Dubuque, IA). Based on milk sample analysis, the ECM (at 3.5% fat) and FCM was calculated 
daily as follows: ECM = [12.82 × fat yield (kg)] + [7.13 × protein yield (kg)] + 0.323 × milk 
yield (kg)], FCM = (0.4324 × kg of milk yield) + (16.216 × kg of milk fat) (Hutjens, 2010).   
  The EB was calculated for each cow using equations from NRC (2001). Net energy 
intake (NEI) was determined using daily DMI multiplied by NEL density of the diet. Net energy 
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of maintenance (NEM) was calculated as BW
0.75 × 0.080. Requirements of NEL were calculated 
as NEL = (0.0929 × fat% +0.0547 × protein % + 0.0395 × lactose %) × milk yield. The net 
energy requirement for pregnancy (NEP; Mcal/d) was calculated as NEP = [(0.00318 × day of 
gestation – 0.0352) × calf birth weight/ 45)]/0.218. The equation used to calculate prepartal EB 
(EBPRE; Mcal/d) was EBPRE = NEI – (NEM + NEP) and EBPRE (as % of requirements) = 
[NEI/(NEM + NEP)] × 100. The equation used to calculate postpartal EB (EB-POST) was EBPOST 
(Mcal/d) = NEI – (NEM + NEL) and EBPOST (as % of requirements) = [NEI/(NEM + NEL)] × 100.  
 Blood Collection and Analyses  
  Blood was sampled from the coccygeal vein on -10 d relative to expected calving date 
and on 4, 8, 20, and 30 d relative to actual calving date before the morning feeding. Samples 
were collected into evacuated tubes (BD Vacutainer; BD and Co., Franklin Lakes, NJ) 
containing either clot activator or lithium heparin for serum and plasma, respectively. After 
blood collection, tubes with lithium heparin were placed on ice and tubes with clot activator were 
kept at 21 C until centrifugation (~30 min). Serum and plasma were obtained by centrifugation 
at 2,000 × g for 30 min at 4 C. Aliquots of serum and plasma were frozen (-20 C) until further 
analysis. Concentrations of NEFA, BHBA, and glucose were analyzed by methods described in 
Osorio et al. (2013). Plasma insulin was assayed by a double-antibody radioimmunoassay that 
uses a primary antiserum to bovine insulin (Gutierrez et al., 2013).  
Liver Tissue Composition  
Liver was sampled via puncture biopsy (Dann et al., 2005) from cows under local 
anesthesia at approximately 0800 h on d -10, 7, 20, and 30 d relative to parturition. Liver was 
frozen immediately in liquid N and stored until further analysis for concentration of TAG. A 
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total of 50 mg of tissue was first homogenized in 1.5 mL of PBS/10 mM EDTA using a hand-
held homogenizer (Tissue-Tearor, Biospec Products). Subsequently, 200 µL of GPBS-142 
EDTA along with 3 mL of isopropanol-hexane-water (80:20:2 vol/vol) were added to each 
sample, the tube was covered with aluminum foil, and the mixture was incubated for 30 min at 
room temperature. One milliliter of hexane-diethyl ether (1:1) was then added to each sample 
followed by vortexing and incubating for 10 min at room temperature (protected from light). One 
milliliter of water was added to each sample to separate the lipid phase and the mixture was 
vortexed. Samples were incubated covered with aluminum foil for ~20 min at room temperature. 
The organic phase was then aspirated and placed into glass vials, prior to evaporation under a 
stream of N gas. An 8-point TAG standard was prepared with Infinity TG reagent 
(catalog#10010509, Cayman Chemicals). Each 150 µL sample was mixed with 540 µL of 
Infinity TG reagent prior to vortexing. A total of 160 µL of this sample mixture was pipetted into 
a flat-bottom 96-well plastic microplate. The plate was incubated for 15 min at 37 C prior to 
determining absorbance at 540 nm using a microplate reader. Concentration of TAG was 
calculated from the standard curve.  
Statistical Analysis  
 Data were analyzed using PROC MIXED of SAS (SAS Institute Inc., Cary, NC) 
according to the following model:  
𝑦𝑖𝑗𝑘𝑙𝑚 = 𝜇 + 𝑏𝑖 + 𝑀𝑗 + 𝐶𝑘 + 𝑀𝐶𝑗𝑘 + 𝑇𝑙 + 𝑇𝑀𝑗𝑙 + 𝑇𝐶𝑘𝑙 + 𝑇𝑀𝐶𝑗𝑘𝑙 + 𝐴𝑚:𝑖𝑗𝑘 + 𝜀𝑖𝑗𝑘𝑙𝑚 
where 𝑌𝑖𝑗𝑘𝑙𝑚 is the dependent, continuous variable; 𝜇 is the overall mean; 𝑏𝑖 is the random effect 
of the 𝑖th block; 𝑀𝑗 is the fixed effect of MET (𝑗 = with or without); 𝐶𝑘 is the fixed effect of 
CHOL (𝑘 = with or without);𝑇𝑙 is the fixed effect of time (day or week) of the experiment; 
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𝐴𝑚:𝑖𝑗𝑘 is the random effect of the mth animal (cow) nested within block×MET×CHOL; 𝜀𝑖𝑗𝑘𝑙𝑚 is 
the residual error. The covariates of parity (2nd vs. 3rd lactation and greater), previous 305-d milk 
yield, and BCS before the close-up period were kept in the model for all variables when 
significant (P < 0.05). For the analysis of prepartal DMI, the average DMI of each cow during 
the last week of the far-off period were used as covariate in the model. Blood metabolites and 
liver composition were analyzed at various time points that were not equally spaced with a 
heterogeneous variance over time. Therefore, the first order ante-dependence covariance 
structure ANTE (1) was used for repeated measures. Health data, except for mastitis and metritis 
with a single case each, were analyzed with PROC GLIMMIX (distribution = binary and link = 
logit) of SAS. Statistical differences were declared significant at P ≤ 0.05 and tendencies at P ≤ 
0.15.  
RESULTS 
Health 
Health-related problems that occurred during the experiment and causes for the removal 
of cows are summarized in Table 2.2. Seven cows, none belonging to SMA, were removed from 
the experiment due to health-related problems. Failure to recover from surgery to correct DA 
was the major contributor (n = 6) to the removal of cows. Out of the 6 cows excluded due to DA, 
3 cows from CON, REA, and MIX also were diagnosed with ketosis. Among the 81 cows 
completing the study, ketosis had the highest occurrence (n = 20) while mastitis and metritis only 
occurred once. Among the 3 main health-related problems, incidence of ketosis (7 vs. 13) and 
retained placenta (3 vs. 9) tended (P = 0.07) to be lower in MET-supplemented cows. It should 
be noted that incidence of ketosis in 3 cows, 2 fed the CON diet and the other fed MIX, occurred 
 47 
along with DA. Similarly, 3 other ketotic cows, 2 fed the CON diet and one REA, also were 
diagnosed with retained placenta. 
Ingredient and Nutrient Composition of Diets 
 The ingredient composition of the diets is presented in Table 2.1. The nutrient 
composition (Table 2.3) was determined by analyzing each individual feed ingredient for its 
chemical composition and then entering the feed analysis results into the NRC (2001) model. 
Analyzed chemical composition of diets is presented in Suppl. Table 2.1. 
Prepartal DMI, BW, and BCS 
As expected, DMI of cows in all treatments (Fig. 2.1E) gradually decreased (P < 0.01) 
from -21 d to calving. A significant (P = 0.02) increase in prepartal DMI was detected due to the 
main effect of MET (Fig. 2.1A); no such effect (P = 0.28) was detected for CHOL (Fig. 2.1C). 
Analysis of prepartal DMI as percentage of BW (Table 2.4) also revealed a tendency for an 
increase in response to MET (P = 0.13) compared with CHOL (P = 0.27). This response 
appeared mostly associated with differences in DMI than BW because no differences (P > 0.15) 
were detected in prepartal BW and BCS (Table 2.4). Similarly, the tendency (P = 0.12) for an 
increase in EB with MET rather than CHOL also could be explained by differences in DMI 
prepartum. Prepartal BW and EB were the only variables for which parity explained some of the 
variation. Visual inspection indicated that all cows consumed the MET or CHOL supplement 
top-dressed on the TMR, thus, differences in DMI did not seem to be associated with product 
palatability or smell. 
Postpartal DMI, BW, and BCS 
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Similar to prepartum, postpartal DMI was greater (P = 0.02) in cows supplemented with 
MET (Fig. 2.1B) while DMI was similar (P = 0.79) with or without CHOL supplementation 
(Fig. 2.1D). The BW postpartum did not differ (P > 0.15) among treatments (Table 2.4); 
however, there was greater DMI as a percentage of BW when cows were fed MET (P = 0.05) 
compared with CHOL (P = 0.93). Although no main effect of MET or CHOL was detected for 
BCS, there was an interaction (P = 0.09) of CHOL × Time for postpartal BCS (Table 2.4). 
Postpartal EB did not differ (P > 0.15) among treatments (Table 2.4). 
Milk Production and Composition 
Main effects and interactions for milk composition and milk production variables are 
presented in Table 2.5. The MET supplementation resulted in greater (P < 0.01) milk protein 
percentage while CHOL had no effect (P = 0.19). Milk fat, SCC, lactose, other solids, and MUN 
percentage were not affected (P > 0.15) by treatments. However, a tendency (P = 0.13) for 
higher total solids percentage was detected in response to MET supplementation.  
Overall milk yield, ECM and FCM were greater (P < 0.05) with MET supplementation 
compared with CHOL (P > 0.15). The significant response in milk fat yield (P = 0.02) detected 
in cows fed MET was due to the higher milk production in MET-supplemented cows because no 
difference (P = 0.91) in milk fat percentage was detected among treatments. The higher (P < 
0.01) milk protein yield in MET-supplemented cows was due to both greater (P < 0.05) milk 
protein percentage and milk production.   
Blood Biomarkers and liver TAG composition 
The main effects of MET, CHOL, and their interactions for blood and milk biomarkers as 
well as liver TAG composition are reported in Table 2.6. Significant (P < 0.05) main effects 
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were detected for glucose and insulin, which were greater in cows supplemented with CHOL 
(Fig 2.4D). Although no main effects of MET or CHOL were detected for NEFA:insulin, the 
glucose:insulin ratio was significantly lower (P = 0.05) in CHOL-supplemented cows (Table 
2.6). Concentration of BHBA tended (P = 0.12) to be lower in response to CHOL 
supplementation, mainly due to lower concentration at 20 d postpartum (Fig 2.4H). Although 
there was no main effect of MET for NEFA or BHBA, a tendency (P = 0.15) for a MET×time 
interaction was detected for NEFA, which was associated with greater NEFA at 20 d in MET-
supplemented cows (Fig 2.4E). Although liver TAG increased after calving (P < 0.01) for all 
treatments, a tendency (P = 0.13) for a CHOL×time interaction was detected because of greater 
concentration in CHOL-supplemented cows at 20 d postpartum (Table 2.6, Fig. 2.4J). 
DISCUSSION 
Ingredient, Nutrient Composition, and NRC Evaluation of Diets 
The abrupt increase in MP demand and inability of cows to consume sufficient protein 
around parturition contribute to negative MP and AA balances, especially when the onset of 
lactation greatly increases the mammary gland demand for AA (Bell et al., 2000). Nutrient 
composition evaluation of prepartal and postpartal diets using the NRC (2001) and the mean 
chemical composition of feed ingredients throughout the experiment revealed different effects of 
MET and/or CHOL supplementation (Table 2.3). For instance, during the prepartal period, MET-
supplemented diets (SMA and MIX) provided an average of 133 g/d more MP than diets without 
MET supplementation. Similarly, postpartum the average increase of MP was 288 g/d in cows 
fed MET-supplemented diets. This was due, at least in part, to a greater DMI in MET-
supplemented cows both prepartum (14.3 kg/d) and postpartum (19.2 kg/d). In contrast, 
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supplementation of CHOL did not result in increased MP supply partly due to the failure to 
increase voluntary feed intake both prepartum and postpartum.  
In accordance with results from a previous similar study, MP balance was positive 
prepartum and negative postpartum regardless of treatments (Osorio et al., 2013). Considering 
there was no difference in cow BW and calf birth weight (data not shown), it was expected that 
MET cows had a more positive MP balance prepartum. However, despite the greater estimated 
supply of MP in MET-supplemented cows, a more negative MP balance postpartum (an average 
of -88 g/d more) was detected in these cows. This was likely due to a greater (an average of 375 
g/d more) MP requirement in MET cows to sustain the greater milk yield. Conversely, a lesser 
degree of imbalance of MP postpartum (an average of 18 g/d less) was detected in CHOL-
supplemented cows (REA and MIX), which might have been the result of numerically lower 
(41.4 vs. 43.2 kg/d) milk yield.  
Regardless of treatment, the estimated requirement of RUP increased by 11-fold from 
close up to the postpartal period (Table 2.3), which is similar to results reported previously 
(Osorio et al., 2013). Compared with unsupplemented cows, those fed MET had a lower 
estimated requirement for RUP prepartum (164 g/d vs. 187 g/d) as a result of a sparing effect 
from the MET supplementation. However, the postpartal requirement for RUP in MET cows was 
greater (an average of 315 g/d more) compared with cows without MET supplementation, which 
also was likely associated with the increased requirement to sustain the higher milk yield. In 
contrast, with or without CHOL, the estimated RUP requirement was similar both prepartum 
(179.5 g/d vs. 171.5 g/d) and postpartum (1938 g/d vs. 1968 g/d).  
The desired duodenal supply of Lys and MET to maximize milk protein content and yield 
has been suggested to be 7.2% and 2.4% of MP, respectively, during established lactation (NRC, 
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2001b). In the present study, MET supplementation at the rate of 0.08% DM achieved a 
duodenal Lys:Met ratio of 2.80:1 prepartum and 2.71:1 postpartum, which was lower than the 
ideal Lys:Met of 3.0:1 for optimal milk protein production. In contrast, prepartum and 
postpartum Lys:Met ratio in response to CHOL supplementation were 3.61:1 and 3.54:1, 
respectively, which were higher than the ideal ratio (Table 2.3). Therefore, the greater milk yield 
and milk protein content detected in MET compared with CHOL might have been due, at least in 
part, to a lower ratio of Lys:Met ratio and closer to the ideal 3.0:1. It is well-known that MET 
and CHOL metabolism are interrelated (Stipanuk, 1986, Zeisel, 1992), and that CHOL can 
provide labile methyl groups for biosynthesis of MET after oxidation to betaine (Mato et al., 
1994). Therefore, it is possible that CHOL supplementation alters the Lys:Met ratio by 
promoting the re-synthesis of MET. However, the production results in the present study do not 
support this assumption.  
Effects on DMI, BW, and BCS 
The effects of rumen-protected MET supplementation on DMI in previous studies has 
been inconsistent (Ordway et al., 2009, Chen et al., 2011, Osorio et al., 2013). For instance, 
Ordway et al. (2009) detected an increase in postpartal DMI with Metasmart (HMBi) 
supplementation but not SMA (Ordway et al., 2009). Socha et al. (2005) reported a tendency 
towards a decrease in DMI postpartum with 15 g/d SMA supplementation (Socha et al., 2005). In 
contrast, a recent study from Osorio et al. (2013) detected an increase in postpartal DMI as a 
percentage of BW when MET was supplemented in the form of SMA at a rate of 0.07% DM 
(Osorio et al., 2013). It has been suggested that the contrasting results in the literature may be 
due to the differences in level of MET supplementation, length of feeding, and/or stage of 
lactation (Osorio et al., 2013). In this regard, MET was top-dressed from -21 d to 30 d relative to 
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calving in the present study, which was similar to previous work from our group (Osorio et al., 
2013). However, SMA was supplemented at a slightly higher rate (0.08% DM vs 0.07% DM), 
which probably contributed to the more pronounced effect of MET on DMI postpartum, 
suggesting that aiming at a lower than 3.0:1 Lys:Met during this stage of the lactation may be 
beneficial to the cow. 
To our knowledge, this is the first report of greater DMI during the close-up dry period in 
response to rumen-protected MET supplementation. In fact, results from a previous study with 
cows consuming similar amounts of DM (14.1 kg/d vs. 13.8 kg/d) and dietary NEL (21.2 
Mcal/kg vs. 20.9 Mcal/kg) indicated that greater prepartum DMI was associated with detrimental 
metabolic responses postpartum (Douglas et al., 2006). Clearly, the greater DMI prepartum 
coupled with greater DMI postpartum and lower disease incidence in MET-supplemented cows 
suggest otherwise. Whether this response was due to the fine-tuned Met:Lys ratio through MET 
supplementation merits further investigation. In the case of CHOL supplementation, the lack of 
effect on DMI during the peripartal period is consistent with previous reports (Erdman and 
Sharma, 1991, Hartwell et al., 2000, Piepenbrink and Overton, 2003, Guretzky et al., 2006, Zom 
et al., 2011). In accordance with previous reports, MET or CHOL supplementation did not affect 
BW and BCS (Erdman and Sharma, 1991, Piepenbrink and Overton, 2003, Socha et al., 2005, 
Ordway et al., 2009).  
Milk Production and Composition 
Previous results both from our group (Osorio et al., 2013) and others (Overton et al., 
1996, Piepenbrink et al., 2004) detected greater milk yield with MET or MET analog 
supplementation. Although other studies did not detect increases in milk yield with rumen-
protected MET (Socha et al., 2005, Ordway et al., 2009, Preynat et al., 2009b) or MET analog 
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(Piepenbrink et al., 2004, Ordway et al., 2009) supplementation, an average increase of 3.8 kg/d 
in milk production in the first 30 d of lactation was detected in the present study in response to 
MET. Considering that MET has been identified as one of the two most-limiting AA for lactating 
cows (NRC, 2001b) and a greater DMI would increase daily protein intake, the milk yield 
response when supplementing MET to achieve a Lys:Met close to the suggested optimum was as 
expected.  
Similar to previous reports (Ordway et al., 2009, Osorio et al., 2013), the greater milk 
protein percentage in response to MET supplementation underscores that milk protein early 
postpartum is affected in direct proportion to adequacy of MET in the MP (NRC, 2001b). 
Considering the increased milk yield in MET cows, the increase in milk protein yield was not 
surprising. As milk fat percentage was not affected by MET supplementation, the significant 
increase in milk fat yield was due to the increase in milk production. The tendency for greater 
total solids percentage in MET-supplemented cows likely was associated with the higher protein 
percentage in those cows.  
The effect of CHOL supplementation on milk yield, ECM, and FCM in previous studies 
has been inconsistent. Although no significant effects on milk production and composition were 
reported in studies supplementing CHOL from -21 d to 42 d or longer (Hartwell et al., 2000, 
Guretzky et al., 2006), there also are studies reporting a tendency or significant increases in milk 
yield when CHOL was supplemented either during the peripartal period (Pinotti et al., 2003, 
Zahra et al., 2006, Elek et al., 2008) or from 5 to 21 wk of lactation (Erdman and Sharma, 1991). 
It has been suggested that CHOL would more likely have a positive effect in overconditioned 
cows because they are considered to be at a greater risk for hepatic accumulation of TAG 
(Guretzky et al., 2006). In agreement with this notion, Zahra et al. (2006) detected greater milk 
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production with supplemental CHOL specifically in cows with a BCS of 4 entering the close-up 
period, which was driven primarily by greater DMI (Zahra et al., 2006). Based on those results, it 
was suggested that in herds with over 1 in 5 cows (20%) entering the transition period at BCS 
≥4, CHOL supplementation may result in a positive effect on milk production. In the present 
study, 11 cows (13.6%) entered the transition period with BCS ≥4, and were randomly assigned 
to one of the 4 treatments. Five cows received CHOL and the other 6 did not. On average, the 5 
CHOL-fed cows produced 5.62 kg/d less milk compared with the other 6 cows (43.8 kg/d vs. 
38.2 kg/d). Therefore, results from the present study do not seem to support the suggestion by 
Zahra et al. (2006). However, considering that only 11 cows were overconditioned in the present 
study, there is merit in further work with overconditioned cows and supplementation of CHOL 
and MET.  
Energy Balance and Apparent Efficiency 
Mean values of EB postpartum in the present study were between -7.8 and -10.7 Mcal/d 
(Table 2.4), which is similar to the range (-7.6 to -9.5 Mcal/d) reported previously by Osorio et 
al. (2013). Although Socha et al. (2005) and Ordway et al. (2009) reported less negative values 
for EB from calving to 105 and 140 d postpartum, the differences among studies are probably 
associated with the rate and length of MET supplementation (Socha et al., 2005, Ordway et al., 
2009, Osorio et al., 2013).  
Energy Balance Biomarkers and Liver TAG Content 
Previous reports from both monogastric and ruminant studies have illustrated the 
importance of adequate lipotropic agents in the prevention of liver lipid accumulation (Cooke et 
al., 2007, Corbin and Zeisel, 2012).  As lipotropic agents, MET and CHOL fed to ruminants may 
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help clear lipid from the liver through stimulating VLDL formation and export (Waterman and 
Schultz, 1972). Although some studies have detected lower liver TAG with CHOL 
supplementation (Cooke et al., 2007, Zom et al., 2011, Elek et al., 2013), other studies detected 
no differences in liver TAG  (Hartwell et al., 2000, Piepenbrink and Overton, 2003). Similarly, 
rumen-protected MET in the form of SMA or analog (Piepenbrink et al., 2004, Osorio et al., 
2013) either elicited no difference or increased liver TAG (Preynat et al., 2009b) in periparturient 
dairy cows. Therefore, the lack of main effect of MET or CHOL on liver TAG in the present 
study is not surprising (Table 2.6). In fact, the tendency for CHOL×time interaction due to 
greater liver TAG in CHOL-supplemented cows at 20 d postpartum indicates a lack of 
lipotrophic effect with CHOL.  
The greater NEFA concentration in MET-supplemented cows at 20 d (MET×Time P = 
0.15) was similar to results from previous research, where an interaction towards greater NEFA 
was detected in cows supplemented with Metasmart compared with controls (Osorio et al., 
2013). However, whether this difference was due to greater NEFA release from adipose tissue or 
lower utilization by peripheral tissues is unclear (Piepenbrink et al., 2004). It is worth noting that 
despite the higher NEFA in MET-supplemented cows, liver TAG did not increase (Fig 2.4C and 
4E). Therefore, it is reasonable to speculate that MET-supplemented cows were able to export 
TAG more efficiently in spite of the greater influx of NEFA from blood.  
Blood insulin concentration in periparturient dairy cows was reported to increase in 
response to CHOL supplementation (Leiva et al., 2015), which agrees with the results in the 
present study. The glucose:insulin ratio is considered a crude index of tissue insulin sensitivity 
(Subiyatno et al., 1996), and has been previously used in dairy cattle receiving daily injections of 
the insulin-sensitizing drug 2,4-thiazolidinedione (Hosseini et al., 2015). In contrast with the lack 
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of CHOL effect on the glucose:insulin ratio in the study of Leiva et al. (2015), the significantly 
lower glucose:insulin in CHOL cows in the present study was indicative of lower insulin 
sensitivity. In agreement with this, dietary supplementation of CHOL (2.7 g/kg diet) increased 
plasma glucose concentration and induced insulin resistance in mice (Wu et al., 2013). Although 
the greater glucose and insulin concentration in response to CHOL supplementation in the 
present study seem to agree with the mouse data, the underlying mechanisms for these increases 
are not readily apparent.  
Despite the fact that hepatic mRNA expression of pyruvate carboxylase and 
phosphoenolpyruvate carboxykinase early postpartum were not altered in response to CHOL 
(Hartwell et al., 2000), it is possible that changes in gluconeogenesis contributed to the glucose 
and insulin response detected in the present study. It is noteworthy that administration of choline 
chloride increased the number of pancreatic β-cells in non-ruminants (Sergeyeva, 1940). In 
agreement with this early finding, it was suggested more recently that choline may stimulate 
insulin secretion indirectly by enhancing synthesis and release of acetyl choline (Ilcol et al., 
2003). Whether the same mechanism exists in ruminants merits further study.  
Subclinical ketosis in the present study was defined as blood BHBA concentration 
between 1.4 to 3 mmol/L (Oetzel, 2004). Although the main effect of MET on BHBA 
concentration was not significant, in agreement with the results from previous studies 
(Piepenbrink et al., 2004, Osorio et al., 2013), the fact that fewer MET cows had clinical ketosis 
(Table 2.2; as judged from the urine ketone test) suggests that MET supplementation might play 
a role in reducing ketosis occurrence during the peripartal period. The CON, SMA, REA, and 
MIX groups had similar numbers of cows, i.e. 3, 4, 4, and 3 cows, respectively, with BHBA 
within the range of subclinical ketosis on d 4 and d 8 postpartum.  
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Previous studies reported no significant effect of CHOL on blood glucose or BHBA 
concentrations (Guretzky et al., 2006, Zahra et al., 2006, Zom et al., 2011). In the present study, 
the tendency for lower BHBA in response to CHOL supplementation agreed with the greater 
glucose concentration. Although speculative, the pattern of BHBA and glucose detected (Fig 
2.4B) in CHOL-supplemented cows in the present study was associated with numerically lower 
negative EB (Table 2.4) as a result of lower milk production. The exact mechanisms for the 
lower milk yield in these cows that maintained greater blood glucose merits further study.  
CONCLUSIONS 
The greater DMI and greater milk production in MET-supplemented cows, coupled with 
a tendency for lower incidence of ketosis and retained placenta, underscore a smoother transition 
from pregnancy to lactation when an approximately 2.8:1 Lys:Met ratio was achieved through 
MET supplementation. The better prepartal DMI response with supplemental MET indicates that 
higher and sustained feed intake prior to calving might not always be detrimental to the 
postpartal metabolic response. Although rumen-protected CHOL has been suggested to improve 
cow performance through stimulating liver TAG export as well as sparing MET, CHOL 
supplementation failed to increase DMI, decrease liver TAG, milk yield, or optimize milk 
composition. The reasons for the lack of effects of CHOL are not readily apparent, but might be 
related to the cow BCS. Future research should concentrate on the interrelated metabolism of 
MET and CHOL to better understand unique and synergistic effects on cow performance. 
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TABLES AND FIGURES 
Table 2.1. Ingredient composition of diets fed during far-off (-50 to -22 d relative to calving), 
close-up (-21 d to calving) and early lactation (calving to 30 d) periods. 
 Diet 
Ingredient (% of DM) Far-off Close-up Lactation 
Alfalfa silage 12.00 8.34 5.07 
Alfalfa hay - 4.29 2.98 
Corn silage 33.00 36.40 33.41 
Wheat straw 36.00 15.63 2.98 
Cottonseed - - 3.58 
Wet brewers grains - 4.29 9.09 
Ground shelled corn 4.00 12.86 23.87 
Soy hulls 2.00 4.29 4.18 
Soybean meal, 48% CP 7.92 2.57 2.39 
Expeller soybean meal1 - 2.57 5.97 
Soychlor2 0.15 3.86 - 
Blood meal, 85% CP 1.00 - - 
ProVAAl AADvantage3 - 0.86 1.50 
Urea 0.45 0.30 0.18 
Rumen-inert fat4 - - 1.02 
Limestone 1.30 1.29 1.31 
Salt 0.32 0.30 0.30 
Dicalcium phosphate 0.12 0.18 0.30 
Magnesium oxide 0.21 0.08 0.12 
Magnesium sulfate 0.91 0.99 - 
Sodium bicarbonate - - 0.79 
Potassium carbonate - - 0.30 
Calcium sulfate - - 0.12 
Mineral vitamin mix5 0.20 0.17 0.18 
Vitamin A6 0.015 - - 
Vitamin D7 0.025 - - 
Vitamin E8 0.38 0.39 - 
Biotin - 0.35 0.35 
1SoyPLUS (West Central Soy, Ralston, IA) 
2By West Central Soy 
3Perdue AgriBussiness (Salisbury, MD) 
4Energy Booster 100 (Milk Specialties Global, Eden Prairie, MN) 
5Contained a minimum of 5% Mg, 10% S, 7.5% K, 2.0% Fe, 3.0% Zn, 3.0% Mn, 5000 mg of 
Cu/kg, 250 mg of I/kg, 40 mg of Co/kg, 150 mg of Se/kg, 2200 kIU of vitamin A/kg, 660 kIU of 
vitamin D3/kg, and 7,700 IU of vitamin E/kg. 
6Contained 30,000 kIU/kg 
7Contained 5,009 kIU/kg 
 59 
Table 2.1 (Continued) 
8Contained 44,000 kIU/kg
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Table 2.2. Frequency of occurrence of health problems in multiparous Holstein cows 
supplemented with rumen-protected MET (Smartamine M, Adisseo NA) or rumen-protected 
CHOL (ReaShure; Balchem Inc.) during the peripartal period. 
 Diets1 P value 
Variable CON SMA REA MIX MET CHOL MET×CHOL 
Cows        
  n2 20 21 20 20 -- -- -- 
  Ketosis3 8 3 5 4 0.07 0.93 0.21 
  Displaced abomasum 2 0 3 1 0.99 0.99 0.99 
  Retained placenta4 4 2 5 1 0.07 0.76 0.50 
  Endometritis 0 0 0 1 -- -- -- 
  Mastitis 0 1 0 0 -- -- -- 
Excluded cows        
  n5 2 0 2 3    
  Displaced abomasum 1 0 2 3    
  Endometritis6 1 0 0 0    
1CON = control; SMA = rumen-protected methionine (0.08% of DMI); REA = rumen-protected 
choline (60 g/d); MIX = SMA+REA; MET = SMA+MIX; CHOL = REA+MIX. 
2Actual number of cows completing the study. 
3Defined as cows having moderate (~40 mg/dL) or large ketone concentrations (>80 mg/dL) in 
urine and treated by veterinarians with oral propylene glycol or intravenous dextrose. 
4Defined as fetal membranes retained >24 h after calving. 
5Actual number of cows excluded due to failure to recover after prolonged treatment or from 
surgery. 
6Diagnosed by the attending veterinarian and defined as foul, watery or purulent orange-brown 
colored uterine discharge together with fever (T >39.5 C) and decreased appetite. 
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Table 2.3. Nutrient composition and evaluation (NRC, 2001) of prepartal and postpartal diets fed 
to multiparous Holstein cows supplemented with rumen-protected MET (Smartamine M, 
Adisseo NA) or rumen-protected CHOL (ReaShure; Balchem Inc.) during the peripartal period1. 
 Prepartum  
  Close-up2 Postpartum 
Chemical component Far off CON SMA REA MIX CON SMA REA MIX 
NEL (Mcal/kg of DM) 1.40 1.52 1.52 1.51 1.51 1.72 1.70 1.72 1.70 
CP (% of DM) 14.3 14.6 14.6 14.4 14.4 17.2 17.3 17.2 17.3 
RDP (% of DM) 10.2 9.2 9.2 9.1 9.0 9.7 9.6 9.7 9.6 
RUP (% of DM) 4.1 5.3 5.4 5.3 5.4 7.4 7.7 7.4 7.7 
NDF (% of DM) 51.1 42.0 41.9 41.7 41.7 33.9 33.9 33.7 33.6 
ADF (% of DM) 35.4 28.3 28.3 28.2 28.1 21.4 21.4 21.3 21.2 
RDP supplied (g/d) 1248 1180 1289 1231 1332 1679 1862 1662 1849 
RDP balance (g/d) 138 -51 -61 -63 -79 -120 -141 -121 -144 
RUP supplied (g/d) 507 680 763 714 798 1280 1481 1268 1474 
RUP required (g/d) 92 184 159 190 169 1787 2149 1814 2062 
RUP balance (g/d) 415 496 605 525 629 -507 -669 -546 -587 
MP supplied (g/d) 1058 1255 1390 1314 1445 2090 2374 2070 2361 
MP balance (g/d) 324 404 493 426 513 -434 -573 -467 -504 
Lys:Met 3.89:1 3.62:1 2.81:1 3.61:1 2.79:1 3.54:1 2.71:1 3.54:1 2.71:1 
Lys (% of MP) 7.24 6.74 6.66 6.72 6.63 6.33 6.24 6.33 6.24 
MP-Lys (g) 77 85 93 88 96 132 148 131 147 
Met (% of MP) 1.86 1.86 2.37 1.86 2.38 1.79 2.30 1.79 2.30 
MP-Met (g) 20 23 33 24 34 37 55 37 54 
NEL allowable milk (kg/d) - - - - - 27.3 30.0 26.3 30.6 
MP allowable milk (kg/d) - - - - - 31.5 33.5 29.8 33.3 
NFC (% of DM) 25.0 32.2 32.2 32.2 32.2 37.8 37.8 37.7 37.7 
EE (% of DM) 2.2 3.3 3.3 3.6 3.6 5.7 5.7 5.9 5.9 
Ca (% of DM) 0.99 1.09 1.09 1.09 1.09 0.92 0.92 0.92 0.92 
P (% of DM) 0.25 0.29 0.29 0.29 0.29 0.37 0.37 0.37 0.37 
Mg (% of DM) 0.51 0.45 0.45 0.45 0.45 0.28 0.28 0.28 0.28 
Cl (% of DM) 0.63 0.88 0.88 0.92 0.92 0.38 0.38 0.40 0.41 
K (% of DM) 1.32 1.17 1.17 1.17 1.17 1.20 1.20 1.20 1.19 
Na (% of DM) 0.15 0.15 0.15 0.15 0.15 0.37 0.37 0.37 0.37 
S (% of DM) 0.40 0.31 0.32 0.31 0.32 0.22 0.24 0.22 0.24 
1The NRC (2001) evaluation of diets was based on final averaged pre and postpartum DMI, 
production data, and feed analysis. 
2CON = control; SMA = rumen protected methionine (0.08% of DMI); REA = rumen protected 
choline (60 g/d); MIX = SMA+REA. Composition of Smartamine and Reashure supplied by 
Adisseo NA (Alpharetta, GA) and Balchem Inc. (New Hampton, NY). 
 62 
Table 2.4. Effects of supplementing multiparous Holstein cows during the peripartal period with rumen-protected Met (Smartamine 
M, Adisseo NA), rumen-protected choline (ReaShure; Balchem Inc.), or both (MIX) on DMI, BW, and BCS. 
 MET CHOL  Treatments  P-value  
Item With Without With Without SEM1 CON SMA REA MIX SEM MET2 CHOL3 M×C4 Time M×T5 C×T6 M×C×T 
Prepartum                  
BW (kg)* 775.1 772.1 769.3 777.9 11.5 774.2 781.5 769.9 768.6 16.4 0.85 0.60 0.79 <0.01 0.18 0.28 0.18 
BCS 3.53 3.50 3.48 3.55 0.05 3.54 3.56 3.46 3.51 0.07 0.60 0.35 0.87 0.50 0.52 0.48 0.66 
DMI (kg/d)$ 14.3a 13.2b 14.0 13.5 0.3 12.8 14.2 13.7 14.3 0.5 0.02 0.28 0.41 <0.01 0.98 0.81 0.49 
DMI (% of BW)*$ 1.84 1.74 1.83 1.76 0.05 1.71 1.81 1.78 1.88 0.07 0.13 0.27 0.98 <0.01 0.98 0.74 0.48 
Energy balance (Mcal/d)* 6.20 4.76 5.86 5.10 0.66 4.63 5.56 4.88 6.84 0.94 0.12 0.40 0.57 <0.01 0.95 0.30 0.82 
Postpartum                  
BW (kg)* 681.7 671.1 672.3 680.5 9.6 678.0 683.1 664.2 680.3 13.9 0.44 0.54 0.70 <0.01 0.44 0.62 0.63 
BCS 3.19 3.10 3.13 3.16 0.06 3.11 3.21 3.09 3.17 0.08 0.26 0.71 0.95 <0.01 0.46 0.09 0.10 
DMI (kg/d)# 19.2a 17.2b 18.1 18.3 0.6 17.6 19.0 16.8 19.4 0.8 0.02 0.79 0.49 <0.01 0.59 0.54 0.61 
DMI (% of BW)# 2.87 a 2.60 b 2.73 2.74 0.10 2.67 2.81 2.53 2.92 0.14 0.05 0.93 0.37 <0.01 0.95 0.63 0.79 
Energy balance (Mcal/d) -9.25 -8.84 -8.84 -9.25 1.02 -7.84 -10.67 -9.83 -7.84 1.47 0.77 0.77 0.10 <0.01 0.84 0.97 0.40 
a,bMean values with different superscripts differ (P < 0.05).  
1Greatest SEM.  
2Overall effect of methionine supplementation.  
3Overall effect of choline supplementation.  
4Interaction of MET × CHOL. 
5Interaction of MET × time. 
6Interaction of CHOL × time. 
*Parity included in the model as a covariate (P < 0.05). $Last week of far-off period DMI included in the model as a covariate (P < 
0.05). #Previous 305 d milk yield included in the model as a covariate (P < 0.05).  
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Table 2.5. Effects of supplementing multiparous Holstein cows during the peripartal period with rumen-protected Met (Smartamine 
M, Adisseo NA), rumen-protected choline (ReaShure; Balchem Inc.), or both (MIX) on milk production and composition. 
 MET CHOL  Treatments  P-value 
Parameter With Without With Without SEM1 CON SMA REA MIX SEM MET2 CHOL3 M×C4 Time M×T5 C×T6 M×C×T 
Milk composition 
(%) 
                 
Fat 3.72 3.74 3.78 3.68 0.10 3.61 3.75 3.87 3.70 0.15 0.91 0.47 0.28 <0.01 0.54 0.92 0.70 
Protein# 3.32a 3.14b 3.27 3.19 0.04 3.07 3.31 3.22 3.32 0.06 <0.01 0.19 0.20 <0.01 0.56 0.68 0.07 
SCC7* 1.86 1.82 1.85 1.82 0.06 1.87 1.77 1.76 1.94 0.09 0.64 0.75 0.12 <0.01 0.83 0.19 0.86 
Lactose* 4.70 4.69 4.69 4.70 0.03 4.71 4.69 4.67 4.71 0.04 0.80 0.80 0.39 <0.01 0.85 0.55 0.28 
Total solids 12.65 12.39 12.60 12.43 0.12 12.19 12.67 12.58 12.62 0.17 0.13 0.32 0.20 <0.01 0.18 0.97 0.52 
Other solids* 5.62 5.60 5.61 5.62 0.03 5.62 5.61 5.59 5.63 0.04 0.59 0.90 0.46 <0.01 0.74 0.55 0.34 
MUN* 12.85 12.90 12.99 12.77 0.28 12.65 12.89 13.15 12.82 0.40 0.91 0.58 0.47 0.46 0.93 0.55 0.21 
Milk production                  
Milk yield# 44.2a 40.4b 41.4 43.2 1.2 41.8 44.6 39.1 43.7 1.6 0.02 0.27 0.60 <0.01 0.25 0.73 0.87 
Milk fat yield*# 1.58a 1.45b 1.50 1.54 0.04 1.46 1.61 1.45 1.55 0.06 0.02 0.49 0.61 0.01 0.42 0.53 0.42 
Milk protein yield 1.43a 1.25b 1.32 1.35 0.04 1.27 1.44 1.23 1.42 0.06 <0.01 0.61 0.86 <0.01 0.72 0.76 0.01 
ECM# 44.6a 40.5b 41.9 43.1 1.0 41.0 45.3 40.0 43.9 1.5 0.01 0.40 0.89 <0.01 0.10 0.89 0.10 
FCM# 44.6a 40.8b 42.1 43.4 1.0 41.3 45.4 40.3 43.8 1.4 0.01 0.36 0.84 <0.01 0.25 0.56 0.84 
Efficiency                  
Milk:DMI 2.45 2.65 2.56 2.54 0.10 2.54 2.54 2.76 2.36 0.15 0.17 0.87 0.17 0.22 0.89 0.75 0.19 
ECM:DMI 2.43 2.55 2.49 2.49 0.08 2.47 2.50 2.62 2.36 0.12 0.34 0.99 0.23 <0.01 0.04 0.42 0.25 
FCM:DMI 2.44 2.58 2.51 2.51 0.09 2.51 2.51 2.65 2.36 0.13 0.26 0.99 0.25 <0.01 0.10 0.43 0.36 
a,bMean values with different superscripts differ (P < 0.05).  
1Greatest SEM.  
2Overall effect of methionine supplementation.  
3Overall effect of choline supplementation.  
4Interaction of MET × CHOL  
5Interaction of MET × time.  
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Table 2.5 (Continued) 
6Interaction of CHOL × time.  
7SCC somatic cell count data were log transformed.  
*Parity included in the model as a covariate (P < 0.05).  
#Previous 305 d milk yield included in the model as a covariate (P < 0.05).  
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Table 2.6. Effects of supplementing multiparous Holstein cows during the peripartal period with rumen-protected MET (Smartamine 
M, Adisseo NA), rumen-protected CHOL (ReaShure; Balchem Inc.), or both (MIX) on pre- and post-partum blood and liver 
biomarkers. 
 MET CHOL  Treatments   P-value  
Biomarker With Without With Without SEM1 CON SMA REA MIX SEM MET2 CHOL3 M×C4 Time M×T5 C×T6 M×C×T 
Blood                   
  Glucose (mmol/L) 3.80 3.78 3.87a 3.71b 0.05 3.66 3.76 3.90 3.85 0.07 0.68 0.02 0.31 <0.01 0.27 0.84 0.75 
  NEFA (mmol/L) 0.62 0.61 0.60 0.64 0.04 0.63 0.64 0.59 0.60 0.06 0.87 0.53 0.99 <0.01 0.15 0.85 0.25 
  BHBA (mmol/L) 0.92 0.88 0.83 0.97 0.06 0.91 1.04 0.86 0.81 0.09 0.66 0.12 0.33 <0.01 0.54 0.24 0.51 
  Insulin (µg/L) 0.57 0.53 0.63 0.47 0.04 0.42 0.52 0.64 0.61 0.06 0.53 0.01 0.25 <0.01 0.56 0.21 0.26 
Glucose:insulin 9.52 10.65 9.03 11.14 0.76 11.96 10.33 9.34 8.71 1.14 0.29 0.05 0.64 <0.01 0.49 0.61 0.25 
NEFA:Insulin 1.78 1.70 1.60 1.88 0.24 1.97 1.80 1.43 1.77 0.35 0.79 0.39 0.44 <0.01 0.33 0.52 0.47 
Liver                  
  TAG (mg/g wet wt) 28.09 29.06 29.68 27.47 3.18 26.32 28.45 31.81 27.56 4.61 0.83 0.62 0.47 <0.01 0.95 0.13 0.16 
a,bMean values with different superscripts differ (P < 0.05).  
1Greatest SEM.  
2Overall effect of methionine supplementation.  
3Overall effect of choline supplementation.  
4Interaction of MET × CHOL.  
5Interaction of MET × time.  
6Interaction of CHOL × time.  
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Fig. 2.2 
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Fig. 2.3  
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Fig. 2.4 
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Figure 2.1. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected Met (Smartamine M, Adisseo NA), rumen-protected choline (ReaShure; 
Balchem Inc.), or both (MIX) on prepartal (A, C, E) and postpartal (B, D, F) DMI. CON = 
control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure (60 g/d); MIX = SMA+REA; 
MET = SMA+MIX; CHOL = REA+MIX. Values are means, with standard errors represented by 
vertical bars. *MET×day, CHOL×day and MET×CHOL×day effects (P < 0.05) at a specific day. 
 
Figure 2.2. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected Met (Smartamine M, Adisseo NA), rumen-protected choline (ReaShure; 
Balchem Inc.), or both (MIX) on milk yield (A, B), ECM (C, D) and FCM (E, F). CON = 
control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure (60 g/d); MIX = SMA+REA; 
MET = SMA+MIX; CHOL = REA+MIX. Values are means, with standard errors represented by 
vertical bars. *MET×day, CHOL×day and MET×CHOL×day effects (P < 0.05) at a specific day. 
 
Figure 2.3. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected Met (Smartamine M, Adisseo NA), rumen-protected choline (ReaShure; 
Balchem Inc.), or both (MIX) on milk protein percentage (A, B), milk protein yield (C, D) and 
milk fat yield (E, F). CON = control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure 
(60 g/d); MIX = SMA+REA; MET = SMA+MIX; CHOL = REA+MIX. Values are means, with 
standard errors represented by vertical bars. *MET×week, CHOL×week and MET×CHOL×week 
effects (P < 0.05) at a specific week. 
 
Figure 2.4. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected Met (Smartamine M, Adisseo NA), rumen-protected choline (ReaShure; 
Balchem Inc.), or both (MIX) on blood glucose (A, B), NEFA (C, D) and liver TAG (E, F). CON 
= control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure (60 g/d); MIX = 
SMA+REA; MET = SMA+MIX; CHOL = REA+MIX. Values are means, with standard errors 
represented by vertical bars. *MET×day, CHOL×day and MET×CHOL×day effects (P < 0.05) at 
a specific day. 
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CHAPTER 3 
RUMEN-PROTECTED METHIONINE COMPARED WITH RUMEN-PROTECTED 
CHOLINE IMPROVES IMMUNOMETABOLIC STATUS IN DAIRY COWS DURING 
THE PERIPARTAL PERIOD 
- Journal of dairy science, 2016, 99(11):8956-8969. 
INTRODUCTION 
During the peripartal period, dairy cattle experience a state of negative energy and MP 
balance due to reduced DMI and increased nutrient requirements to support fetal growth and 
lactation (Drackley, 1999, Bell et al., 2000). Although some cows are able to adapt 
physiologically without being afflicted with metabolic and infectious diseases, the metabolic and 
immunologic challenges that occur during the peripartal period are important factors that limit 
the ability of most cows to achieve optimal performance and immunometabolic status (Drackley, 
1999, Loor et al., 2013b).  
Due to extensive microbial degradation in the rumen, dietary availability of key methyl 
donors [(e.g., methionine (MET) and choline (CHOL)] are limited (Sharma and Erdman, 1989, 
Girard and Matte, 2005). Therefore, a negative methyl donor balance also may be an important 
challenge for the peripartal dairy cow owing to the fact that the synthesis of key compounds such 
as phosphatidylcholine (PC) and carnitine in tissues requires methyl donors (Pinotti et al., 2002). 
The biological role of methyl donors goes beyond metabolism because they are important 
sources of the intracellular antioxidants glutathione (GSH) and taurine (Brosnan and Brosnan, 
2006).  
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In the context of liver metabolism and function, endogenous synthesis of PC from 
supplemental MET and/or CHOL could play a role in the ability of the tissue to handle the 
incoming fatty acids produced from lipolysis of adipose tissue. It is well-established that 
excessive hepatic fatty acid infiltration (Drackley, 1999) can negatively impact the normal 
functions of the liver. In addition to hepatic fat infiltration, the peripartal period is characterized 
by an increase of reactive oxygen metabolite (ROM) production, the accumulation of which 
could deplete intracellular antioxidants such as GSH and give rise to oxidative stress that may 
cause substantial tissue damage (Bertoni et al., 2009, Sordillo and Aitken, 2009, Trevisi et al., 
2012a). Increased oxidative stress likely leads to inflammation and could compromise the 
leukocyte responses during the peripartal period. 
Biomarkers in plasma such as cholesterol and paraoxonase (PON), among others, have 
been used successfully to assess the degree of liver function around parturition (Bionaz et al., 
2007, Bertoni et al., 2008, Loor et al., 2013b). Furthermore, because parturition also is 
characterized by inflammatory conditions (Bionaz et al., 2007), pro-inflammatory cytokines (e.g. 
IL-1β) (Trevisi et al., 2015) and the changes in concentrations of positive (e.g. haptoglobin) and 
negative acute-phase proteins (APP) offer a valuable tool to evaluate the functional welfare of 
the cow (Loor et al., 2013). Changes in inflammatory cytokines are closely linked with PMNL 
development and immunity-related activities (Burton et al., 2005), thus, coupling plasma 
biomarkers with measures of leukocyte function provide a more holistic view of the cow immune 
system. Immune dysfunction is a feature of the transition period and is characterized by impaired 
neutrophil trafficking, phagocytosis, and killing capacity (Kehrli et al., 1989, Goff and Horst, 
1997), but also different ability of leukocytes to produce cytokines (Jahan et al., 2015). In the 
context of transition period management, the available data provide benchmarks that could be 
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used to assess relationships among liver function, performance, and fertility (Bertoni and Trevisi, 
2013a). 
Milk from dairy cows is high in methylated compounds and the levels secreted into milk 
are maintained even at the cost of depleting liver tissue reserves (Pinotti et al., 2002). Such effect 
would exert an even greater challenge on the cow soon after calving, and coupled with the needs 
of cells to synthesize sulfur-containing antioxidants the supplementation of MET (and potentially 
CHOL) may be beneficial. However, to date, data demonstrating whether CHOL alone or in 
combination with MET provide equal or different benefits to the immunometabolic status in 
transition cows are limited. 
Our general hypothesis was that supplementation of rumen-protected MET or CHOL 
improves liver function and alleviates inflammation and oxidative stress during the peripartal 
period. Therefore, the objectives of the present study were to measure concentrations of 
biomarkers in plasma, liver tissue, and milk, and also PMNL function to assess the 
immunometabolic status of cows supplemented with MET or CHOL.  
MATERIALS AND METHODS 
Experimental Design and Dietary Treatments 
All procedures for this study (protocol no. 13023) were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Illinois. Details of the 
experimental design have been described previously (Zhou et al., 2016b). Briefly, the experiment 
was conducted as a randomized complete block design with 2×2 factorial arrangement of MET 
(Smartamine M, Adisseo NA) and CHOL (ReaShure, Balchem Inc) level (with or without). 
Cows were blocked according to expected calving date. Each block has 12 cows (except for the 
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last block). Cows within each block were balanced for parity, previous lactation milk yield, and 
BCS before close-up diet. A total of 81 cows were used in a randomized complete block design 
with 2 × 2 factorial arrangement of MET and CHOL level (with or without). Treatments were 
control (CON, n = 20), with no MET or CHOL supplementation; Smartamine (SMA, n = 21), 
CON plus MET at a rate of 0.08% of DM; Reashure (REA, n = 20), CON+CHOL at 60 g/d; or 
Smartamine and Reashure (MIX, n = 20), CON+MET+CHOL. Dosage of MET was based on 
Osorio et al. (2013), whereas CHOL was supplemented following the manufacturer’s 
recommendations. Per IACUC guidelines a subset of 48 multiparous cows (12 cows/treatment) 
were used for this portion of the study. All cows received the same far-off diet (1.40 Mcal/kg of 
DM, 10.2% RDP, and 4.1% RUP) from -50 to -22 d before expected calving, close-up diet (1.52 
Mcal/kg of DM, 9.1% RDP, and 5.4% RUP) from -21d to expected calving, and lactation diet 
from calving (1.71 Mcal/kg of DM, 9.7% RDP, and 7.5% RUP) through 30 DIM.  
The MET and CHOL supplements were both top-dressed from -21 ± 2 to 30 DIM once 
daily at the AM feeding using approximately 50 g of ground corn as carrier for all treatments. 
Supplementation of SMA (0.08% DM of TMR offered) was calculated daily for each cow. 
Smartamine M was supplied as small beads containing a minimum of 75% DL-Met, physically 
protected by a pH sensitive coating, which is considered to have a Met bioavailability of 80% 
(Graulet et al., 2005); therefore, per 10 g of SMA, the cows received 6 g of metabolizable MET. 
The REA supplement is reported to contain 28.8% choline chloride and is protected by 
microencapsulation. The product is considered to have CHOL bioavailability of 72% (Benoit et 
al., 2009); therefore, per 60 g of REA, the cows received 12.4 g of metabolizable choline 
chloride. To our knowledge, neither SMA nor REA have specific characteristics that may affect 
palatability of diets. 
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Animal Management 
Dry cows were housed in a ventilated enclosed barn during the dry period and fed 
individually once daily at 0630 h using an individual gate system (American Calan Inc., 
Northwood, NH). Cows had access to sand-bedded free stalls until 3 d before expected 
parturition, when they were moved to individual maternity pens bedded with straw until 
parturition. On average, cows remained in the maternity pen for 3.69 ± 3.61 d. After parturition, 
cows were housed in a tie-stall barn and were fed a common lactation diet once daily and milked 
3 daily at approximately 6:00, 14:00, and 22:00 through the end of the trial at 30 DIM. Feed 
offered was adjusted daily to achieve ~10% refusals.  
Blood, Milk, and Liver Sample Collection and Biomarker Analyses 
Blood was sampled for biomarker analysis from the coccygeal vein on -10 d relative to 
expected calving date and on 4, 8, 20, and 30 d relative to actual calving date before the morning 
feeding. An additional tube of plasma was collected on 1, 4, 14, and 28 d relative to calving for 
neutrophil and monocyte phagocytosis and oxidative burst analyses. Samples were collected into 
evacuated tubes (BD Vacutainer; BD and Co., Franklin Lakes, NJ) containing either clot 
activator or lithium heparin for serum and plasma, respectively. 
Consecutive morning, midday, and evening milk samples were collected every 
Wednesday and Saturday until 30 DIM (Zhou et al., 2016b). Weekly composite milk samples 
were prepared in proportion to milk yield at each milking and frozen at -20 C until analysis. 
Liver was sampled via puncture biopsy (Dann et al., 2005) from cows under local 
anesthesia at approximately 0800 h on d -10, 7, 20, and 30 d relative to parturition. Liver was 
frozen immediately in liquid nitrogen and stored until analysis. 
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Serum or plasma was analyzed for creatinine, urea, bilirubin, AST/AGT, GGT, 
cholesterol, PON, albumin, ceruloplasmin, haptoglobin, myeloperoxidase (MPO), ROM, and 
ferric reducing ability of plasma (FRAP) using kits purchased from Instrumentation Laboratory 
(Lexington, MA) following the procedures described previously (Jacometo et al., 2015) using the 
clinical auto-analyzer (ILAB 600, Instrumentation Laboratory). Bovine IL-1β (Cat. No. 
ESS0027; Thermo Scientific, Rockford, IL) and IL-6 (Cat. No. ESS0029; Thermo Scientific, 
Rockford, IL) plasma concentration were determined using commercial kits. Plasma 
phosphatidylcholine (Cat. No.10009926; Cayman chemical, Ann Arbor, MI) and free CHOL 
(Cat. No. K615-100; Biovision Inc., Milpitas, CA) concentration was quantified using 
commercial kits. The concentration of free CHOL in milk was determined in weekly composite 
samples (Cat. No. KA1662; Abnova, Taipei City, Taiwan). 
The simultaneous phagocytosis capacity and oxidative burst activity of peripheral 
monocytes and neutrophils was determined upon challenge with enteropathogenic bacteria 
(Escherichia coli 0118:H8) as described by Hulbert et al. (2011) with modifications. Briefly, 200 
µL of whole blood with 40 µL 100 µM dihydrorhodamine 123 (Sigma-Aldrich, St. Louis, MO), 
and 40 µL of propidium iodine labeled bacteria (109 cfu/mL) at 38.5°C for 10 min. After red 
blood cells were lysed with ice cold distilled deionized water, cells were resuspended in PBS 
solution. Subsequently, monocytes were marked with allophycocyanin-labeled anti-CD14 
antibody (Cat. No. 301808; Biolegend, San Diego, CA) while neutrophils were stained with 
CH138A primary anti-bovine granulocyte monoclonal antibody (Cat. No. BOV2067, 
Washington State University, WA) and phycoerythrin-labeled secondary antibody (Cat. No. 
1020-09S, Southern Biotech, AL). Lastly, the cells were re-suspended in PBS solution for flow 
cytometry analyses (LSR II; Becton Dickinson, San Jose, CA). Neutrophils and monocytes were 
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gated based on their side scatter properties in combination with the phycoerythrin and 
allophycocyanin signal, respectively. Compared with the negative controls, the neutrophils and 
monocytes from E. coli-stimulated samples with greater emissions of propidium iodine were 
considered positive for phagocytosis. Similarly, compared with negative controls the E. coli-
stimulated samples with greater emissions of rhodamine 123 were considered positive for 
oxidative burst. Data are reported as percentages of CD14/CH138A positive cells with 
phagocytosis and oxidative burst capability. The detailed protocol of the assay is described in the 
supplemental file. 
Liver tissue total and oxidized GSH were measured at -10, 7, 20, and 30 d relative to 
parturition using a commercial kit (Cat. No. NWH-GSH01; Northwest Life Science Specialties 
LLC, Vancouver, WA). Reduced GSH was calculated as reduced GSH = total GSH – oxidized 
GSH. 
Statistical analysis 
Data were analyzed using PROC MIXED of SAS (SAS Institute Inc., Cary, NC) 
according to the following model:  
𝑦𝑖𝑗𝑘𝑙𝑚 = 𝜇 + 𝑏𝑖 + 𝑀𝑗 + 𝐶𝑘 + 𝑀𝐶𝑗𝑘 + 𝑇𝑙 + 𝑇𝑀𝑗𝑙 + 𝑇𝐶𝑘𝑙 + 𝑇𝑀𝐶𝑗𝑘𝑙 + 𝐴𝑚:𝑖𝑗𝑘  +  𝜀𝑖𝑗𝑘𝑙𝑚 
where 𝑌𝑖𝑗𝑘𝑙𝑚 is the dependent, continuous variable; 𝜇 is the overall mean; 𝐵𝑖 is the random effect 
of the 𝑖th block; 𝑀𝑗 is the fixed effect of MET (𝑗 = with or without); 𝐶𝑘 is the fixed effect of 
CHOL (𝑘 = with or without);𝑇𝑙 is the fixed effect of time (day or week) of the experiment; 
𝐴𝑚:𝑖𝑗𝑘 is the random effect of the mth animal (cow) nested within block×MET×CHOL; 𝜀𝑖𝑗𝑘𝑙𝑚 is 
the residual error. The covariate of parity (2nd vs. 3rd lactation and above), was maintained in the 
model for all variables when significant (P < 0.05). Blood metabolites and liver composition 
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were analyzed at various time points that were not equally spaced. Therefore, an exponential 
correlation covariance structure SP (POW) was used for repeated measures. Least square means 
separation between time points was performed using the PDIFF statement. Statistical differences 
were declared significant at P ≤ 0.05 and tendencies at P ≤ 0.10.  
RESULTS 
Biomarkers of Muscle Mass Catabolism and N Metabolism 
Main effects of MET, CHOL, time, and interactions are presented in Table 3.1. As 
expected, creatinine concentrations in all treatments gradually decreased after calving (Suppl. 
Fig. 3.1). A lower creatinine concentration in plasma was detected due to the main effect of 
CHOL (P = 0.02, Suppl. Fig. 3.1B) but not MET (P > 0.05, Suppl. Fig. 3.1A). Unlike creatinine, 
overall concentration of urea in plasma did not differ in response to MET or CHOL, and was 
only affected by time (P < 0.01) because of an increase after calving.  
Biomarkers of Liver Function 
Main effects of MET, CHOL, time, and interactions for liver function biomarkers are 
summarized in Table 3.1. MET or CHOL supplementation had no effect on cholesterol 
concentrations or AST/AGT ratio (P > 0.10, Table 3.1). However, a tendency (P = 0.07) was 
detected in cows fed MET due to an overall greater increase in PON concentrations compared 
with cows without MET supplementation, especially after calving. Although concentration of 
PON in cows fed CHOL also increased (P < 0.01) over time after calving, CHOL did not result 
in greater PON compared with cows without CHOL supplementation (P = 0.87, Fig. 3.1D).  
Biomarkers of Choline Metabolism 
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The main effect of MET, CHOL, and their interactions for blood and milk CHOL 
metabolism biomarkers are reported in Table 3.1. The main effects of MET and CHOL and their 
interactions were not significant (P > 0.05) for any of the CHOL metabolism biomarkers (Table 
3.1).  Regardless of treatment, plasma PC and free CHOL concentrations decreased (P < 0.05) 
around calving and reached a nadir at 4 d after parturition. Unlike PC, plasma free CHOL 
concentration remained low after 4 d and did not return to prepartum levels by 30 DIM (Suppl. 
Fig. 3.3), which could be mainly attributed to the constant increase in milk CHOL regardless of 
treatment (P < 0.01, Suppl. Fig. 3.3).  
Biomarkers of Inflammation and APP 
Among the APP determined in the present study, MET-supplemented cows had greater 
albumin concentration (P = 0.04) compared with cows without MET. In fact, plasma albumin in 
MET cows increased (P < 0.05, Fig. 3.2C) after calving, whereas albumin concentration in cows 
without MET supplementation remained unchanged compared with the prepartum period (P > 
0.05). As expected, plasma haptoglobin concentration increased (P < 0.01, Fig. 3.2A and 3.2B) 
soon after calving. Although plasma haptoglobin reached a zenith on d 4 regardless of treatment, 
a tendency (P = 0.08) for lower haptoglobin was detected in response to MET supplementation 
but not CHOL (P = 0.94).  
For pro-inflammatory cytokines, there was no main effect or interactions for CHOL. In 
contrast, a main effect with greater IL-6 in MET-supplemented cows was detected (P = 0.03, 
Fig. 3.3G). IL-1β concentration did not change (P = 0.14, Fig. 3.2E) in MET-supplemented 
cows.   
Biomarkers of Oxidative Stress 
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Although no main effect or interactions of MET and CHOL were detected for plasma 
MPO, ROM, or FRAP, the concentration of ROM increased after calving and did not return to 
prepartum level by 30 DIM regardless of treatment (data not shown). In accordance with the 
temporal changes in ROM, liver total and reduced GSH concentrations decreased after calving 
and did not return to prepartum level by 30 DIM. However, unlike ROM, liver total (P = 0.01, 
Fig. 3.3A) and reduced GSH (P = 0.01, Fig. 3.3C) were greater in MET-supplemented cows, 
which was mainly attributed to greater concentration of total and reduced GSH on -10 d and 30 d 
relative to parturition.  
Whole Blood Phagocytosis and Oxidative Burst 
Upon challenge, a greater increase in neutrophil phagocytosis capability was detected in 
cows supplemented with MET (P = 0.01, Fig. 3.4A) but not CHOL (P = 0.81, Fig. 3.4B). In 
contrast, for blood monocytes, phagocytosis capability did not change in response to MET (P = 
0.28, Suppl. Fig. 3.2A) or CHOL (P = 0.15, Suppl. Fig. 3.2B).  
As expected, MET supplementation also resulted in greater blood neutrophil oxidative 
burst (P = 0.03, Fig. 3.4C). In contrast, blood neutrophil oxidative burst did not change in 
response to CHOL supplementation (P = 0.54, Fig. 3.4D). Although changes in monocyte 
oxidative burst capability were not detected for main effects of MET or CHOL (P > 0.10), a 
significant MET×CHOL interaction (P < 0.01, Table 3.2) were shown mainly due to increased 
monocyte oxidative burst capability in SMA and REA supplemented cows. No temporal changes 
were detected for blood monocyte (P = 0.77, Suppl. Fig 3.2) and neutrophil (P = 0.45, Fig. 3.4) 
oxidative burst activity. 
DISCUSSION 
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Biomarkers of Muscle Mass and N Metabolism 
During the periparturient period, the inability of cows to consume sufficient protein leads 
to negative MP balance and lower plasma AA, especially around parturition (Bell et al., 2000, 
Zhou et al., 2016da). Considering that the demands for fetal development in late-pregnancy and 
the onset of lactation greatly increase the tissue requirements for AA, muscle mobilization during 
this period can be expected. Creatinine is a suitable indicator of body muscle mass and the 
plasma level of creatinine has been used as an indirect marker for evaluation of body muscle 
catabolism both in the peripartal period (Kokkonen et al., 2005, Osorio et al., 2014b) and mid 
lactation (Pires et al., 2013). Thus, the lower plasma concentration of creatinine in CHOL cows 
indicated less body mass in these cows and therefore a higher degree of muscle mass 
mobilization. The mechanism for such response is unclear, however, it is likely to be associated 
with reduced insulin sensitivity in these cows because blood glucose:insulin ratio was lower in 
response to CHOL supplementation during the peripartal period (Zhou et al., 2016b).  
Biomarkers of Liver Function and Choline Metabolism 
It is well-known that cholesterol is required for synthesis of the hydrophobic core of 
lipoproteins synthesized in liver or the intestine (Cohen, 2008), and the concentrations of the 
various lipoprotein fractions are modified greatly around parturition (Bionaz et al., 2007). The 
suitability of cholesterol as a biomarker of liver function during the peripartal period is partly 
because the variation in concentrations depends to a large extent on the lipoprotein level in blood 
(Bionaz et al., 2007).  
As lipotropic agents, MET and CHOL fed to ruminants may help clear lipid from the 
liver through stimulating VLDL formation and export (Waterman and Schultz, 1972). Previous 
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reports from both non-ruminant and ruminant studies have illustrated the importance of adequate 
lipotropic agents in the prevention of hepatic lipidosis (Cooke et al., 2007, Corbin and Zeisel, 
2012).  
As precursor of PC, which is essential for VLDL synthesis (Auboiron et al., 1995), 
CHOL supplementation also was expected to improve liver function at least in part by enhancing 
lipoprotein export from liver. In contrast with this notion, results from previous reports either 
observed no differences (Guretzky et al., 2006) or detected a lower concentration (Zahra et al., 
2006) of blood cholesterol in response to CHOL supplementation. Thus, the lack of change in 
plasma cholesterol in CHOL-supplemented cows is not entirely surprising (Table 3.1). In 
agreement with these results, the fact that plasma PC concentration also was not affected by 
CHOL supplementation together with the higher liver TAG on 20 d in the CHOL-supplemented 
cows (Zhou et al., 2016b) indicated that the export of lipoproteins from liver was not increased.  
Paraoxonase is synthesized in the liver after which it is released into the blood stream 
where it associates with high-density lipoprotein (HDL) and protects it from oxidative damage 
(Turk et al., 2004). Therefore, PON concentration has been used as one biomarker of liver 
function in peripartal cows (Bionaz et al., 2007). The general trend of decrease in PON around 
parturition with a nadir at 4 d postpartum (Figure 3.1C) was in agreement with previous work 
(Bionaz et al., 2007, Grossi et al., 2013, Osorio et al., 2014b). It was proposed previously that 
excessive deposition of triacylglycerol (TAG) in liver and its negative impact on hepatocytes 
was partly responsible for the decrease in PON after calving (Turk et al., 2004). However, the 
fact that liver TAG increased after calving (Zhou et al., 2016b) regardless of treatment does not 
seem to support a negative effect on PON. What is apparent from the present study and data on 
HDL profiles after calving (Bernabucci et al., 2004) is that PON plays a role in lipoprotein 
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metabolism besides potentially alleviating negative effects of oxidative stress (Aviram and 
Rosenblat, 2004). In that context, it is noteworthy that the overall correlation between PON and 
cholesterol was positive regardless of treatment (240 observations total; r = 0.50, P < 0.01).  
Biomarkers of Inflammation and APP 
As a negative APP, hepatic production of albumin is commonly decreased during 
inflammation, and serves as a useful biomarker to evaluate chronic inflammation (Bertoni et al., 
2008, Ceciliani et al., 2012a). The substantially lower concentration of albumin in cows without 
MET supplementation was suggestive of a more profound inflammatory status during the 
peripartal period. In fact, albumin concentration in MET cows was already numerically greater at 
4 compared with -10 d relative to parturition and continued to increase at 8 d postpartum. It is 
also noteworthy that cows without MET maintained a constant concentration of albumin 
throughout the study. Considering the detoxification function of albumin upon binding to NEFA 
as well as bilirubin, the greater concentration of albumin in MET-supplemented cows may have 
helped alleviate inflammation (Weinberg, 2006, van der Vusse, 2009) during the peripartal 
period. It is also noteworthy that in spite of an apparently greater hepatic synthesis of albumin in 
MET-supplemented cows, they also had greater overall milk protein percentage and milk yield 
(Zhou et al., 2016b). It has been suggested that a reduction in the synthesis of albumin within the 
liver would spare AA for gluconeogenesis and production of hepatic proteins, especially positive 
APP (Ceciliani et al., 2012a).  
Production of the positive APP such as haptoglobin and ceruloplasmin are expected to 
increase during an inflammatory event. In transition cow research, haptoglobin has been of 
particular interest due to its quick increase during the acute-phase response and has, therefore, 
been used as diagnostic biomarker previously (Hirvonen et al., 1999, Sheldon et al., 2001). In 
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terms of the peripartal period, haptoglobin concentration in blood is commonly elevated as a 
consequence of common inflammatory conditions around calving (Bionaz et al., 2007), e.g. 
stimulation of parenchymal cells by fatty acid infiltration of the liver in transition cows 
(Eckersall, 2000, Katoh et al., 2002). The overall positive correlation (240 observations total; r = 
0.14, P = 0.03) between haptoglobin and IL-1β was indicative of a pro-inflammatory state during 
the transition period. In accordance with the greater albumin in MET cows, the tendency for 
lower concentration of blood haptoglobin confirmed the less pronounced inflammatory status in 
these cows.  
Although IL-6 is well-known for its pro-inflammatory properties, recent findings have 
revealed an anti-inflammatory property for this cytokine (Scheller et al., 2011). In fact, the anti-
inflammatory activities of IL-6 are mediated by gp130 and IL-6R (classic signaling) whereas 
pro-inflammatory activities are mediated by the IL-6/soluble IL-R complex (trans-signaling) 
(Scheller et al., 2011). Therefore, depending on a given stimulus inducing a given signaling 
pathway, IL-6 should be considered as both a pro- and an anti-inflammatory cytokine. Because 
IL-6 does not upregulate major inflammatory mediators and directly inhibits TNFα and IL-1 
expression and their signal transduction (Rehman et al., 1997), the current view is that IL-6 has 
primarily an anti-inflammatory effect (Pedersen et al., 2001, Lauder et al., 2013, Hunter and 
Jones, 2015). Therefore, considering the tendency for lower haptoglobin as well as the markedly 
greater albumin in MET-supplemented cows, it is reasonable to speculate that the higher IL-6 
concentration in MET-supplemented cows reflected a less pronounced inflammatory status. It 
also is possible that the greater IL-6 concentration in MET-supplemented cows served to 
maintain a certain degree of peripheral tissue inflammation (Vailati Riboni et al., 2016).  
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It is noteworthy that complex indices such as liver activity index (LAI) and liver 
functionality index (LFI) have been generated to evaluate changes in health and productivity 
caused by inflammatory events (Bertoni and Trevisi, 2013a). Previous studies have shown 
greater plasma AA concentrations, milk yield, DMI as well as better health and fertility in high 
vs. low LFI or LAI cows (Bertoni et al., 2008, Bertoni and Trevisi, 2013a, Zhou et al., 2016d). 
Considering such indices were generated from plasma inflammation biomarkers (e.g. albumin, 
ceruloplasmin), it is not surprising that high LFI cows have on average 2.4 g/L greater plasma 
albumin as well as 0.08 g/L lower haptoglobin compared with low LFI cows postpartum (Zhou 
et al., 2016d). Similar differences in haptoglobin (0.12 g/L) was observed in the present study 
between cows with or without MET supplementation. Considering greater albumin was also 
observed in MET cows, although less in magnitude of difference (1.2 g/L), the favorable changes 
in health and productivity observed previously (Zhou et al., 2016b) are likely due in part to 
alterations in inflammation status suggested by inflammation biomarkers such as albumin and 
haptoglobin.  
Biomarkers of Oxidative Stress 
Oxidative stress, defined as the serious imbalance between oxidants and antioxidants, as a 
consequence of augmented ROM production due to the increased demand for nutrients and 
energy can exert pleiotropic actions in peripartal dairy cows (Sordillo and Aitken, 2009). In fact, 
ROM has been widely-adopted as a biomarker for oxidative stress in both non-ruminants (Fukui 
et al., 2011, Jansen et al., 2013) and ruminants (Bernabucci et al., 2002, 2005, Trevisi et al., 
2009, Celi et al., 2010). Although ROM concentrations in the present study were not affected by 
MET or CHOL supplementation, the substantially higher ROM starting at 4 d postpartum was 
indicative of an increased risk for the onset of oxidative stress. In that context, it is noteworthy 
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that cows supplemented with MET had clear signs of a reduced inflammatory status. The reason 
for this is unclear but it could have been related with the differences between groups in the 
concentration of intracellular antioxidants such as GSH. In fact, GSH is the most abundant 
endogenous antioxidant due to its marked ability to scavenge ROM and free radicals. Hence, 
concentration of GSH has been used as biomarker in various oxidative stress-related diseases 
(Romeu et al., 2010, Vetrani et al., 2013, Saharan and Mandal, 2014). The overall decrease in 
total and reduced GSH concentration after parturition could have been due to the increased 
production of ROM and free radicals.  
Previous work with dairy cows has demonstrated a positive effect of MET 
supplementation on intrahepatic GSH concentration during the peripartal period (Osorio et al., 
2014b). Such effect may be directly associated with MET supplementation considering that MET 
can be incorporated upstream in the de novo synthesis pathway for GSH (Halsted, 2013). Studies 
with non-ruminants also have observed reduced concentrations of hepatic GSH in cases of 
protein-energy malnutrition, with GSH being replenished when sulfur AA or methyl donors are 
supplemented (Cho et al., 1984, Bauman et al., 1988, Goss et al., 1994). In fact, both in vitro 
(Hartman et al., 2002) and in vivo (Tabachnick and Tarver, 1955) studies using radioactive-
labelled methionine have demonstrated hepatic incorporation of [35S] into GSH. Therefore, the 
higher GSH concentration in MET-supplemented cows was in agreement with these reports and 
confirm a direct association between MET supplementation and hepatic GSH concentration.  
Although CHOL does not contain sulfur, MET can be generated in tissues like the liver 
from CHOL when homocysteine accepts a methyl group from CHOL through betaine (Wong 
and Thompson, 1972a, Li and Vance, 2008b). Therefore, an increase in hepatic GSH also was 
expected from CHOL supplementation but it did not occur (Fig. 3.3). Because cysteine is the 
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limiting substrate for GSH synthesis and receives sulfur from MET (Franklin et al., 2009), it is 
reasonable to speculate that lack of sulfur was a key limiting factor for GSH synthesis from 
CHOL supplementation. Alternatively, it also is possible that MET synthesis from CHOL was 
limited during the peripartal period, either as a result of insufficient expression or activity of key 
enzymes (e.g., betaine homocysteine methyltransferase), or because CHOL was predominantly 
used for synthesis of other compounds such as PC or acetylcholine. The specific mechanisms for 
this response merit further study. 
Blood Neutrophil and Monocyte Killing Capacity 
Compromised neutrophil and monocyte phagocytic capacity and oxidative burst activity 
in response to pathogen challenge are direct indicators of an impaired immune response, 
resulting in increased risk of bacterial infections to the host (Unanue, 1976). Data available to 
date seem to indicate that peripartal dairy cows have a dysfunctional immune system around 
calving (Loor et al., 2013b). Therefore, the greater neutrophil phagocytosis and oxidative burst in 
blood from MET-supplemented cows indicated a better immune system status. However, the 
precise mechanisms for the “priming” effect are unknown. Human studies have reported that 
greater Ca2+ flux into PMNL increases markedly the oxidative burst intensity and the initiation of 
the oxidative burst (Bei et al., 1998). It is noteworthy that IL-6 increases intracellular stores of 
Ca2+, which is the known basis for PMNL activation and degranulation of oxidative burst 
oxidase-containing granules (Sitaraman et al., 2001). Therefore, considering the sustained greater 
concentration of IL-6 together with the overall lower disease incidence in MET-supplemented 
cows (Zhou et al., 2016b), it can be speculated that MET supplementation enhanced 
phagocytosis and oxidative burst in PMNL at least in part by increasing intracellular Ca2+ stores 
which “sensitized” or “primed” these cells for pathogen challenge.  
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Although the intensity of the oxidative burst in monocytes stimulated by E. coli has been 
suggested to be lower than in PMNL (Yan et al., 2012), monocytes also have the ability to 
phagocytose and carry out oxidative burst (Keogh et al., 2011). The fact that CHOL 
supplementation lead to greater monocyte oxidative burst without elevating plasma Ca2+ suggest 
existence of alternative mechanisms. Other mechanisms related directly to metabolism of MET 
and CHOL or their metabolites by innate immune cells also could play a role. For instance, the 
respiratory burst in monocytes is accompanied by increased uptake of GSH (Seres et al., 2000). 
Studies with GSH reductase-deficient mice indicated they had an impaired oxidative burst and 
produced less ROM due to GSH depletion (Yan et al., 2012). In agreement with this, reduced 
neutrophil oxidative burst in humans was detected in response to chronic oxidative stress (Amer 
and Fibach, 2005). As precursors of GSH upstream in methionine cycle via transsulfuration 
pathway, it could be possible that supplemental MET and CHOL contributes to increased 
phagocytosis and oxidative burst upon challenge through increasing GSH availability to 
neutrophils and monocytes.  
CONCLUSIONS 
Overall, the changes observed in plasma PON, haptoglobin, and higher albumin revealed 
favorable alterations of liver function as well as inflammation status during lactation in MET-
supplemented cows. MET supplementation resulted in better immune response in terms of 
greater phagocytosis and oxidative burst capabilities upon pathogen challenge. Biomarker 
analyses in blood, milk, and liver indicated that the effect of feeding MET on postpartal cow 
performance is likely due, in part, to a better immunometabolic status. Although some previous 
studies have demonstrated beneficial effects of CHOL supplementation on performance, the 
contrasting responses detected between MET and CHOL supplementation on immunometabolic 
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biomarkers in this study could be due, for example, to the fact that CHOL supplementation was 
insufficient for cows during the transition period. The requirements of CHOL and methionine 
during the transition period, along with potential interactions at a mechanistic level, merit further 
study. 
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TABLES AND FIGURES 
Table 3.1. Effects of supplementing multiparous Holstein cows during the peripartal period with rumen-protected MET (Smartamine 
M, Adisseo NA) or rumen-protected CHOL (ReaShure; Balchem Inc.) on blood and liver biomarkers.  
 MET  CHOL  P-value 
Parameter1 Without With SEM
2 Without With SEM MET3 CHOL4 Parity Time M×T5 C×T6 
Muscle body mass             
  Creatinine (µmol/L) 90.80 92.29 1.58 94.17 88.92 1.58 0.51 0.02 - <0.01 0.33 0.63 
  Urea (mmol/L) 5.16 5.14 0.13 5.16 5.13 0.13 0.91 0.88 - 0.01 0.90 0.52 
Liver function markers             
  Bilirubin (µmol/L) 4.38 4.22 0.49 4.44 4.16 0.49 0.82 0.69 - <0.01 0.67 0.98 
  AST/AGT (U/L) 100.11 100.91 2.85 99.23 101.79 2.85 0.84 0.53 - <0.01 0.54 0.77 
  Cholesterol (mmol/L) 3.31 3.62 0.15 3.41 3.53 0.16 0.11 0.55 - <0.01 0.17 0.82 
  GGT (U/L) 24.58 24.03 1.44 23.41 25.20 1.44 0.79 0.38 - <0.01 0.75 0.41 
  Paraoxonase (U/ml) 84.54 93.09 3.20 88.45 89.18 3.20 0.07 0.87 - <0.01 0.17 0.74 
Inflammation and APP             
  Albumin (g/L) 35.53 36.55 0.35 36.21 35.87 0.35 0.04 0.50 - 0.37 0.15 0.68 
  Ceruloplasmin (µmol/L) 2.84 2.73 0.10 2.74 2.82 0.10 0.45 0.56 - <0.01 0.18 0.68 
  Haptoglobin (g/L) 0.47 0.35 0.05 0.41 0.41 0.05 0.08 0.94 - <0.01 0.90 0.70 
  Myeloperoxidase (U/L) 415.40 432.02 14.60 423.50 423.92 14.60 0.42 0.98 - <0.01 0.96 0.49 
  IL-1β (pg/mL) 7.12 4.98 1.04 6.25 5.86 1.02 0.14 0.79 <0.01 <0.01 0.88 0.37 
  IL-6 (pg/mL) 835.16 1086.51 62.2 963.74 957.93 82.08 0.03 0.96 - <0.01 0.87 0.55 
Oxidative stress             
  ROM (mg H2O2/100mL) 13.71 13.42 0.39 13.46 13.66 0.39 0.60 0.72 - <0.01 0.44 0.84 
  FRAP (µmol/L) 135.84 135.54 3.66 135.02 136.36 3.66 0.95 0.80 - 0.03 0.28 0.31 
  Glutathione (µmol/g protein) 23.32 62.83 10.65 46.55 39.61 10.65 0.01 0.64 - <0.01 0.22 0.58 
  Reduced glutathione (µmol/g protein) 22.81 62.10 10.59 45.87 39.04 10.59 0.01 0.65 - <0.01 0.21 0.58 
Choline metabolism             
  Plasma choline (mg/dL) 38.04 37.38 1.16 37.25 38.16 1.16 0.69 0.58 - <0.01 0.69 0.82 
  Plasma phosphatidylcholine (mg/mL) 111.56 115.96 3.77 112.79 114.73 3.77 0.41 0.72 <0.01 <0.01 0.60 0.65 
  Milk choline (mg/L) 26.78 27.13 1.70 27.43 26.47 1.70 0.88 0.68 - <0.01 0.41 0.21 
1MET × CHOL interaction was not significant for any of the parameters and included in the supplemental file. 
2Greatest SEM. 
3Overall effect of MET supplementation. 
4Overall effect of CHOL supplementation. 
5Interaction of MET × time. 
6Interaction of CHOL × time.
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Table 3.2. Effects of supplementing multiparous Holstein cows during the peripartal period with rumen-protected MET (Smartamine 
M, Adisseo NA) or rumen-protected CHOL (ReaShure; Balchem Inc.) on blood neutrophil and monocyte phagocytosis and oxidative 
burst.  
 MET CHOL  Treatments2   P-value  
Parameter (%) Without With Without With SEM1 CON SMA REA MIX SEM MET3 CHOL4 M×C5 Time M×T6 C×T7 M×C×T 
Phago_mono8 43.03 45.28 42.62 45.69 1.59 40.01 45.22 46.04 45.34 2.30 0.28 0.15 0.16 0.08 0.27 0.48 0.03 
Phago_neutro 54.69 61.05 57.60 58.14 1.67 53.14 62.08 56.23 60.05 2.43 0.01 0.81 0.25 0.10 0.73 0.80 0.42 
Oxi_mono 21.35 23.99 21.96 23.38 1.37 17.72b 26.19a 24.99a 21.78ab 2.00 0.15 0.43 <0.01 0.77 0.12 0.90 0.41 
Oxi_neutro 49.28 57.27 52.20 54.34 2.63 45.05 59.36 53.51 55.18 3.83 0.03 0.54 0.07 0.45 0.57 0.19 0.76 
a,b Mean values with different superscripts differ (P < 0.05). 
1Greatest SEM. 
2CON = control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure (60 g/d); MIX = SMA+REA. 
3Overall effect of MET supplementation. 
4Overall effect of CHOL supplementation. 
5Interaction of MET × CHOL. 
6Interaction of MET × time. 
7Interaction of CHOL × time. 
8Phago_mono = monocytes phagocytosis; Phago_neutro = neutrophils phagocytosis; Oxi_mono = monocytes oxidative burst; 
Oxi_neutro = neutrophils oxidative burst
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Fig. 3.2 
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Fig. 3.3 
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Fig. 3.4 
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Figure 3.1. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or rumen-protected 
choline (CHOL; ReaShure, Balchem Inc.) on blood cholesterol (A, B) and paraoxonase (C, D). 
Values are means, with standard errors represented by vertical bars. Only MET and CHOL main 
effect were shown since MET × CHOL interaction was not significant for any of the parameters. 
 
Figure 3.2. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or rumen-protected 
choline (CHOL, ReaShure, Balchem Inc.) on blood haptoglobin (A, B), albumin (C, D), IL-1β 
(E, F), and IL-6 (G, H). Values are means, with standard errors represented by vertical bars. Only 
MET and CHOL main effect were shown since MET × CHOL interaction was not significant for 
any of the parameters. 
 
Figure 3.3. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or rumen-protected 
choline (CHOL, ReaShure, Balchem Inc.) on liver total glutathione (A, B) and reduced 
glutathione (C, D). Values are means, with standard errors represented by vertical bars. Only 
MET and CHOL main effect were shown since MET × CHOL interaction was not significant for 
any of the parameters. 
 
Figure 3.4. Effects of supplementing multiparous Holstein cows during the peripartal period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or rumen-protected 
choline (CHOL; ReaShure, Balchem Inc.) on phagocytosis (A, B) and oxidative burst (C, D, E, 
F). CON = control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure (60 g/d); MIX = 
SMA+REA; Values are means, with standard errors represented by vertical bars.  
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CHAPTER 4 
HEPATIC ACTIVITY AND TRANSCRIPTION OF BETAINE-HOMOCYSTEINE 
METHYLTRANSFERASE, METHIONINE SYNTHASE, AND CYSTATHIONINE 
SYNTHASE IN PERIPARTURIENT DAIRY COWS ARE ALTERED TO DIFFERENT 
EXTENTS BY SUPPLY OF METHIONINE AND CHOLINE 
-The Journal of Nutrition, 2017, 147(1):11-19. 
INTRODUCTION 
The increased nutrient demands around parturition to sustain fetal growth and lactation 
coupled with the gradual decrease in voluntary feed intake as parturition approaches induce a 
tremendous metabolic stress on dairy cows. Consequently, the ensuing negative nutrient balance 
after parturition contributes greatly to disease incidence and sub-optimal production efficiency 
(Goff and Horst, 1997, Zhou et al., 2016e), e.g. decreased supply of amino acids (AA)6 reaching 
the small intestine due to reduced feed intake. The fact that supplementation of rumen-protected 
methionine (MET) was able to stimulate milk production despite a marked negative 
metabolizable protein balance (i.e. microbial and rumen-undegradable protein reaching the small 
intestine) underscored the critical role of post-ruminal essential AA availability (Zhou et al., 
Osorio et al., 2013). Although the AA profile of microbial protein is excellent for supporting 
lactation (Schwab et al.), AA profiles of rumen undegradable protein may be less than ideal 
(Brake et al., 2013). Hence, improvements in health and production performance might be 
achieved either by dietary supplementation of rumen-protected MET (Overton et al., 1996, 
Piepenbrink et al., 1996, Osorio et al., 2013, Osorio et al., 2014c) or other essential nutrients that 
could potentially spare methionine (e.g. rumen-protected choline (CHOL)) (Piepenbrink and 
Overton, 2003, Pinotti et al., 2003, Elek et al., 2008, Zom et al., 2011). 
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Due to extensive microbial degradation in the rumen, post-ruminal availability of MET 
and CHOL is limited (Sharma and Erdman, 1989, Girard and Matte, 2005). Inadequate MET and 
CHOL may be an important challenge for “transition” dairy cows, i.e. cows navigating the last 3-
4 weeks prior to parturition through the first 3-4 weeks postpartum. Increasing the delivery of 
MET to the liver via supplementation is particularly important for transition cows not only 
because of its key role in milk protein synthesis but also for intra-hepatic VLDL synthesis, 
production of intracellular antioxidants (glutathione and taurine) (Atmaca, 2004), and provision 
of methyl groups to various compounds including choline (Finkelstein, 1990). Similarly, CHOL 
containing three methyl groups also acts an important source for the biosynthesis of methylated 
compounds. More importantly, CHOL is a precursor for VLDL assembly in the liver and, thus, 
has a crucial role in the export of triacylglycerol that helps prevent fatty liver (Pinotti et al., 
2002). Therefore, both MET and CHOL are indispensable for the dairy cow’s adaptation to 
metabolic challenges during the transition period.  
It is noteworthy that the metabolism of MET and CHOL is closely interrelated (Figure 
4.1). For instance, MET can be regenerated when homocysteine receives a methyl group from 
CHOL through betaine (Wong and Thompson, 1972b, Li and Vance, 2008a). Alternatively, 
MET donates its methyl group for de novo synthesis of CHOL through S-adenosyl methionine 
(SAM) (Vance et al., 1997). Because deficiency in one or more of the methyl group donors 
results in compensatory changes in the other (Wells and Remy, 1961, Selhub et al., 1991), 
supplementing MET can potentially spare a portion of choline needed and vice versa. However, 
as the quantity of MET utilized to generate the required CHOL (and vice versa) during the 
transition period has yet to be determined, it has been debatable whether supplementing MET or 
CHOL alone will be enough to satisfy the transition cow’s requirement for both. More 
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importantly, the proportion of flux from MET to CHOL and vice versa utilized to alleviate 
metabolic stress in transition dairy cow remains unknown.  
Considering that MET and CHOL are interrelated in vivo, it can be expected that 
enhancing post-ruminal delivery of MET and CHOL via rumen-protected supplementation 
should be able to exert similar beneficial effect on cow performance, health, and stress. 
However, results from our recent study indicated better production performance, immune 
function, and inflammatory status in cows supplemented with MET than CHOL (Zhou et al., 
Zhou et al.). Because the limitations in substrate availability as well as enzyme abundance and 
activity could potentially influence the rate by which methyl groups from CHOL can be used for 
the re-methylation of homocysteine to regenerate CHOL and vice versa, the hypothesis for the 
present study was that the increase, if any, in flux from CHOL to MET during the transition 
period through rumen-protected CHOL supplementation is diminished due to limitations in 
substrate availability and enzymes involved in MET and CHOL metabolism. Therefore, specific 
objectives were to characterize mRNA expression and activity of key enzymes involved in MET 
and CHOL metabolism to identify potential mechanism for the production and immuno-
metabolic status differences observed previously (Zhou et al., Zhou et al.).  
METHODS 
Experimental design and treatments 
All procedures for this study (protocol no. 13023) were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Illinois. Details of the 
experimental design have been reported previously (Zhou et al.). Briefly, the experiment was 
conducted as a randomized complete block 2×2 factorial design. The main effects include MET 
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(cows either supplemented with (+MET) or without (-MET) Smartamine M, Adisseo NA) and 
CHOL (cows either supplemented with (+CHOL) or without (-CHOL) ReaShure, Balchem Inc). 
Cows within each block were balanced for parity, previous lactation milk yield, and BCS before 
MET and/or CHOL treatments were applied starting at -21 d before expected parturition. A total 
of 40 cows were used. Treatments (MET×CHOL) were control (CON, n = 10), with no MET or 
CHOL supplementation; Smartamine (SMA, n = 10), with only MET supplementation at a rate 
of 0.08% of DM; Reashure (REA, n = 10), with only CHOL supplementation at 60 g·d-1; or 
Smartamine and Reashure (MIX, n = 10), with both MET and CHOL supplementation. Dosage 
of MET was based on a previous study (Osorio et al., 2013), whereas CHOL was supplemented 
following the manufacturer’s recommendations. All cows received the same controlled-energy 
diet (far-off diet, 1.40 Mcal·kg-1 of dry matter) from -50 to -22 d before expected parturition, a 
moderate-energy diet (close-up diet, 1.52 Mcal·kg-1 of dry matter) from -21 d to expected 
parturition, and a higher-energy diet (lactation diet, 1.71 Mcal·kg-1 of dry matter) from 
parturition through 30 DIM. Diet composition is reported in Supplemental Table 4.1. The MET 
and CHOL were supplemented to each cow by placing on top of the mixed diet from -21 ± 2 to 
30 DIM once daily at the AM feeding using approximately 50 g of ground corn as carrier for all 
treatments. Supplementation of SMA (0.08% DM of TMR offered) was calculated daily for each 
cow. Smartamine M was supplied as small beads containing a minimum of 75% DL-Met, 
physically protected by a pH sensitive coating, which is considered to have a Met bioavailability 
of 80% (Zhou et al.); therefore, per 10 g of SMA, the cows received 6 g of MET available for 
absorption. The REA supplement is reported to contain 28.8% choline chloride and is protected 
by microencapsulation. The product is considered to have CHOL bioavailability of 72% (Zhou et 
al.); therefore, per 60 g of REA, the cows received 12.4 g of choline chloride available for 
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absorption. To our knowledge, neither SMA nor REA have specific characteristics that may 
affect palatability of diets. 
Animal management  
Dry cows were housed in a ventilated enclosed barn during the dry period and fed 
individually once daily at 0630 h using an individual gate system (American Calan Inc., 
Northwood, NH). After parturition, cows were housed in a tie-stall barn and were fed a common 
lactation diet once daily. Feed offered was adjusted daily to achieve ~10% refusals. Nutrient 
composition and evaluation of the diets are reported in Supplemental Table 4.2. 
Liver biopsy 
Liver was sampled via puncture biopsy (Zhou et al.) from cows under local anesthesia at 
approximately 0800 h on d -10, 7, 20, and 30 d relative to parturition before they had access to 
feed and MET and/or CHOL supplements (fed after the morning milking). Liver was frozen 
immediately in liquid nitrogen and stored until analysis. 
Hepatic MET and CHOL metabolites 
Liver tissue L-methionine was measured at -10, 7, 20, and 30 d relative to parturition 
using a commercial kit (Cat. No. TRF-1-1-1006B; Mediomics, LLC; St. Louis, MO); hepatic 
phosphatidylcholine (PC) concentrations were determined using a commercial kit (Cat. No. 
K576-100; BioVision Inc., Mountain View, CA). 
qRT-PCR 
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The qPCR was performed as describe previously (Osorio et al., 2014a). qPCR 
performance, relative mRNA abundance, and primer information are included in the Online 
Supporting Material.  
Enzyme activity assays 
BHMT activity was measured as described by Garrow (Garrow, 1996). MTR activity was 
determined based on Banerjee et al. (Banerjee et al., 1997). CBS activity was determined based 
on Lambert et al. (Lambert et al., 2002), except that the separation of 14C-cystathionine from 14C-
Ser was done according to Taoka et al. (Taoka et al., 1998). Enzyme assay details are included in 
Online Supporting Material.  
Statistical analysis  
Data were analyzed using PROC MIXED of SAS (SAS Institute Inc., Cary, NC) 
appropriate for a 2 × 2 factorial design as described previously (Zhou et al.). Briefly, the 
statistical model included the main effects of MET, CHOL, day, and their interactions. The 
covariate of parity (2nd vs. 3rd lactation and above), was maintained in the model for all variables 
when significant (P < 0.05). Gene expression and enzyme activities were analyzed at various 
time points that were not equally spaced. Therefore, the first order ante-dependence covariance 
structure ANTE (1) were used for repeated measures. Least square means separation between 
time points was performed using the PDIFF statement. Data were reported as means ± pooled 
SEM. Statistical differences were declared significant at P ≤ 0.05 and tendencies at P ≤ 0.10.  
RESULTS 
CHOL oxidation to Betaine 
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Main effects of MET and CHOL for genes involved in CHOL oxidation are presented in 
Table 4.1. Means for MET×CHOL are presented in Supplemental Table 4.1. Regardless of 
treatments, BADH and CHDH expression was lower (P = 0.01) postpartum (7 d) compared with 
prepartum. CHOL supplementation lead to an overall tendency towards greater (P = 0.10) 
expression of CHDH, which agreed with the greater (C×T P = 0.01) transcript expression at -10 
d (Supplemental Figure 4.1D). Overall BADH expression also was greater (P = 0.01) in CHOL 
cows compared with cows without CHOL supplementation. However, both the prepartum (-10 d, 
C×T P < 0.01) and postpartum (7 d, C×T P < 0.01) BADH expression was greater in response to 
CHOL supplementation (Supplemental Figure 4.1B). Similarly, an overall greater expression of 
BADH (P = 0.03) and a tendency for greater CHDH (P = 0.07) were detected in MET-
supplemented cows.  
Re-methylation of homocysteine to MET 
Main effects of MET, CHOL, time, and interactions for mRNA abundance of enzymes 
involved homocysteine re-methylation to MET are presented in Table 4.1 and Table 4.2, 
respectively. Means for MET×CHOL are presented in Supplemental Table 4.1. Compared with 
the prepartum level, overall BHMT expression and enzyme activity increased 0.7- and 1.7-fold 
respectively soon after parturition (7d, Fig. 4.2). Although there was a decrease in MTR 
expression (P < 0.01) after parturition the MTR activity was greater (P < 0.01) postpartum 
regardless of treatment. There was no overall effect (P > 0.10) of MET or CHOL for BHMT 
expression or BHMT enzyme activity. However, a tendency (P = 0.06) for greater DMGDH 
expression was detected in response to CHOL supplementation. Although no MET or CHOL 
main effects were detected (P > 0.10) for MTR, MTR activity was greater (P = 0.04) overall in 
response to MET supplementation. In contrast, CHOL supplementation led to lower overall (P = 
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0.05) MTR activity, mainly due to lower MTR activity at -10 d (C×T P = 0.04, Figure 4.3D). 
Although SAHH expression was lower (P < 0.01) postpartum regardless of treatment, MET cows 
had overall greater SAHH as a result of greater expression at -10 d and 7 d (M×T P < 0.05). 
Despite the fact that SAHH expression was also greater in CHOL cows on -10 d and 7 d (C×T P 
< 0.05), there was no significant (P = 0.32) CHOL main effect (Supplemental Figure 4.3F).  
PC synthesis from MET 
Main effects of MET, CHOL, time, and interactions for genes involved in PC synthesis 
from MET are presented in Table 4.1. Means for MET×CHOL are presented in Supplemental 
Table 4.1. Expression of MAT1A and MAT2A both increased (P < 0.05) after parturition. Unlike 
the abrupt increase in MAT1A and MAT2A expression soon after parturition, PEMT expression 
increased gradually, reaching statistical significance (P < 0.05) at 20 d postpartum. Although 
MAT2A expression was not affected (P > 0.10) by MET or CHOL, greater (P = 0.02) expression 
and a tendency (P = 0.06) for greater MAT1A expression were observed in MET and CHOL 
cows, respectively. However, greater (P = 0.05) expression of PEMT was only observed in 
response to MET supplementation mainly due to greater (M×T P < 0.05) expression of PEMT at 
-10 d and 7 d in MET cows (Supplemental Figure 4.3C).  
CDP-choline pathway 
Main effects of MET, CHOL, time, and interactions for genes in CDP-choline pathway 
are presented in Table 4.1. Means for MET×CHOL are presented in Supplemental Table 4.1. 
Overall expression of CHKA was greater (P = 0.05) in CHOL compared with MET cows. 
Although CHKB expression increased soon after parturition (P = 0.03), there was no overall 
effect of MET and CHOL (P > 0.10). Both PCYT1A and PCYT1B expression was greater (P < 
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0.05) in response to CHOL supplementation, mainly due to greater PCYT1A and PCYT1B 
expression on -10 d and 7 d in CHOL cows (C×T P < 0.05, Supplemental Figure 4.2D & 
Figure 4.2F). Similarly, a tendency (P = 0.06) for greater PCYT1B expression and greater 
PCYT1A expression were observed in MET cows. However, CEPT1 expression (P > 0.10) was 
not affected by MET or CHOL supplementation. 
Transsulfuration pathway 
Main effects of MET, CHOL, time, and interactions for genes involved in the 
transsulfuration pathway are presented in Table 4.1. Means for MET×CHOL are presented in 
Supplemental Table 4.1. Both CBS expression and enzyme activity increased (P < 0.05) after 
parturition (Figure 4.4). However, CBS enzyme activity was not affected (P > 0.10) by MET or 
CHOL supplementation (Table 4.2). At the transcription level, CBS expression was overall 
greater in MET but not CHOL cows. Despite the increase (P < 0.05) in CDO1, CSAD, and GSR 
expression soon after parturition, there was no overall effect (P > 0.10) of MET or CHOL. 
Similarly, although a decrease in expression of GCLC and GSS was detected postpartum, their 
expression was not affected (P > 0.10) by MET or CHOL supplementation.  
Hepatic L-MET and PC concentrations 
Main effects of MET, CHOL, time, and interactions for L-MET and PC are presented in Table 
4.2. Means for MET×CHOL are presented in Supplemental Table 4.2. As expected, there was a 
decrease (P < 0.01) in hepatic L-MET concentration postpartum, with a nadir at 7 d. Regardless, 
MET and CHOL supplementation did not affect (P > 0.10) hepatic L-MET concentration. In 
contrast, hepatic PC concentration was constant (P = 0.91) during the transition period. There 
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was an overall lower hepatic PC concentration in response to MET (P = 0.05) and CHOL (P = 
0.03). 
DISCUSSION 
Synthesis of PC from MET and CHOL 
As a nutritionally-important methyl donor, rumen-protected MET supplementation 
during the transition period is expected to promote overall production and health of dairy cows 
not only by serving as a limiting AA for milk synthesis, but also by promoting synthesis of 
important methylated compounds including PC. Apart from the well-characterized demand for 
PC during VLDL synthesis as a way to prevent fatty liver, transition dairy cows also are 
expected to have high PC requirements owing to the high PC output in milk (Pinotti et al., 2002). 
In fact, levels of CHOL secretion into milk are maintained even at the cost of depleting liver 
reserves of choline and its metabolites (Pinotti et al., 2002). Therefore, to achieve the normal 
high rates of milk synthesis after parturition without compromising liver VLDL export, MET 
supplementation is expected to increase synthesis of PC in transition dairy cows.  
In vivo synthesis of PC from MET can be achieved by sequential methylation of PE, 
acquiring three methyl groups from the global methyl donor SAM. MAT1A mediates the first 
step in the hepatic synthesis of PC from MET to generate SAM (Kotb et al., 1997, Martinov et 
al., 2010a). Subsequently, PEMT controls the committed step in PC synthesis by sequentially 
transferring three methyl groups from SAM to PE (Zeisel, 1992). The observed increase in 
MAT1A and PEMT in MET cows support the thesis that MET supplementation led to greater 
availability of SAM to synthesize PC.  
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In vivo synthesis of PC from CHOL can be achieved through the CDP-choline pathway. 
Choline kinases catalyzes the first committed step in PC synthesis from CHOL (Fagone and 
Jackowski, 2013). Due to the micromolar affinity of choline kinase for CHOL, the CHOL taken 
up into cells is readily trapped as phosphocholine (Fagone and Jackowski, 2013). Therefore, the 
greater CHKA in CHOL cows indicates an enriched phosphocholine pool during the transition 
period. Various studies have detected intracellular accumulation of phosphocholine due to 
limited intracellular amount of PCYT enzymes which convert phosphocholine to CDP-choline 
(Clement and Kent, 1999, Sugimoto et al., 2008). In fact, it is the rate-limiting step in PC 
synthesis and thereby determines the biosynthetic flux from CHOL to PC (Weinhold and 
Feldman, 1992). The observed increase in PCYT1A and PCYT1B in CHOL cows support the 
thesis that CHOL supplementation led to greater availability of CDP-choline to synthesize PC. 
However, expression of CEPT1, which catalyzes the final step of PC synthesis via the Kennedy 
pathway, was not affected by CHOL supplementation. Whether such lack of change at the 
transcription level leads to accumulation of CDP-choline in hepatocytes of CHOL cows during 
the transition period remains unknown, but it is possible that biosynthetic flux from CHOL to PC 
can increase without elevating CEPT1 mRNA expression. For instance, greater CEPT1 activity 
could also lead to increased flux from CHOL to PC.  
Synthesis of MET from CHOL 
The essential role of MET as liming AA for milk protein synthesis during the transition 
period has been well-established (Schwab et al., 1992, Pisulewski et al., 1996). The fact that 
circulating MET concentration decreased markedly through parturition and was not restored to 
prepartum levels until 28 d postpartum underscored the deficiency of MET during this period 
(Zhou et al., 2016e). Previous studies have observed benefits of supplementing MET in terms of 
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production, health, and stress status (Overton et al., 1996, Osorio et al., 2013, Osorio et al., 
2014c). Considering that MET can be re-synthesized in vivo from CHOL-derived methyl groups 
and homocysteine, similar benefits during the transition period would be expected if a 
comparable amount of MET is generated from CHOL.  
CHOL could promote MET synthesis in vivo by supplying methyl groups for 
homocysteine re-methylation. Although re-methylation of homocysteine to MET can be 
achieved either through BHMT in the MET cycle or MTR from the THF cycle, betaine and 
methyl-THF, rather than CHOL, are the direct methyl donors for these reactions. To generate 
methyl groups for MET synthesis, there is an irreversible two-step oxidation process from CHOL 
to betaine. CHDH mediates the first and committed step in which choline is first oxidized to 
betaine aldehyde. Subsequently, betaine aldehyde is further oxidized to betaine by BADH (Slow 
and Garrow, 2006).  
The tendency towards greater CHDH expression together with greater BADH expression 
in CHOL cows indicated there might have been greater betaine generated in response to CHOL 
supplementation. However, no differences in mRNA expression or activity of BHMT were 
observed in CHOL cows. Therefore, despite potentially increased betaine synthesis, MET 
synthesis might not have been increased in CHOL cows. In fact, the lack of change in MTR 
expression and the lower MTR activity further support the idea of decreased MET synthesis in 
those cows. It is noteworthy that CHOL relies on homocysteine to provide the sulfur required for 
MET synthesis. Because of its key role in the re-methylation and transsulfuration pathway, 
homocysteine could have been a limiting substrate for MET synthesis, especially considering the 
greater demands after parturition for intracellular sulfur-containing antioxidants such as GSH 
and taurine.  
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Despite the fact that transcription and activity data both indicate that CHOL 
supplementation did not seem to have promoted MET synthesis during the transition period, it is 
noteworthy that flux from CHOL to MET could still have increased in CHOL cows. For 
instance, it is possible that hepatic MTR and BHMT activity are not limiting but rather the 
availability of homocysteine and their respective methyl donors control the flux of homocysteine 
to MET. Hence, no change in expression or activity in these enzymes would be necessary to 
support the increase in flux. In fact, the greater MAT1A in CHOL cows could be an indication of 
increased MET synthesis from CHOL because high hepatic MET concentrations lead to 
increased hepatic SAM concentrations (Corrales et al., 2002). Similarly, the tendency towards 
greater DMGDH in CHOL cows also could be due to increased dimethylglycine generated from 
MET synthesis. Therefore, a better question would be whether the increase in flux from CHOL 
to MET, if any, could provide sufficient MET to achieve comparable benefits as MET 
supplementation. Previous results in these same cows revealed that CHOL supplementation 
failed to induce equal benefits as MET in terms of production performance, health, and stress 
status (Zhou et al., Zhou et al.). Therefore, it seems that the difference observed between MET 
and CHOL supplementation during the transition period was due, at least in part, to insufficient 
synthesis of MET from CHOL.  
Synthesis of taurine and glutathione through the transsulfuration pathway 
Around parturition, production of reactive oxygen metabolites (ROM) is greatly 
enhanced (Reynolds et al., 2003). Although cellular antioxidants are capable of neutralizing 
ROM, depletion of such antioxidants leads to ROM accumulation giving rise to substantial tissue 
damage and inflammation (Sordillo and Aitken, 2009). Both glutathione (GSH) and taurine are 
potent sulfur-containing antioxidants that can be synthesized through the transsulfuration 
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pathway. The committed step in the transsulfuration pathway is regulated by CBS, which 
converts homocysteine to cystathionine. Regardless of treatment, the overall increase in both 
CBS expression and enzyme activity soon after calving was highly suggestive of a greater flux in 
the transsulfuration pathway postpartum. 
Biomarker analysis from these same cows revealed a reduced oxidative stress status in 
MET cows (Zhou et al.). In agreement with this, the greater SAHH in MET cows indicated the 
potential for greater homocysteine being generated in response to MET supplementation. 
Additionally, the lower MTR activity as well as greater CBS expression observed in MET cows 
suggested an increase in flux through the transsulfuration pathway instead of re-methylation to 
MET during the transition period. Although expression of genes in the steps leading to GSH and 
taurine synthesis was not affected by MET or CHOL, the fact that hepatic total and reduced GSH 
concentrations (Zhou et al.) as well as plasma taurine (Zhou et al., 2016f) were greater in 
response to MET supplementation indicated that synthesis of GSH and taurine might not be 
regulated at the transcriptional level.  
Limitations 
The dynamic nature of one carbon metabolism makes it less ideal to use substrate 
concentrations as indicators of flux. For instance, one would expect hepatic MET concentration 
to increase in response to MET supplementation. However, increased flux via the transulfuration 
pathway for antioxidant synthesis could be responsible for the similar hepatic MET 
concentrations observed among treatments. Similarly, the decrease in hepatic PC concentration 
in response to MET or CHOL supplementation could have been the result of increased liver 
export.  
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Although enzyme activity can serve as an indicator of alterations in flux in response to 
treatments, it is important to note that changes in flux may exist without inducing transcriptional 
or activity level alterations (Fell, 2005). In fact, as a saturated concentration of substrate was 
used during incubations in the present study, it is reasonable to assume that changes in enzyme 
activities observed reflect corresponding changes in enzyme protein content plus potential post-
translational changes such as phosphorylation, acetylation, and methylation. Therefore, a stable 
isotope flux study is required to confirm our speculation about alterations in flux.  
CONCLUSIONS  
Our findings provide evidence that MET and CHOL supplementation during the 
periparturient period can affect hepatic mRNA expression and enzyme activity of enzymes 
controlling flux between MET and CHOL as well as the transsulfuration pathway. The greater 
expression of PEMT and CBS indicates an increase in synthesis of PC and antioxidants in MET 
cows. In CHOL cows, the lack of change in BHMT and MTR, together with unchanged BHMT 
and a lower MS enzyme activity indicated that CHOL supplementation did not increase MET 
synthesis as postulated. In summary, the overall better health and production performance 
reported previously in MET cows was due, at least in part, to increased PC and antioxidant 
synthesis. Failure to generate a comparable amount of MET from CHOL could be one of the 
reasons preventing CHOL-fed cows from achieving comparable performance and health benefits 
during the transition period. 
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TABLES AND FIGURES 
Table 4.1. Hepatic gene expression in periparturient cows that were unsupplemented or were supplemented with rumen-protected 
MET and CHOL for 51 d1. 
 MET CHOL  Day P-value2 
Gene -MET +MET -CHOL +CHOL SEM -10 7 20 30 MET3 CHOL4 Time M×T5 C×T6 
MET and CHOL metabolism 
 BADH 0.95 1.05 0.93 1.07 0.05 1.06a 0.98b 0.97b 0.99b 0.03 0.01 0.01 0.17 0.05 
 BHMT 0.91 0.95 0.90 0.96 0.07 0.76c 1.31a 0.91b 0.82bc 0.58 0.41 <0.01 0.73 0.80 
 BHMT2 0.20 0.39 0.28 0.27 0.13 0.19b 0.32a 0.31a 0.31a 0.12 0.89 <0.01 0.02 0.12 
 CHDH* 0.32 0.43 0.33 0.42 0.06 0.45a 0.33b 0.37a 0.36a 0.07 0.10 <0.01 0.03 0.01 
 DMGDH 1.06 0.95 0.90 1.11 0.11 0.73c 1.24a 1.09b 1.03bc 0.33 0.06 <0.01 0.36 0.01 
 MAT1A* 0.27 0.38 0.28 0.37 0.05 0.26b 0.32a 0.33a 0.37a 0.02 0.06 <0.01 <0.01 <0.01 
 MAT2A 1.09 1.01 1.07 1.03 0.06 0.84c 1.19a 1.20a 1.01b 0.24 0.44 <0.01 0.49 0.34 
 MTHFR 1.15 1.09 1.13 1.11 0.05 1.26a 1.16b 1.04c 1.04c 0.29 0.79 <0.01 0.50 0.12 
 MTR 1.00 0.98 1.02 0.96 0.05 1.09a 0.94b 0.99b 0.95b 0.61 0.23 <0.01 0.05 0.54 
 PEMT* 0.58 0.74 0.65 0.66 0.08 0.59c 0.63bc 0.68ab 0.73a 0.05 0.90 <0.01 0.01 0.18 
 SAHH* 0.79 0.93 0.84 0.88 0.05 0.92a 0.80c 0.84bc 0.88ab 0.01 0.32 <0.01 <0.01 <0.01 
 SARDH 1.16 1.19 1.11 1.24 0.12 1.20ab 0.96c 1.21ab 1.35a 0.80 0.26 <0.01 0.48 0.46 
Transsulfuration pathway 
 CBS* 1.02 1.16 1.06 1.12 0.07 0.97b 1.10a 1.18a 1.11a 0.04 0.36 <0.01 0.07 0.11 
 CDO1 1.04 1.06 1.03 1.07 0.07 1.02 1.09 1.06 1.03 0.86 0.53 0.23 0.06 0.48 
 CSAD 0.91 0.81 0.95 0.78 0.11 0.64b 0.95a 0.97a 0.92a 0.34 0.12 0.01 0.40 0.87 
 GCLC 0.97 0.94 0.96 0.95 0.06 1.27a 0.82b 0.87b 0.91b 0.51 0.97 <0.01 0.85 0.34 
 GSR 0.99 0.99 1.00 0.98 0.04 0.88c 1.09a 1.01b 0.97b 0.99 0.62 <0.01 0.95 0.38 
 GSS* 1.12 1.15 1.11 1.16 0.04 1.19a 1.07b 1.15a 1.14a 0.40 0.22 <0.01 0.19 0.32 
CDP-choline pathway 
 CEPT1 1.11 1.01 1.14 0.99 0.11 1.23 1.05 1.08 0.91 0.41 0.17 0.23 0.37 0.36 
 CHKA* 1.13 1.15 1.06 1.22 0.08 1.13 1.14 1.15 1.14 0.88 0.05 0.98 0.48 0.29 
 CHKB 0.96 1.02 0.97 1.00 0.03 0.94b 1.02a 1.02a 0.98ab 0.11 0.31 0.03 0.69 0.13 
 PCYT1A 1.17 1.33 1.19 1.30 0.04 1.18c 1.31a 1.28ab 1.22bc <0.01 0.01 0.02 0.36 <0.01 
 PCYT1B* 1.24 1.39 1.24 1.39 0.08 1.35 1.27 1.32 1.33 0.06 0.05 0.56 0.66 0.01 
*Significant (P < 0.05) parity effect observed.1Values are means and pooled SEM, n = 20/group. Labeled means in a row without a 
common letter differ, P < 0.05. 2MET × CHOL interaction was included in Supplemental Table 4.1. 3Overall effect of MET 
supplementation. 4Overall effect of CHOL supplementation. 5Interaction of MET × time. 6Interaction of CHOL × time. BADH, Betaine  
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Table 4.1 (Continued) 
aldehyde dehydrogenase; BHMT, Betaine homocysteine methyltransferase; BHMT2, Betaine homocysteine methyltransferase 2; CBS, 
Cystathionine β-synthase; CDO, cysteine dioxygenase; CEPT1, Choline/ethanolamine phosphotransferase 1; CHDH, Choline 
dehydrogenase; CHKA, choline kinase A; CHKB, choline kinase B; CSAD, Cysteine sulfinic acid decarboxylase; DMGDH, 
Dimethylglycine dehydrogenase; GCLC, Glutamate-cysteine ligase, catalytic subunit; GSR, Glutathione reductase; GSS, Glutathione 
synthase; MAT1A, Methionine adenosyltransferase 1A; MAT2A, Methionine adenosyltransferase 2A; MTHFR, 
Methylenetetrahydrofolate reductase; MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase; PCYT1A, Phosphate 
cytidylyltransferase 1A; PCYT1B, Phosphate cytidylyltransferase 1B; PEMT, Phosphatidylethanolamine methyltransferase; SAHH, S-
adenosylhomocysteine hydrolase; SARDH, Sarcosine dehydrogenase.
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Table 4.2. Hepatic one carbon metabolism enzyme activity and metabolites in periparturient cows that were unsupplemented or were 
supplemented with rumen-protected MET and CHOL for 51 d1.   
 MET CHOL  Day P-value2 
Parameters -MET +MET -CHOL +CHOL SEM -10 7 20 30 MET3 CHOL4 Time M×T4 C×T5 
Enzyme activity (nmol product·h-1·mg protein-1) 
  BHMT 22.8 22.8 22.7 23.0 1.9 12.3d 29.1a 27.0ab 23.0c 0.99 0.88 <0.01 <0.01 0.99 
  MTR 29.7 23.4 29.6 23.5 2.9 22.8b 28.7a 26.5ab 28.2a 0.04 0.05 0.04 0.68 0.04 
  CBS 48.1 49.6 49.4 48.3 2.5 39.1d 47.1a 59.3c 50.1ab 0.57 0.67 <0.01 0.79 0.84 
Metabolites               
  L-methionine (µmol·g-1 protein) 52.4 53.4 55.3 50.5 4.0 60.0a 47.9b 52.0b 51.8b 0.81 0.25 < 0.01 0.87 0.27 
  Phosphatidylcholine*(mg·g-1) 10.2 9.4 10.2 9.3 0.4 9.8 9.8 9.6 9.8 0.05 0.03 0.91 0.76 0.88 
*Significant (P < 0.05) parity effect observed. 1Values are means and pooled SEM, n = 20/group. Labeled means in a row without a 
common letter differ, P < 0.05. 2MET × CHOL interaction is included in Supplemental Table 4.2. 3Main effect of MET 
supplementation (SMA+MIX compared with CON+REA). 4Main effect of CHOL supplementation (REA+MIX compared with 
CON+SMA). 5Interaction of MET × time. 6Interaction of CHOL × time. BHMT, Betaine homocysteine methyltransferase; CBS, 
Cystathionine β-synthase; MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase. Labeled means in a row without a 
common letter differ, P < 0.05. 
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Fig. 4.1 
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Fig. 4.2 
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Fig. 4.3 
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Fig. 4.4 
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Figure 4.1. Methionine and choline metabolism. BAD, Betaine aldehyde; BADH, Betaine 
aldehyde dehydrogenase; BHMT, Betaine homocysteine methyltransferase; CBS, Cystathionine 
β-synthase; CDO, cysteine dioxygenase; CEPT1, Choline/ethanolamine phosphotransferase 1; 
CHDH, Choline dehydrogenase; CHK, choline kinase; CHOL, Choline; CSAD, Cysteine sulfinic 
acid decarboxylase; DMG, Dimethylglycine; DMGDH, Dimethylglycine dehydrogenase; GCLC, 
Glutamate-cysteine ligase, catalytic subunit; GSH, Glutathione; GSR, Glutathione reductase; 
GSS, Glutathione synthase; GSSG, Glutathione disulfide; Hcy, Homocysteine; MAT, 
Methionine adenosyltransferase; MET, Methionine; MTHFR, Methylenetetrahydrofolate 
reductase; MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase; PC, 
Phosphatidylcholine; PCYT, Phosphate cytidylyltransferase; PE, Phosphatidylethanolamine; 
PEMT, Phosphatidylethanolamine methyltransferase; SAH, S-adenosylhomocysteine; SAHH, S-
adenosylhomocysteine hydrolase; SAM, S-adenosylmethionine; SAR, Sarcosine; SARDH, 
Sarcosine dehydrogenase; THF, Tetrahydrofolate. 
Figure 4.2. Hepatic mRNA expression and activity of BHMT in periparturient cows that were 
unsupplemented or were supplemented with rumen-protected MET or CHOL for 51 d. Hepatic 
BHMT mRNA expression (A, B) and hepatic BHMT activity (C, D) are presented as means and 
SEM (n = 20). BHMT, Betaine homocysteine methyltransferase.  
Figure 4.3. Hepatic mRNA expression and activity of MTR in periparturient cows that were 
unsupplemented or were supplemented with rumen-protected MET or CHOL for 51 d. Hepatic 
MTR mRNA expression (A, B) and hepatic MTR activity (C, D) are presented as means and 
SEM, (n = 20). *Means at that time differ, P < 0.05. MTR, 5-methyltetrahydrofolate-
homocysteine methyltransferase.  
Figure 4.4. Hepatic mRNA expression and activity of CBS in periparturient cows that were 
unsupplemented or were supplemented with rumen-protected MET or CHOL for 51 d. Hepatic 
CBS mRNA expression (A, B), and hepatic CBS activity (C, D) are presented as means and 
SEMs, (n = 20). CBS, Cystathionine β-synthase.
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Supplemental Table 4.1. Ingredient composition of diets fed to periparturient cows that were 
unsupplemented or were supplemented with Smartamine M or Reashure. 
  Close-up Lactation 
Ingredients (g·kg-1 DM) Far off CON1 SMA REA MIX CON SMA REA MIX 
Alfalfa silage 120 83.4 83.4 83.4 83.4 50.7 50.7 50.7 50.7 
Alfalfa hay - 42.9 42.9 42.9 42.9 29.8 29.8 29.8 29.8 
Corn silage 330 
36 
364 364 364 364 334 334 334 334 
Wheat straw 360 156 156 156 156 29.8 29.8 29.8 29.8 
Cottonseed - - - - - 35.8 35.8 35.8 35.8 
Wet brewers grains - 42.9 42.9 42.9 42.9 90.9 90.9 90.9 90.9 
Ground shelled corn 40 129 129 129 129 239 239 239 239 
Soy hulls 20 42.9 42.9 42.9 42.9 41.8 41.8 41.8 41.8 
Soybean meal, 48% CP 79.2 25.7 25.7 25.7 25.7 23.9 23.9 23.9 23.9 
Expeller soybean meal2 - 25.7 25.7 25.7 25.7 59.7 59.7 59.7 59.7 
Soychlor3 1.5 38.6 38.6 38.6 38.6 - - - - 
Blood meal, 85% CP 10 - - - - - - - - 
ProVAAl AADvantage4 - 8.6 8.6 8.6 8.6 15.0 15.0 15.0 15.0 
Urea 4.5 3.0 3.0 3.0 3.0 1.8 1.8 1.8 1.8 
Rumen-inert fat5 - - - - - 10.2 10.2 10.2 10.2 
Limestone 13 12.9 12.9 12.9 12.9 13.1 13.1 13.1 13.1 
Salt 3.2 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Dicalcium phosphate 1.2 1.8 1.8 1.8 1.8 3.0 3.0 3.0 3.0 
Magnesium oxide 2.1 0.8 0.8 0.8 0.8 1.2 1.2 1.2 1.2 
Magnesium sulfate 9.1 9.9 9.9 9.9 9.9 - - - - 
Sodium bicarbonate - - - - - 7.9 7.9 7.9 7.9 
Potassium carbonate - - - - - 3.0 3.0 3.0 3.0 
Calcium sulfate - - - - - 1.2 1.2 1.2 1.2 
Mineral vitamin mix6 2 1.7 1.7 1.7 1.7 1.8 1.8 1.8 1.8 
Vitamin A7 0.15 - - - - - 
- 
- 
 
- 
- 
- 
 
- 
- 
- 
 
- 
- 
- 
 
Vitamin D8 0.25 - - - - - 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
 
Vitamin E9 3.8 3.9 3.9 3.9 3.9 
Biotin - 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 
SMA10 - - 0.8 - 0.8 0.8 0.8 
REA11 - - - 60 g 60 g - - 60 g 60 g 
1CON = control; SMA = rumen-protected methionine; REA = rumen-protected choline; MIX = 
SMA+REA; MET = SMA+MIX; CHOL = REA+MIX. 2SoyPLUS (West Central Soy, Ralston, 
IA). 3By West Central Soy. 4Blood meal-based product (Perdue AgriBusiness,Salisbury, MD). 
5Energy Booster 100 (Milk Specialties Global, Eden Prairie, MN). 6Composition in g·kg-1 DM: 
Mg 50, S 100, K 75, Fe 20, Zn 30, Mn 30, Cu 5, I 0.25, Co 0.04, Se 0.15. Vitamins in mg·kg-1 
DM: retinol 660, cholecaciferol 16.5, alpha-tocopherol 5159. 7Contained 9 g·kg-1 retinol. 
8Contained 0.125 g·kg-1 cholecaciferol. 9Contained 29.5g·kg-1 alpha-tocopherol. 10Rumen 
protected methionine (Smartamine, Adisseo NA) was supplemented on top of the diet given to  
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Supplemental Table 4.1 (Continued) 
the animals.11Rumen protected choline (Reashure, Balchem Inc. NH) was supplemented to cows 
at 60 g·cow-1d -1 to each cow. 
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Supplemental Table 4.2. Nutrient composition and evaluation (NRC, 2001) of prepartal and 
postpartal diets fed to periparturient cows that were unsupplemented or were supplemented with 
Smartamine M or Reashure for 51 d 1. 
  Close-up2 Lactation 
Chemical component Far off CON SMA REA MIX CON SMA REA MIX 
CP (g·kg-1 DM) 143 146 146 144 144 172 173 172 173 
RDP (g·kg-1 DM) 102 93 91 91 91 97 96 96 96 
RUP (g·kg-1 DM) 41 53 55 53 54 75 77 75 76 
NDF (g·kg-1 DM) 511 420 419 417 417 340 339 337 336 
ADF (g·kg-1 DM) 354 283 283 282 281 214 214 213 212 
NFC (g·kg-1 DM) 250 322 322 322 322 378 378 377 377 
EE (g·kg-1 DM) 22 33 33 36 36 57 57 59 59 
RDP supplied (g·d-1) 1248 1228 1377 1218 1340 1773 1911 1780 1918 
RDP balance (g·d-1) 138 -50 -70 -61 -75 -130 -142 -138 -145 
RUP supplied (g·d-1) 507 677 826 703 793 1369 1518 1390 1519 
RUP required (g·d-1) 92 177 163 214 172 1922 2283 1813 2174 
RUP balance (g·d-1) 415 500 663 489 621 -553 -765 -423 -655 
MP supplied (g·d-1) 1058 1251 1494 1297 1446 2222 2435 2245 2440 
MP balance (g·d-1) 324 406 541 397 506 -473 -656 -362 -562 
Lys:Met 3.89:1 3.62:1 2.81:1 3.62:1 2.78:1 3.54:1 2.70:1 3.53:1 2.70:1 
Lys (% of MP) 7.24 6.74 6.62 6.73 6.65 6.30 6.24 6.29 6.24 
MP-Lys (g) 77 104 122 108 119 170 184 171 184 
Met (% of MP) 1.86 1.86 2.36 1.86 2.39 1.78 2.31 1.78 2.31 
MP-Met (g) 20 29 42 30 41 48 65 49 65 
1The NRC (2001) evaluation of diets was based on final averaged pre and postpartum DMI, 
production data, and feed analysis. 2CON = control; SMA = rumen protected methionine 
(Smartamine, Adissseo NA; 0.08% of DMI); REA = rumen protected choline (Reashure, 
Balchem Inc.NH; 60 g·d-1); MIX = SMA+REA. ADF, acid detergent fiber; CP, crude protein; 
EE, ether extract; Lys, lysine; Met, methionine; NDF, neutral detergent fiber; NFC, Non-fat 
carbohydrate; MP, metabolizable protein; RDP, rumen degradable protein; RUP, rumen 
undegradable protein. 
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Supplemental Table 4.3. Hepatic gene expression in transition cows that were unsupplemented 
or were supplemented with Smartamine M and ReaShure for 51 d.   
 Treatments  P-value 
Parameter CON1 SMA REA MIX SEM M×C2 M×C×T3 
MET and CHOL metabolism      
 BADH 0.90 0.97 1.00 1.14 0.05 0.58 0.40 
 BHMT 0.85 0.95 0.97 0.95 0.07 0.47 0.02 
 BHMT2 0.13b 0.63a 0.30b 0.24b 0.16 0.04 0.48 
 CHDH* 0.24b 0.45a 0.43a 0.41a 0.06 0.03 <0.01 
 DMGDH 0.93 0.88 1.20 1.03 0.11 0.66 0.28 
 MAT1A* 0.19b 0.40a 0.38a 0.36a 0.05 0.01 0.17 
 MAT2A 1.13 1.01 1.04 1.01 0.06 0.45 0.16 
 MTHFR 1.13 1.13 1.17 1.06 0.05 0.31 0.79 
 MTR 1.00 1.04 1.00 0.93 0.05 0.24 0.51 
 PEMT* 0.50b 0.84a 0.66b 0.65b 0.08 0.04 0.36 
 SAHH* 0.71b 0.98a 0.89a 0.88a 0.05 <0.01 0.02 
 SARDH 1.09 1.12 1.22 1.25 0.12 0.98 0.33 
Transsulfuration pathway      
 CBS* 0.98 1.15 1.06 1.18 0.07 0.69 0.52 
 CDO1 1.03 1.02 1.06 1.09 0.07 0.75 0.13 
 CSAD 1.04 0.87 0.80 0.75 0.11 0.40 0.30 
 GCLC 0.94 0.97 1.01 0.91 0.06 0.85 0.68 
 GSR 1.01 0.98 0.96 0.99 0.04 0.95 0.13 
 GSS* 1.09 1.14 1.16 1.16 0.04 0.19 0.85 
CDP-choline pathway      
 CEPT1 1.14 1.14 1.07 0.90 0.11 0.42 0.47 
 CHKA* 1.07 1.06 1.20 1.24 0.08 0.75 0.70 
 CHKB 0.93 1.02 1.00 1.01 0.03 0.27 0.01 
 PCYT1A 1.01c 1.40a 1.35ab 1.26b 0.04 <0.01 0.21 
 PCYT1B* 1.01c 1.52a 1.52a 1.27b 0.08 <0.01 0.69 
*Significant (P < 0.05) parity effect observed. 1CON = control; SMA = Smartamine M (0.08% of 
DMI); REA = ReaShure (60 g·d-1); MIX = SMA+REA. Values are means and pooled SEM, n = 
10/group. 2Interaction of MET × CHOL. 3Interaction of MET × CHOL × Time. Labeled means 
in a row without a common letter differ, P < 0.05. BADH, Betaine aldehyde dehydrogenase; 
BHMT, Betaine homocysteine methyltransferase; BHMT2, Betaine homocysteine 
methyltransferase 2; CBS, Cystathionine β-synthase; CDO, cysteine dioxygenase; CEPT1, 
Choline/ethanolamine phosphotransferase 1; CHDH, Choline dehydrogenase; CHKA, choline 
kinase A; CHKB, choline kinase B; CSAD, Cysteine sulfinic acid decarboxylase; DMGDH, 
Dimethylglycine dehydrogenase; GCLC, Glutamate-cysteine ligase, catalytic subunit; GSR, 
Glutathione reductase; GSS, Glutathione synthase; MAT1A, Methionine adenosyltransferase 1A; 
MAT2A, Methionine adenosyltransferase 2A; MTHFR, Methylenetetrahydrofolate reductase; 
MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase; PCYT1A, Phosphate 
cytidylyltransferase 1A; PCYT1B, Phosphate cytidylyltransferase 1B; PEMT,  
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Phosphatidylethanolamine methyltransferase; SAHH, S-adenosylhomocysteine hydrolase; 
SARDH, Sarcosine dehydrogenase. 
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Supplemental Table 4.4. Hepatic one carbon metabolism enzyme activity and metabolites in 
transition cows unsupplemented or supplemented with Smartamine M and ReaShure.  
 Treatments  P-value 
Parameter CON1 SMA REA MIX SEM M×C2 M×C×T
3 
Enzyme activity (nmol product·h-1·mg protein-1)  
  BHMT 21.3 24.0 24.4 21.6 1.9 0.16 0.73 
  MTR 32.3 26.8 27.1 19.9 2.9 0.76 0.63 
  CBS 50.1 48.8 46.2 50.4 2.5 0.29 0.12 
Metabolites        
  L-methionine (µmol·g-1 protein) 57.3 53.3 47.5 53.6 4.0 0.22 0.01 
  Phosphatidylcholine* (mg·g-1) 10.5 9.9 9.9 8.8 0.4 0.50 0.72 
1CON = control; SMA = Smartamine M (0.08% of DMI); REA = ReaShure (60 g/d); MIX = 
SMA+REA. Values are means and pooled SEM, n = 10/group. 2Interaction of MET × CHOL. 
3Interaction of MET × CHOL × Time. BHMT, Betaine homocysteine methyltransferase; CBS, 
Cystathionine β-synthase; MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase. 
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Supplemental Table 4.5. qPCR performance and relative mRNA abundance of genes measured 
in periparturient cow liver. 
1The median is calculated considering all time points and all cows. 2The median of ∆Ct is 
calculated as [Ct gene – geometrical mean of Ct internal controls] for each time point and each 
cow. 3Slope of the standard curve. 4R2 stands for the coefficient of determination of the standard 
curve. 5Efficiency is calculated as [10(-1 / Slope)]. 6Relative mRNA abundance = 1/ Efficiency Median 
∆Ct. BADH, Betaine aldehyde dehydrogenase; BHMT, Betaine homocysteine methyltransferase; 
BHMT2, Betaine homocysteine methyltransferase 2; CBS, Cystathionine β-synthase; CDO, 
cysteine dioxygenase; CEPT1, Choline/ethanolamine phosphotransferase 1; CHDH, Choline 
dehydrogenase; CHKA, choline kinase A; CHKB, choline kinase B; CSAD, Cysteine sulfinic acid 
decarboxylase; DMGDH, Dimethylglycine dehydrogenase; GCLC, Glutamate-cysteine ligase, 
catalytic subunit; GSR, Glutathione reductase; GSS, Glutathione synthase; MAT1A, Methionine 
adenosyltransferase 1A; MAT2A, Methionine adenosyltransferase 2A; MTHFR, 
Methylenetetrahydrofolate reductase; MTR, 5-methyltetrahydrofolate-homocysteine 
methyltransferase; PCYT1A, Phosphate cytidylyltransferase 1A; PCYT1B, Phosphate  
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 Relative mRNA abundance6 
MET and CHOL metabolism     
 BADH 22.957 2.175 -3.217 0.994 2.046 0.211 
 BHMT 20.303 -0.458 -3.359 0.995 1.985 1.369 
 BHMT2 25.524 4.835 -3.086 0.997 2.109 0.027 
 CBS 22.747 2.003 -3.400 0.999 1.968 0.258 
 CHDH 26.784 6.014 -3.223 0.972 2.043 0.014 
 DMGDH 17.986 -2.721 -3.315 0.981 2.003 6.620 
 MAT1A 21.475 0.681 -3.445 0.993 1.951 0.634 
 MAT2A 20.796 0.107 -3.132 0.994 2.086 0.924 
 MTHFR 22.488 1.74 -3.714 0.998 1.859 0.340 
 MTR 24.848 4.103 -3.171 0.997 2.067 0.051 
 PEMT 23.121 2.370 -3.286 0.969 2.015 0.190 
 SAHH 19.239 -1.524 -3.264 0.984 2.025 2.930 
 SARDH 19.942 -0.755 -3.096 0.997 2.104 1.753 
Transsulfuration pathway      
 CDO1 19.811 -0.961 -3.280 0.987 2.018 1.963 
 CSAD 23.701 3.011 -3.354 0.988 1.987 0.127 
 GCLC 22.902 2.132 -3.320 0.985 2.001 0.228 
 GSR 23.603 2.871 -3.454 0.976 1.948 0.148 
 GSS 24.964 4.236 -3.323 0.996 1.999 0.053 
CDP-choline pathway      
 CEPT1 20.860 0.151 -3.387 0.996 1.974 0.902 
 CHKA 20.953 0.232 -3.369 0.983 1.981 0.853 
 CHKB 20.364 -0.368 -3.457 0.993 1.947 1.278 
 PCYT1A 22.044 1.361 -3.844 0.991 1.820 0.443 
 PCYT1B 25.856 5.122 -2.821 0.996 2.262 0.015 
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Table 4.5 (Continued) 
cytidylyltransferase 1B; PEMT, Phosphatidylethanolamine methyltransferase; SAHH, S-
adenosylhomocysteine hydrolase; SARDH, Sarcosine dehydrogenase. 
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Supplemental Table 4.6. Accession number, gene symbol, and forward and reverse primer 
sequences of genes analyzed in periparturient cow liver. 
BADH, Betaine aldehyde dehydrogenase; BHMT, Betaine homocysteine methyltransferase; 
BHMT2, Betaine homocysteine methyltransferase 2; CBS, Cystathionine β-synthase; CDO, 
cysteine dioxygenase; CEPT1, Choline/ethanolamine phosphotransferase 1; CHDH, Choline 
dehydrogenase; CHKA, choline kinase A; CHKB, choline kinase B; CSAD, Cysteine sulfinic acid 
decarboxylase; DMGDH, Dimethylglycine dehydrogenase; GCLC, Glutamate-cysteine ligase, 
catalytic subunit; GSR, Glutathione reductase; GSS, Glutathione synthase; MAT1A, Methionine 
adenosyltransferase 1A; MAT2A, Methionine adenosyltransferase 2A; MTHFR, 
Methylenetetrahydrofolate reductase; MTR, 5-methyltetrahydrofolate-homocysteine 
methyltransferase; PCYT1A, Phosphate cytidylyltransferase 1A; PCYT1B, Phosphate 
cytidylyltransferase 1B; PEMT, Phosphatidylethanolamine methyltransferase; SAHH, S-
adenosylhomocysteine hydrolase; SARDH, Sarcosine dehydrogenase. 
 
Gene Accession number Forward primer Reverse Primer 
 BADH NM_001045969 CAC CTA CTG TCC TGC TAA ATC ACC AAT CTG TCT CAC TAC 
 BHMT NM_001011679 GCT CTC CTC GTC CAT CCT CAT CCG TTC TAG GAT GCC CTT CTT 
 BHMT2 XM_003586514 ACA CCA CAA GGA TGA AGT CAG GCT CTC CAG ATT CTT 
 CBS NM_001102000 GCC ACC ACC TCT GTC AAA TTC GGA CAG AAA GCA GAG TGG TAA CTG 
 CDO1 NM_001034465 ATG GAA GCC TAT GAG AGC AA TTC AGA AAG CAG TGG GAG TC 
 CEPT1 NM_001193130 GGA TAG CCC TGG TCT TCT CTT ATT CGC CTC AAT ATG TTC AGA TTC TT 
 CHDH NM_001205564 AAA CTG AGA AGT GCC AAC ACG GAA GTC TTT AAT GTC A 
 CHKA XM_002699402 GCA CAG GTT CCT CAG TTA GCC ATC CAG CAG TAA GAT 
 CHKB XM_010805827 CCA AGA GGA GCA GAG GAA GTA GAA CTG GAA CCG AGA CT 
 CSAD XM_005206242 GCC TCA ACA CCA GCC AGT A GTT TCT TCA GCA CCT CCT CCT 
 DMGDH NM_001205545 TCT GGT ATG ATG GCA AGG T GCT TCT GGT TGG TTC TGT T 
 GCLC NM_001083674 TAC GAT CAG TTG GCT ACC CCG AGT TCT ATC ATC TAC AGA 
 GSR NM_001114190 GAG AAC GCT GGC ATT GAG AGC AGG CAG TCA ACA TCT 
 GSS NM_001015630 CGA GTG ATC CAA TGC ATT TCA ATG TCC CAC GTG CTT GTT CAT 
 MAT1A NM_001046497 CAA GGG CTT TGA CTT TAA CCG ACA TCC TCT TCA TTT 
 MAT2A NM_001101131 AAT CTA TCA TCT ACA GCC AAG TG CCA ACG AGC AGC ATA AGC 
 MTHFR NM_001011685 TTC AAC TAT GCT ACG GAC TT CCT TCA GGT GCT TCA GAT 
 MTR NM_001030298 ATA CCG CCA ATG CCA AGG ATG AGA CAC GCT GAT GAC AA 
 PCYT1A XM_005201384 GAT GAG GTG GTG AGG AAT CGA GTG ATG ATG TCT GAT G 
 PCYT1B NM_001193051 ACT GTC GCT ATG TGG ATG AA GCC TTC TGT TCT CTG TGT TG 
 PEMT NM_182989 AAT TAC CAA GAG CAG AGG CAG ATT CCA GAT TCC AGA T 
 SAHH NM_001034315 CAA TGT CAA TGA CTC TGT CTT GAT GCC ATC TAT GAG 
 SARDH NM_001193041 GAG GAG GTG TCA GAT GAG GCA GAC TGT GGA CTT AAT C 
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Supplemental Figure 4.1. Hepatic mRNA expression of BADH (A, B), CHDH (C, D), and 
DMGDH (E, F) in cows that were unsupplemented or were supplemented with rumen-protected 
MET or CHOL for 51 d. Values are means + SEMs (n = 20). *Means at that time differ, P < 
0.05. BADH, Betaine aldehyde dehydrogenase; CHDH, Choline dehydrogenase; DMGDH, 
Dimethylglycine dehydrogenase. 
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Supplemental Figure 4.2. Hepatic mRNA expression of CHKA (A, B), PCYT1A (C, D), and 
PCYT1B (E, F) in periparturient cows that were unsupplemented or were supplemented with 
rumen-protected MET or CHOL for 51 d. Values are means + SEMs (n = 20). *Means at that 
time differ, P < 0.05. CHKA, choline kinase A; PCYT1A, Phosphate cytidylyltransferase 1A; 
PCYT1B, Phosphate cytidylyltransferase 1B. 
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Supplemental Figure 4.3. Hepatic mRNA expression of MAT1A (A, B), PEMT (C, D), and 
SAHH (E, F) in periparturient cows that were unsupplemented or were supplemented with 
rumen-protected MET or CHOL for 51 d. Values are means + SEMs (n = 20). *Means at that 
time differ, P < 0.05.  MAT1A, Methionine adenosyltransferase 1A; PEMT, 
Phosphatidylethanolamine methyltransferase; SAHH, S-adenosylhomocysteine hydrolase. 
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Supplemental Methods 
RNA extraction and mRNA expression calculation 
Liver RNA extraction. Liver tissue (30-50 mg) was homogenized in a TissueLyser II (Qiagen 
GmbH) for 2 x 2 min bursts at 30 Htz. Total RNA and DNA were extracted using a Qiagen 
AllPrep DNA/RNA mini kit (Qiagen GmbH) as per manufacturer’s instructions and RNA was 
treated with DNase (Ambion DNA-free kit; Ambion Inc., Austin, TX). 
mRNA expression calculation. Efficiency of qPCR amplification for each gene was calculated 
using the standard curve method [Efficiency = 10(–1/slope)]. The mRNA expression of the 
measured genes was calculated as previously reported (Bionaz and Loor, 2008), using the 
inverse of PCR efficiency raised to ΔCt (gene abundance = 1/EΔCt, where ΔCt = Ct of tested 
gene - geometric mean Ct of 3 internal control genes). Overall mRNA expression for each gene 
among all samples of the same liver tissue was calculated using the median ΔCt, and overall 
percentage of each mRNA as a proportion of measured genes was computed from the equation: 
100 × mRNA abundance of each individual gene / sum of mRNA abundance of all the genes 
investigated. 
qRT-PCR. The qPCR was performed in a MicroAmp Optical 384-Well Reaction Plate (Cat. 
#4309849, Applied Biosystems). Within each well, 4 μL of diluted cDNA combined with 6 μL 
of mixture composed of 5 μL 1×SYBR Green master mix (Cat. #4309155, Applied Biosystems), 
0.4 μL each of 10 μM forward and reverse primers, and 0.2 μL of DNase/RNase-free water were 
added. Three replicates and a 6-point standard curve plus the nontemplate control (NTC) were 
run for each sample to test the relative expression level. qPCR was conducted in ABI Prism 7900 
HT SDS instrument (Applied Biosystems) following the conditions below: 2 min at 50°C, 10 
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min at 95°C, 40 cycles of 15 s at 95°C (denaturation), and 1 min at 60°C (annealing + 
extension). The presence of a single PCR product was verified by the dissociation protocol using 
incremental temperatures to 95°C for 15 s, then 65 °C for 15 s. The threshold cycle (Ct) data 
were analyzed and transformed using the standard curve with the 7900 HT Sequence Detection 
System Software (version 2.2.1, Applied Biosystems, CA). Data were then normalized with the 
geometric mean of the three Internal Control Genes (ICG).  
Enzyme activity assays  
BHMT activity assay. All liver samples were weighed and homogenized immediately in 4 vol of 
50 mM potassium phosphate buffer (pH 7.4) containing 2 mM EDTA and 1 mM 
mercaptoethanol. The homogenates was centrifuged at 4 °C for 45 min at 18,000 × g. The 
supernatant fraction was used for enzyme assay and protein concentration determination via the 
Bradford assay. DL-homocysteine was prepared fresh daily from homocysteine thiolactone 
hydrochloride (15.4 mg) in 400 µL 2 N sodium hydroxide and 600 µL saturated mono potassium 
phosphate. The standard assay contained 5 mM DL-Hcy, 2 mM betaine (0.05-0.1 µCi), and 50 
mM Tris-HCl (pH = 7.5). The final reaction volume was 0.5 mL. Reaction tubes were capped 
with rubber stoppers and kept in ice water until the assay was started by transferring the tubes 
into a 37 °C water bath. After 1 h incubation, the reaction was terminated by adding 2.5 mL of 
ice-cold water into each tube. The samples were applied to a Dowex 1-X4 (OH-; 200-400 mesh) 
column (0.6 × 3.75 cm), and the unreacted betaine was washed off the column with 15 mL water. 
Dimethylglycine and methionine were eluted into scintillation vials with 3 mL of 1.5 N HCl. 
Seventeen milliliters of scintillation mixture (Ecolume, ICN) were added to each vial and 
counted. Blanks contained all of the reaction components except enzyme, and their values were 
subtracted from the sample values. All samples were assayed in duplicate. 
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MTR activity assay. All liver samples were weighed and homogenized immediately in 4 vol of 
50 mM potassium phosphate buffer (pH 7.5) containing 2 mM EDTA. The homogenates was 
centrifuged at 4 °C for 45 min at 18,000 × g. The supernatant fraction was used for enzyme assay 
and protein concentration determination by the Bradford assay. The standard assay contained 1 
M potassium phosphate buffer (pH 7.2), 0.5 M DTT, 3.8 mM S-adenosylmethionine, 100 mM 
DL-Hcy, 5 mM hydroxocobalamin, and 5 mM methyl-tetrahydrofolate (0.1 µCi). The final 
reaction vol was 0.5 mL. Reaction tubes were capped with rubber stoppers and kept in ice water 
until the assay was started by transferring the tubes into a 37 °C water bath. After 0.5 h 
incubation, the reaction was terminated by adding 0.5 mL of ice-cold water into each tube. The 
samples were applied to an AG 1X8 column, and elute was collected also from additional 2 mL 
of ice-cold water applied to the column. Seventeen milliliters of scintillation mixture (Ecolume, 
ICN) were added to each vial and counted. Blanks contained all of the reaction components 
except enzyme, and their values were subtracted from the sample values. All samples were 
assayed in duplicate. 
CBS activity assay. All liver samples were weighed and homogenized immediately in 4 vol of 50 
mM potassium phosphate buffer (pH 7.4) containing 2 mM EDTA and 1 mM mercaptoethanol. 
The homogenates was centrifuged at 4 °C for 45 min at 18,000 × g. The supernatant fraction was 
used for enzyme assay and protein concentration determination by the Bradford assay. The 
standard assay mixture (400 μL) contained 0.38 mmol·L-1 S-adenosylmethionine, 7.5 mM L-
Hcy, 10 mM 14C-Ser (0.07 μCi), and 50 μL cow liver extract. Reaction tubes were capped with 
rubber stoppers and kept in ice water until the assay was started by transferring the tubes into a 
37 °C water bath. After 1 h incubation, the reaction was terminated by adding 0.4 mL 10% 
trichloroacetic acid and 2.2 mL ice-cold water into each tube. The samples were applied to an 
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AG 50 W X8 column, 8 mL of water was applied to the column, and 14C-Ser was eluted by 
applying 24 mL of 0.6M hydrochloric acid to the column. Following an additional wash with 16 
mL water, 14C-cystathionine was eluted by applying 5 mL of 3M ammonium hydroxide to the 
column and collected in scintillation vials. Seventeen milliliters of scintillation mixture 
(Ecolume, ICN) were added to each vial and counted. Blanks contained all of the reaction 
components except enzyme, and their values were subtracted from the sample values. All 
samples were assayed in duplicate. 
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CHAPTER 5 
METHIONINE AND CHOLINE SUPPLEMENTATION DURING THE 
PERIPARTURIENT PERIOD ALTER PLASMA AMINO ACID PROFILES TO 
VARIOUS EXTENTS: POTENTIAL ROLE ON HEPATIC METABOLISM AND 
ANTIOXIDANT STATUS 
- Nutrients, 2017, 9(1):10. 
INTRODUCTION 
Around parturition, the increased demand for nutrients to sustain fetal growth and 
lactation coupled with depressed dry matter intake (DMI) impose tremendous metabolic stress 
on dairy cows. Consequently, health problems and compromised production efficiency likely 
occur not only due to negative energy balance-induced increases in circulating free fatty acids, 
but a negative AA balance (Goff and Horst, 1997, Bell et al., 2000, Zhou et al., 2016d). For 
instance, increased mobilization of tissue protein is often observed due to inadequate availability 
of AA substrates for gluconeogenesis as well as synthesis of protein in liver and mammary gland 
(Overton, 1998). In fact, a moderate net loss of carcass protein was observed even in animals fed 
to predicted metabolizable protein requirements around parturition (McNeill et al., 1997, Bell et 
al., 2000), indicating suboptimal AA profile may be the limiting factor for AA utilization during 
this period. In line with this assumption, improving AA profile through balancing limiting AA in 
the diet or supplementing rumen-protected limiting AA has achieved various benefits in terms of 
lactation performance and health status of periparturient dairy cows (Lee et al., 2012, Osorio et 
al., 2013, Paz et al., 2013, Osorio et al., 2014a, Zhou et al., 2016f, Zhou et al., 2016g).  
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Methionine (Met) is an essential sulfur-containing AA engaged in various key 
physiologic events. Previous research has underscored the importance of Met as a limiting AA 
for milk protein synthesis in many diets (Schwab et al., 1992, Pisulewski et al., 1996). Apart 
from its apparent key role in mammary gland and liver protein synthesis, Met also serves as 
substrate for sulfur-containing antioxidants, namely glutathione (GSH) and taurine (Brosnan and 
Brosnan, 2006). Additionally, as a key component of one-carbon metabolism, hundreds of 
methylation reactions acquire methyl groups from Met via S-adenosyl methionine (SAM) (Ulrey 
et al., 2005). Furthermore, as a gluconeogenic AA, a portion of Met may be taken up by liver to 
sustain the abrupt increase in demand for glucose at the onset of lactation. In line with the 
various demands for Met, its deficiency has often been reported in cows around parturition 
(Zhou et al., 2016d). In fact, circulating Met concentration decreased markedly through 
parturition and was not restored to prepartum level until 28 d postpartum (Zhou et al., 2016d).  
An unfavorable circulating AA profile around parturition likely occurs due to 1) 
increased production of positive acute-phase proteins (APP) and immune related proteins 
induced by oxidative stress and inflammation; 2) enhanced carcass protein mobilization to 
provide AA for gluconeogenesis; and/or 3) limited uptake of other AA and increased N excretion 
due to lack of Met. Recent research with periparturient dairy cows has demonstrated benefits to 
overall health and production performance in response to MET supplementation (Osorio et al., 
2014a, Zhou et al., 2016f, Zhou et al., 2016g). However, how plasma AA and downstream 
products of their metabolism respond to periparturient MET supplementation is lacking.  
Although CHOL is not an AA, it may regulate AA metabolism by altering AA 
requirements, especially Met, around parturition. For instance, Met can be regenerated when 
homocysteine receives a methyl group from CHOL through betaine (Wong and Thompson, 
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1972b, Li and Vance, 2008a), suggesting a potential reduction around parturition in Met 
requirement with CHOL supplementation. Additionally, accumulation of fat in liver can induce 
inflammation and oxidative stress, which almost certainly leads to increased AA requirements 
for production of positive APP and other immune function-related proteins (Pinotti et al., 2002). 
As precursor for hepatic very low-density lipoprotein (VLDL) assembly, CHOL has a crucial 
role in the export of triacylglycerol to prevent fatty liver by promoting phosphatidylcholine 
synthesis via the Kennedy pathway instead of sequential methylation using Met derived SAM, 
which may also spare a portion of Met around parturition.  
Few studies have attempted to characterize the profile of circulating AA and their 
derivatives around parturition in cows (Verbeke et al., 1972, Meijer et al., 1995b, Doepel et al., 
2002, Zhou et al., 2016d). To our knowledge, this is the first study profiling AA and their 
derivatives in dairy cows in response to MET or CHOL supplementation around parturition. 
Considering that periparturient MET supplementation leads to greater feed intake, increased milk 
yield, and better overall cow health while CHOL cows did not achieve similar benefits (Zhou et 
al., 2016g), our hypothesis was that MET and CHOL supplementation result in different 
alterations in AA metabolism-associated events which ultimately contribute to their distinct role 
in the overall health and production efficiency of the animal. 
MATERIALS AND METHODS 
Experimental design and treatments  
All procedures for this study (protocol no. 13023) were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Illinois. Details of the 
experimental design have been described previously (Zhou et al., 2016g). Briefly, the experiment 
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was conducted as a randomized, complete, unbalanced, block design with 2×2 factorial 
arrangement of MET (Smartamine M, Adisseo NA) and CHOL (ReaShure, Balchem Inc) level 
(with or without). Cows within each block were balanced for parity, previous lactation milk 
yield, and BCS before the close-up diet groups were assigned. A total of 81 cows were used. 
Treatments were control (CON, n = 20), with no MET or CHOL supplementation; Smartamine 
(SMA, n = 21), CON plus MET at a rate of 0.08% of DM; Reashure (REA, n = 20), 
CON+CHOL at 60 g/d; or Smartamine and Reashure (MIX, n = 20), CON+MET+CHOL. 
Dosage of MET was based on Osorio et al. (2013) (Osorio et al., 2013), whereas CHOL was 
supplemented following the manufacturer’s recommendations. Per IACUC guidelines only a 
subset of 40 multiparous cows (10 cows/treatment) were used for this portion of the study. All 
cows received the same far-off diet from -50 to -22 d before expected parturition, close-up diet 
from -21 d to expected parturition, and lactation diet from parturition through 30 days in milk 
(DIM). The MET and CHOL supplements were both top-dressed from -21 ± 2 to 30 DIM once 
daily at the AM feeding using approximately 50 g of ground corn as carrier for all treatments. 
Supplementation of SMA (0.08% DM of TMR offered) was calculated daily for each cow. 
Smartamine M was supplied as small beads containing a minimum of 75% DL-Met, physically 
protected by a pH sensitive coating, which is considered to have a Met bioavailability of 80% 
(Graulet et al., 2005); therefore, per 10 g of SMA, the cows received 6 g of metabolizable Met. 
The REA supplement is reported to contain 28.8% choline chloride and is protected by 
microencapsulation. The product is considered to have CHOL bioavailability of 72% (Benoit, 
2009); therefore, per 60 g of REA, the cows received 12.4 g of metabolizable choline chloride. 
To our knowledge, neither SMA nor REA have specific characteristics that may affect 
palatability of diets. 
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Animal management 
Dry cows were housed in a ventilated enclosed barn during the dry period and fed 
individually once daily at 0630 h using an individual gate system (American Calan Inc., 
Northwood, NH). After parturition, cows were housed in a tie-stall barn and were fed a common 
lactation diet once daily. Feed offered was adjusted daily to achieve ~10% refusals.  
Blood Sample Collection and Analyses of Plasma AA and their Derivatives 
 Blood was sampled from the coccygeal vein on -30 and -10 d relative to expected 
parturition date and on 4, 14 and 28 d relative to actual parturition date before the morning 
feeding. Samples were collected into evacuated tubes (BD Vacutainer; BD and Co., Franklin 
Lakes, NJ) containing lithium heparin for isolation of plasma. 
Plasma was used to analyze the concentrations of free arginine (Arg), histidine (His), 
isoleucine (Ile), leucine (Leu), lysine (Lys), methionine (Met), phenylalanine (Phe), threonine 
(Thr), tryptophan (Trp), valine (Val), asparagine (Asn), aspartate (Asp), alanine (Ala), 
glutamate (Glu), glutamine (Gln), glycine (Gly), proline (Pro), serine (Ser), tyrosine (Tyr), 
citrulline (Cit), carnosine, ornithine (Orn), sarcosine (Sar), cystathionine, cystine, homocystine, 
taurine, α-aminoadipic acid, α-aminobutyric acid, β-alanine, γ-aminobutyric acid (GABA), 
hydroxylysine, hydroxyproline, phosphoserine, 1-methyl histidine, and 3-methyl histidine at the 
University of Missouri Agriculture Experiment Station Chemical Laboratories (Columbia, MO) 
using high performance liquid chromatography (Deyl et al., 1986, Fekkes, 1996). Plasma total 
GSH was measured using a commercial kit (Cat. No. NWH-GSH01; Northwest Life Science 
Specialties LLC, Vancouver, WA). The EAA pool included Arg + His + Ile + Leu + Lys + Met + 
Phe + Thr + Trp + Val; the NEAA pool included Asn + Asp + Ala + Gln + Glu + Gly + Pro + 
  
154 
 
Ser + Tyr; total AA was the sum of EAA and NEAA; the total sulfur-containing compounds 
(TSC) included Met + cystine + cystathionine + homocystine + taurine + GSH. 
Liver Sample Collection and Quantitative RT-PCR (qPCR) 
Liver was sampled via puncture biopsy (Dann et al., 2005) from cows under local 
anesthesia at approximately 0800 h on d -10, 7, 20, and 30 d relative to parturition. Liver was 
frozen immediately in liquid nitrogen and stored until analysis. The qPCR was performed in liver 
samples as describe previously (Osorio et al., 2014a).  
Statistical analysis  
Data were analyzed using PROC MIXED of SAS (SAS Institute Inc., Cary, NC) 
according to the following model:  
𝑦𝑖𝑗𝑘𝑙𝑚 = 𝜇 + 𝑏𝑖 + 𝑀𝑗 + 𝐶𝑘 + 𝑀𝐶𝑗𝑘 + 𝑇𝑙 + 𝑇𝑀𝑗𝑙 + 𝑇𝐶𝑘𝑙 + 𝑇𝑀𝐶𝑗𝑘𝑙 + 𝐴𝑚:𝑖𝑗𝑘  +  𝜀𝑖𝑗𝑘𝑙𝑚 
where 𝑌𝑖𝑗𝑘𝑙𝑚 is the dependent, continuous variable; 𝜇 is the overall mean; 𝑏𝑖 is the random effect 
of the 𝑖th block; 𝑀𝑗 is the fixed effect of MET (𝑗 = with or without); 𝐶𝑘 is the fixed effect of 
CHOL (𝑘 = with or without); 𝑇𝑙 is the fixed effect of time (day or week) of the experiment; 𝐴𝑚 
is the random effect of the mth animal (cow); 𝜀𝑖𝑗𝑘𝑙𝑚 is the residual error. The covariate of parity 
(2nd vs. 3rd lactation and above) and concentrations obtained at -30 d for various AA and 
derivatives were maintained in the model for all variables when significant (P < 0.05).  Plasma 
AA and derivatives and hepatic gene expression were analyzed at various time points that were 
not equally spaced. Therefore, the first order ante-dependence covariance structure ANTE (1) 
were used for repeated measures. Variables were assessed for normality of distribution using 
Shapiro-Wilk test. When normality assumption was rejected, data were log-transformed before 
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statistical analysis. Back transformed data were reported in tables and figures for the ease of 
interpretation. Least square means separation between time points was performed using the 
PDIFF statement. Statistical differences were declared significant at P ≤ 0.05 and tendencies at P 
≤ 0.10.  
RESULTS 
Essential AA 
Main effects of MET, CHOL, time, and interactions for essential AA are presented in 
Table 5.1. Overall, plasma concentrations of most EAA (Arg, His, Ile, Leu, Lys, Thr, Trp, Val) 
decreased soon after parturition (4 d) except for Met and Phe, levels of which were increased and 
unchanged at 4 d, respectively (Figure 5.1, Figure 5.2, Figure S5.1, and Figure S5.2). As 
expected, MET-supplemented cows had greater plasma Met concentration (P < 0.01, Figure 
5.1A) compared with cows without MET. In fact, proportion of Met in EAA (P < 0.01, Figure 
5.1D) and TAA (P < 0.01, Figure 5.1F) also was greater in response to MET supplementation. 
In contrast, similar plasma Met (P > 0.10, Figure 5.1B) and Met%EAA (P > 0.10) levels were 
observed regardless of CHOL supplementation. MET main effect (P = 0.02) also was observed 
for Lys, the other most-limiting AA for milk production, mainly due to greater plasma 
concentrations at -10 d and 20 d (M×D P < 0.05, Figure 5.2E). Similarly, plasma Arg 
concentration also was greater (P = 0.02) in MET cows owing to greater concentrations at -10 d 
and 20 d (M×D P < 0.05, Figure 5.2B), but not at 4 d postpartum. Although greater Thr was 
observed in MET cows at -10 d (M×D P < 0.05, Figure S5.2), Thr concentration was similar 
regardless of MET supplementation, thus, only a tendency (P = 0.09) was detected in these cows. 
In addition to greater (P < 0.01) Trp in MET cows, the main effect of CHOL also was observed 
for Trp (P = 0.04, Figure S5.1. G and H). Despite the lack of main effects of MET for plasma 
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His, Phe and BCAA (Val, Leu, Ile) concentrations, the EAA tended to be greater (P = 0.06, 
Figure 5.1C) in response to MET mainly owing to greater Met, Lys, Arg, Thr, and Trp.  
Non-essential AA 
Main effects of MET, CHOL, time, and interactions for non-essential proteinogenic AA 
are presented in Table 5.1. Similar to EAA, plasma concentrations for the majority of the NEAA 
(Asp, Ala, Glu, Gln, Tyr) decreased soon after parturition (Figure S5.3 and Figure S5.4). In 
contrast, plasma concentrations of Asn, Gly, Pro, and Ser increased at 4 d compared with -10 d 
(Figure S5.3 and Figure S5.4). Although total NEAA did not change in response to MET or 
CHOL (P > 0.10), TAA in MET-supplemented cows were greater (P = 0.03) as a result of an 
overall tendency towards greater EAA together with greater Asn, Asp, Ala, and Pro (P < 0.05, 
Figure 5.1C, Figure S5.3, and Fig S5.4) as well as a tendency towards greater Glu (P = 0.10 
Figure S5.3).  
It is noteworthy that similar to Arg and Lys, plasma Ala concentrations were already 
greater (M×D P < 0.05, Figure 5.2A and Figure 5.2C) at -10 d prepartum in MET cows. After 
parturition, plasma Arg, Lys, and Ala were similar in cows regardless of MET supplementation 
at 4 d but were again greater at 14 d (M×D P < 0.05, Figure 5.2) in MET cows. Unlike Met, 
only a tendency towards greater (P = 0.07) Asp was detected in response to CHOL.  
Sulfur-containing compounds 
Main effects of MET, CHOL, time, and interactions for sulfur-containing compounds are 
presented in Table 5.2. As expected, MET supplementation increased plasma concentrations of 
all sulfur-containing AA (P < 0.05, Figure 5.2 and Figure 5.3), which account for the greater 
overall plasma TSC level at all time points evaluated (M×D P < 0.05, Figure 5.3C). Similar to 
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Ala, Arg, and Lys, greater (P < 0.01) cystine and cystathionine concentrations were also detected 
in response to MET due to greater plasma level at -10, 14, and 28 d (M×D P < 0.05, Figure 5.2C 
and Figure 5.2D). In addition to increased circulating sulfur-containing compounds, MET also 
increased the proportion of Met in TSC (P = 0.01, Figure 5.3D). In contrast, although plasma 
cystine concentration was greater (P = 0.02) in response to CHOL supplementation. a decreased 
proportion of Met in TSC was observed in CHOL cows around parturition (P = 0.03, Figure 
S5.8). 
Non-proteinogenic AA and derivatives 
Main effects of MET, CHOL, time, and interactions for essential AA are presented in 
Table 5.2. Although no main effect of MET or CHOL was observed for ornithine, greater Cit (P 
< 0.01, Figure 5.4E) and a tendency (P = 0.07) towards greater urea were observed in MET-
supplemented cows in addition to greater Arg. Besides taurine, plasma concentrations of 
carnosine, another antioxidant, was also greater (P = 0.02, Figure 5.4D) in MET cows. Although 
no main effect of CHOL was observed for carnosine, greater (C×D P < 0.05) concentrations 
were detected at -10 d and 28 d. Both α-aminobutyric acid and γ-aminobutyric acid were greater 
(P < 0.05 Figure 5.4C and Figure 5.4G) in MET cows; however, only greater γ-aminobutyric 
acid plasma concentration was observed in CHOL cows (P = 0.02 Figure 5.4H). The indicator 
of protein mobilization, 3-methylhistidine was lower in CHOL cows (P = 0.02 Figure 5.4B). 
Similarly, plasma 1-methylhistidine concentration also was lower in these cows (P = 0.04 Figure 
5.4A). 
Pyruvate carboxylase and phosphoenolpyruvate caboxykinase 1 expression 
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Main effects of MET, CHOL, time, and interactions for expression of pyruvate 
carboxylase (PC) and phosphoenolpyruvate caboxykinase 1 (PCK1) are presented in Table 5.3. 
Main effects of MET and CHOL or interactions were not detected for the mRNA expression of 
PC and PCK1. 
 
DISCUSSION 
A brief summary of production performance and immunometabolic status of the cows is 
presented in Table 5.4 to facilitate interpretation of the results in this study. Detailed discussion 
of those data have been published elsewhere (Zhou et al., 2016a, Zhou et al., 2016g).  
Supplemental MET improved plasma AA profiles 
MET and Lys in metabolizable protein are the most-limiting AA in a wide-range of diets 
for dairy cows due to their low concentrations in feed protein relative to their concentrations in 
milk (NRC, 2001a). During the periparturient period, the decreased feed intake coupled with 
increased AA requirements to sustain fetal growth and lactation lead to greater tissue protein 
mobilization evidenced in the present study by the highest plasma 3-methyl histidine at 4 d 
regardless of treatments. Although AA released from tissue mobilization can partly mitigate the 
demand for AA, cow body tissue protein is relatively low in Met and Lys (O'Connor et al., 
1993). Consequently, this physiological stage is characterized by an overall decrease in 
circulating AA, especially the most-limiting AA (e.g. Met and Lys). Apart from limiting milk 
production, inadequate Met availability also could potentially limit the utilization of other 
circulating AA according to von Liebig’s hypothesis which is commonly described with the 
analogy of the water barrel with broken staves (Mitchell and Block, 1946). Strategies to increase 
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circulating Met are, therefore, expected to improve overall circulating AA profiles and utilization 
during the periparturient period.  
The fact that various proteinogenic circulating EAA (Arg, Lys, Met, Thr, and Trp), 
NEAA (Ala, Asn, Asp, Glu, Gln, and Pro) and non-proteinogenic AA (Cit) were greater in 
response to rumen-protected MET supplementation, apart from greater plasma Met, are 
indications of a better circulating AA profile during the periparturient period. However, it cannot 
be ignored that MET cows had greater DMI both prepartum and postpartum (Zhou et al., 2016g). 
Therefore, the DMI increase in MET-supplemented cows might have contributed to the observed 
increase in circulating EAA and TAA. However, it is noteworthy that despite concomitant 
increases in circulating Met, EAA and TAA, the proportion of Met in EAA and TAA 
(Met%EAA and Met%TAA) as well as the proportion of Lys in TAA were increased in response 
to MET supplementation, indicating a better AA profile at least in regards to limiting AA, i.e. 
Met and Lys.  
Considering the overall greater milk yield, milk protein %, and milk protein yield (Zhou 
et al., 2016g) (Table 5.4), it is reasonable to speculate that MET supplementation contributes to 
better lactation performance both by increasing intake and proportion of Met and Lys in the 
circulating AA pool. Although CHOL can potentially achieve similar benefits by promoting in 
vivo synthesis of Met, the lack of change in circulating AA does not seem to support such 
hypothesis.   
Utilization of circulating AA close to parturition 
Around parturition, the demand for AA for glucose and protein synthesis increases 
abruptly and results in greatly increased AA uptake from the circulation (Larsen and Kristensen, 
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2013). The few published reports have revealed that circulating AA concentrations in dairy cows 
generally reach a nadir close to parturition mainly as a result of increased demand for milk 
protein synthesis and gluconeogenesis coupled with insufficient dietary intake (Verbeke et al., 
1972, Meijer et al., 1995a, Doepel et al., 2002, Zhou et al., 2016d). In agreement with these 
reports, we detected the lowest circulating concentrations of most AA at 4 d relative to 
parturition regardless of treatment.  
Although circulating concentrations of multiple AA (Ala, Arg, Lys) and peptides 
(cystine, cystathionine) in MET-supplemented cows were already greater at -10 d compared with 
cows without MET supplementation and regained greater levels at 14 d postpartum, the 
circulating concentrations of all AA and peptides at 4 d were similar regardless of MET 
supplementation. Whether the lack of difference in circulating concentrations of these AA at 4 d 
in MET cows was due to inadequate supply in the circulation (e.g. AA from intake and tissue 
mobilization) (Komaragiri and Erdman, 1997) or enhanced utilization (e.g. greater liver and 
mammary uptake) remains unknown. However, the fact that average DMI at d 4 remained 
greater (+3.33 kg/d more) in MET-supplemented cows (Zhou et al., 2016g), together with similar 
3-methylhistidine in cows with or without MET supplementation, seem to support an overall 
greater, rather than lower, AA supply at 4 d in response to MET supplementation. In line with 
the increase in AA supply, MET-supplemented cows regained greater concentrations of these 
AA at 14 d.  
In terms of AA utilization, a previous study detected the greatest liver uptake of EAA at 4 
d postpartum in dairy cows (Larsen and Kristensen, 2013). Similarly, hepatic uptake of total 
NEAA, especially Ala, also was substantially greater in the periparturient period, indicating this 
AA may act as a precursor for glucose synthesis (Kuhla et al., 2011, Larsen and Kristensen, 
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2013). The greater (+4.10 kg/d more) milk yield in MET-supplemented cows at 4 d (Zhou et al., 
2016g) (and Table 5.4) indicated that the greater uptake of these AA by mammary gland soon 
after parturition accounted for the lower AA concentration in the circulation compared with -10 
d. Presumably, greater mammary availability of AA accounted for the greater milk protein % 
(Zhou et al., 2016g).   
It is also noteworthy that a reduction in net flux of carbon from volatile fatty acids across 
the liver and an increase in glucose release was detected early postpartum in a previous report 
(Larsen and Kristensen, 2013), indicating that the greatest flux through citric acid cycle occurs 
soon after parturition. Considering the severe negative energy balance and depressed DMI soon 
after parturition, the increased demand by the liver for energy and glucose synthesis likely 
accounted for such increase. Whether periparturient MET supplementation enhanced 
gluconeogenesis by promoting AA flux through the citric acid cycle is unknown, but does not 
seem to be related to regulation at the transcriptional level as evidenced by unchanged mRNA 
abundance of the key gluconeogenic genes PC and PCK1.  
Sulfur-containing compound pool and metabolism 
Met and cysteine are the two sulfur-containing AA that are incorporated into proteins. 
Apart from their well-known role in contributing sulfur bonds during protein synthesis, Met and 
cysteine are precursors for downstream functional compounds (homocysteine, cystathionine, and 
taurine) and, thus, are considered the principal components in vivo of the sulfur-containing 
compound pool (Brosnan and Brosnan, 2006). The fact that circulating concentrations of all 
sulfur-containing compounds measured (except GSH) were greater in MET-supplemented cows 
during the periparturient period indicate an enriched sulfur-containing compound pool. 
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It is noteworthy that other than Met, all other plasma sulfur-containing compounds 
measured are components of the transsulfuration pathway. Considering plasma homocystine 
concentrations are highly dependent on intracellular homocysteine metabolism in liver 
(Schalinske and Smazal, 2012), and cystathionine is a sensitive marker of changes in flux 
through the transsulfuration pathway (Guttormsen et al., 2004), the greater homocystine and 
cystathionine indicate increased hepatic flux through this pathway in response to MET 
supplementation. In addition to the involvement of sulfur-containing compounds, the fact that 
circulating concentrations of α-aminobutyric acid also was greater in MET-supplemented cows 
indicates increased flux through the transsulfuration pathway (Stabler et al., 2009). Considering 
the key role of Met as the most-limiting AA for milk protein synthesis, the fact that it is the 
major precursor for sulfur-containing compounds in the transsulfuration pathway indicates that 
such increase may result in depletion of Met which could potentially give rise to unfavorable 
lactation performance. However, despite the increased flux through the transsulfuration pathway, 
the sustained greater circulating concentration of Met and proportion of Met in TSC during the 
periparturient period indicates that sufficient Met was available in MET-supplemented cows 
even at 4 d. In contrast, although greater circulating cystine was detected in response to CHOL 
supplementation, the proportion of Met in TSC was decreased, indicating enhanced flux through 
the transsulfuration pathway at the expense of Met. Whether the decrease of plasma Met 
proportion in TSC in CHOL-supplemented cows contributed to the lack of benefit in 
performance is unknown; however, it does not seem to support the hypothesis that CHOL can 
promote Met synthesis in vivo in periparturient dairy cows.  
Around parturition, the increased demand for nutrients and energy leads to an increase in 
the production reactive oxygen metabolites (ROM), the accumulation of which could deplete 
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antioxidants and give rise to oxidative stress that may cause substantial tissue damage and render 
cows more susceptible to various health disorders (Bernabucci et al., 2005, Castillo et al., 2005). 
Among the sulfur-containing compounds measured, taurine and GSH are potent intracellular 
antioxidants due to their marked ability to scavenge ROM and free radicals (Young and 
Woodside, 2001). Hence, hepatic concentrations of GSH and taurine have been widely-used as 
oxidative stress biomarkers (Romeu et al., 2010, Vetrani et al., 2013, Saharan and Mandal, 
2014). It is noteworthy that liver is the main site of taurine synthesis and releases taurine into 
plasma (Garcia and Stipanuk, 1992), but not for transport to other tissues (Hayes and Sturman, 
1981). Therefore, the greater overall circulating taurine in response to MET supplementation 
indicates greater hepatic taurine availability and, hence, potentially less oxidative stress in these 
cows. However, although previous results from our group revealed greater total and reduced 
hepatic GSH in MET-supplemented cows (Osorio et al., 2014c, Zhou et al., 2016f), plasma GSH 
was barely detectable and did not respond to MET. Considering that concentration of GSH in 
whole blood was 200-fold higher than in plasma due to high concentration in erythrocytes, small 
amounts of hemolysis may lead to great variations in plasma GSH concentration (Pocius et al., 
1981). Therefore, plasma GSH may not be a reliable oxidative stress biomarker for periparturient 
dairy cows.  
AA derivatives 
AA derivatives have unique metabolic properties and, thus, many have been adopted as 
biomarkers for metabolic status. For instance, because 3-methylhistidine is released from the 
catabolism of actin and myosin in skeletal muscle and is not further metabolized in the body, it 
has been regarded as a reliable marker for tissue protein mobilization (Harris and Milne, 1981). 
The overall lower plasma 3-methylhistidine in response to CHOL supplementation during the 
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periparturient period indicates less degree of muscle catabolism in these cows. Although lower 
circulating 1-methylhistidine concentration also was observed in response to CHOL, the 
postpartum pattern of a gradual increase with time indicates that it is not a suitable indicator of 
muscle catabolism considering that it was at its greatest right after parturition as indicated by 3-
methylhistidine.  
The antioxidant activity of carnosine in non-ruminants has been demonstrated both in 
terms of reducing oxidative damage and improving the enzymatic and non-enzymatic activity of 
other antioxidants (Boldyrev et al., 2013). The fact that supplementation of carnosine in non-
ruminants was able to rescue prooxidant-antioxidant balance by restoring depleted levels of 
blood GSH and activities of antioxidant enzymes (Aydin et al., 2010) indicates the potential 
decrease in circulating carnosine in events of oxidative stress. Although the contribution of 
carnosine to restore prooxidant-antioxidant balance under physiologic (without carnosine 
supplementation) conditions remains unknown, the overall greater circulating carnosine together 
with greater circulating taurine as well as hepatic GSH reported previously (Zhou et al., 2016a) 
indicate a less pronounced oxidative stress status in response to periparturient MET 
supplementation.  
As a neurotransmitter distributed in both neural and non-neural tissue, GABA has various 
physiologic functions including feed intake regulation (Cheng et al., 2014). In rats, GABA-B 
agonist administration increased intake by attenuating satiety signals (Higgs and Barber, 2004). 
In lactating dairy cows, increased DMI in response to rumen-protected GABA supplementation 
during mid-lactation has been reported (Wang et al., 2013, Cheng et al., 2014). The greater 
circulating GABA in response to periparturient MET supplementation along with the greater 
DMI (Zhou et al., 2016g) seem to suggest a role of GABA in mediating DMI regulation by 
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MET. However, considering that CHOL supplementation failed to increase periparturient DMI 
yet it led to a similar increase in circulating GABA, this response is likely unrelated to MET or 
CHOL supplementation and may not play a regulatory role in the control of intake.  
CONCLUSIONS  
The greater Ala, Arg, and Lys together with cystine and cystathionine concentrations at -
10 d and 14 d, but not at 4 d, in cows fed MET indicated greater utilization of these AA and 
peptides at the time of most-severe negative AA balance. The enriched circulating sulfur-
containing compound pool together with greater α-aminobutyric acid revealed enhanced 
transsulfuration pathway activity in response to MET supplementation. Despite the greater 
circulating cystine in CHOL cows, the lower proportion of Met in TSC indicates enhanced flux 
through the transsulfuration pathway at the expense of Met. Whether the decrease in the 
proportion Met was due to insufficient choline supplementation remains unknown. As a 
precursor for Met synthesis in vivo, it is possible that increasing periparturient choline 
supplementation could mitigate a decrease in Met. Although plasma GSH did not differ in 
response to MET due to barely detectable concentration in plasma, the greater circulating taurine 
and carnosine indicate less oxidative stress in MET supplemented cows. In conclusion, the 
overall better health and production performance reported previously in MET cows was due, at 
least in part, to a better plasma AA profile and overall lower oxidative stress status. Hence, the 
lack of change in AA profiles could be one of the reasons preventing CHOL-fed cows from 
achieving comparable performance and health benefits during the periparturient period. 
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TABLES AND FIGURES 
Table 5.1. Plasma proteinogenic AA concentrations during the periparturient period in cows supplemented with or without rumen-
protected MET and CHOL.   
 MET CHOL  Day P-value2 
AA (µM) Without With Without With SEM1 
-10 4 14 28 
MET3 CHOL4 Time M×T5 C×T6 
Essential AA               
 Arginine 54.75 60.43 57.99 57.05 1.75 58.58
ab 48.47c 63.29a 60.92ab 0.02 0.69 <0.01 0.05 0.96 
 Histidine 52.38 54.55 54.04 52.87 1.18 57.28a 53.53b 52.30b 50.92b 0.19 0.49 <0.01 0.13 0.17 
 Isoleucine 95.58 103.61 100.64 98.40 4.42 98.18 95.54 106.87 97.83 0.19 0.72 0.18 0.07 0.36 
 Leucine 153.31 161.79 152.70 162.43 6.69 151.35b 153.51b 173.18a 152.92b 0.35 0.31 0.03 0.27 0.31 
 Lysine 60.99 68.74 63.47 66.06 2.45 66.75ab 57.56c 70.47a 64.91b 0.02 0.47 <0.01 0.03 0.85 
 Methionine 18.65 28.95 24.04 23.55 0.83 22.75c 25.25a 24.92ab 22.27c <0.01 0.68 <0.01 0.14 0.17 
 Phenylalanine 46.64 47.09 45.88 47.86 1.02 45.00b 47.64b 51.16a 43.97b 0.75 0.17 <0.01 0.26 0.92 
 Threonine 72.55 78.67 75.93 75.30 2.50 71.87 72.22 78.70 79.66 0.09 0.86 0.07 0.01 0.52 
 Tryptophan 22.26 25.04 22.68 24.61 0.64 24.56ab 19.44c 25.08a 25.50a <0.01 0.04 <0.01 0.42 0.63 
 Valine 226.77 244.54 229.16 241.99 9.32 230.11 223.02 249.41 240.25 0.17 0.33 0.08 0.26 0.31 
 BCAA 476.69 510.97 483.71 503.55 19.87 480.67 473.17 530.28 491.93 0.21 0.48 0.08 0.19 0.27 
 EAA 827.12 896.20 849.22 874.1 25.54 848.26bc 816.78bc 921.2a 860.39ab 0.06 0.50 0.03 0.08 0.32 
 Met%EAA 2.26 3.18 2.73 2.64 0.09 2.59b 3.04a 2.62b 2.52b <0.01 0.41 <0.01 0.11 0.23 
Non-essential AA               
 Alanine 187.39 206.37 198.37 195.39 5.55 188.83b 175.45c 211.30a 211.95a 0.02 0.71 <0.01 0.05 0.32 
 Asparagine 34.90 39.63 37.78 36.61 1.48 27.82c 34.08b 45.67a 44.19a 0.02 0.56 <0.01 0.22 0.42 
 Aspartate 4.21 4.79 4.24 4.76 0.21 4.91a 3.78b 4.80a 4.57a 0.04 0.07 <0.01 0.59 0.14 
 Glutamate 35.93 38.34 36.44 37.81 1.04 44.24a 32.17d 37.84b 35.24c 0.10 0.36 <0.01 0.54 0.38 
 Glutamine 246.22 259.53 257.92 247.82 6.18 278.17a 252.84b 242.52b 237.96b 0.15 0.25 <0.01 0.21 0.29 
 Glycine* 426.83 406.23 427.39 405.67 15.10 236.99c 456.97b 536.19a 435.98b 0.35 0.31 <0.01 0.92 0.22 
 Proline 72.30 78.24 74.03 76.50 2.02 59.19c 67.52b 90.21a 84.15a 0.04 0.39 <0.01 0.35 0.74 
 Serine 86.62 88.92 88.67 86.87 2.28 73.88c 90.85b 100.78a 85.57b 0.48 0.58 <0.01 0.16 0.49 
 Tyrosine 40.82 43.39 40.78 43.43 1.53 42.03a 36.26b 46.32a 43.80a 0.24 0.24 <0.01 0.08 0.94 
 NEAA 1114.59 1151.58 1153.58 1112.59 24.79 946.13c 1136.83b 1301.27a 1177.00b 0.29 0.24 <0.01 0.36 0.23 
 TAA 1926.95 2052.97 1995.87 1982.22 41.32 1781.41d 1947.89bc 2215.47a 2035.97b 0.03 0.82 <0.01 0.10 0.53 
 Met%TAA 0.94 1.37 1.15 1.13 0.04 1.20a 1.25a 1.06b 1.05b <0.01 0.64 <0.01 0.14 0.23 
 Lys%TAA 3.22 3.47 3.26 3.42 0.10 3.84a 3.02c 3.23bc 3.29b 0.08 0.28 <0.01 0.13 0.85 
*Significant (P < 0.05) parity effect observed. 
1Greatest SEM. 
 2MET × CHOL interaction was included in the supplemental file. 
3Overall effect of MET supplementation. 
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Table 5.1 (Continued) 
4Overall effect of CHOL supplementation. 
5Interaction of MET × time. 
6Interaction of CHOL × time. 
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Table 5.2. Plasma non-proteinogenic AA and AA derivatives concentrations during the periparturient period in cows supplemented 
with or without rumen-protected MET and CHOL.   
 MET CHOL  Day P-value2 
Parameter (µM) Without With Without With SEM1 
-10 4 14 28 
MET3 CHOL4 Time M×T5 C×T6 
AA and derivatives#               
 1-methyl histidine 15.36 16.56 16.79 15.15 0.57 12.82c 12.58c 18.38b 21.85a 0.12 0.04 <0.01 0.36 0.50 
 3-methyl histidine 6.44 6.48 6.97 5.99 0.29 5.21c 11.00a 6.91b 4.40d 0.92 0.02 <0.01 0.12 0.75 
 α-aminoadipic acid 7.37 8.15 8.03 7.48 0.36 6.09d 6.99c 8.65b 9.81a 0.12 0.27 <0.01 0.91 0.30 
 α-aminobutyric acid 15.64 19.78 18.13 17.07 0.81 8.94c 23.60a 22.77a 19.93b <0.01 0.32 <0.01 0.61 0.44 
 β-alanine 9.06 8.87 8.81 9.11 0.32 8.97 8.69 9.24 8.94 0.68 0.50 0.54 0.96 0.92 
 γ-aminobutyric acid 2.42 3.49 2.46 3.45 0.29 1.88b 3.08a 3.44a 3.41a 0.01 0.02 <0.01 0.27 0.75 
 Carnosine* 15.88 19.92 16.60 19.07 1.29 16.74c 14.20d 18.71b 22.51a 0.02 0.14 <0.01 0.30 0.02 
 Citrulline 71.19 83.47 79.08 75.14 2.92 69.61c 63.69c 82.86b 96.11a <0.01 0.30 <0.01 0.99 0.60 
 Glutathione 4.68 4.73 4.84 4.57 0.27 4.60b 6.11a 4.35bc 3.76c 0.89 0.50 <0.01 0.50 0.74 
 Hydroxylysine 0.32 0.28 0.30 0.29 0.04 0.33 0.29 0.33 0.25 0.37 0.79 0.21 0.61 0.70 
 Hydroxyproline 15.19 15.36 15.42 15.13 0.48 12.80c 18.10a 16.31b 13.89c 0.81 0.67 <0.01 0.94 0.12 
 Ornithine 29.14 32.00 30.48 30.60 1.35 39.37a 22.11d 30.04c 33.25b 0.13 0.95 <0.01 0.12 0.45 
 Phosphoserine 6.22 6.18 6.07 6.33 0.18 5.53c 5.91bc 6.72ab 6.74a 0.88 0.30 <0.01 0.71 0.91 
 Sarcosine 10.65 11.43 11.50 10.58 0.56 8.32b 11.31a 12.03a 12.50a 0.33 0.27 <0.01 0.76 0.37 
 Urea 4121.63 4442.94 4323.55 4235.16 123.89 4104.53bc 4317.26b 4036.81c 4687.49a 0.07 0.60 <0.01 0.55 0.62 
Sulfur-containing compounds            
 Cystathionine 1.60 2.12 1.84 1.89 0.07 2.30 1.51 1.71 1.92 <0.01 0.61 <0.01 0.08 0.36 
 Cystine 7.56 9.58 7.65 9.48 34.5 11.20a 6.41d 7.73c 8.92b <0.01 0.02 <0.01 0.01 0.17 
 Homocystine 4.17 5.10 4.52 4.70 0.30 4.80a 3.99b 4.80a 4.92a 0.02 0.65 0.01 0.69 0.28 
 Taurine 33.23 47.04 39.43 40.84 1.28 34.51 40.49 40.06 45.48 <0.01 0.44 <0.01 0.16 0.92 
 TSC7 70.65 97.37 82.47 85.95 1.93 80.52 84.03 83.93 87.57 <0.01 0.44 0.08 0.07 0.48 
 Met%TSC 28.44 31.4 31.09 28.74 0.72 29.65b 32.35ab 31.15b 26.51c 0.01 0.03 <0.01 0.74 0.24 
*Significant (P < 0.05) parity effect observed. #β-aminobutyric acid undetectable 
1Greatest SEM. 
 2MET × CHOL interaction was included in the supplemental file. 
3Overall effect of MET supplementation. 
4Overall effect of CHOL supplementation. 
5Interaction of MET × time. 
6Interaction of CHOL × time. 
7Total sulfur-containing AAs and derivatives (methionine, cystathionine, cystine, homocystine, and taurine). 
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Table 5.3. Hepatic relative PC# and PCK1 mRNA expression during the periparturient period in cows supplemented with or without 
rumen-protected MET and CHOL.   
 MET CHOL  Day P-value2 
Genes Without With Without With SEM1 -10 7 20 30 MET3 CHOL4 Time M×T5 C×T6 
 PC 2.12 2.02 2.09 2.05 0.07 1.49c 2.88a 2.23b 1.93d 0.33 0.70 <0.01 0.28 0.34 
 PCK1 2.27 2.43 2.39 2.31 0.10 1.57c 2.62ab 2.74a 2.69ab 0.27 0.55 <0.01 0.48 0.46 
*Significant (P < 0.05) parity effect observed. #PC=pyruvate carboxylase; PCK1=Phosphoenolpyruvate carboxykinase 1. 
1Greatest SEM. 
 2MET × CHOL interaction was included in the supplemental file. 
3Overall effect of MET supplementation. 
4Overall effect of CHOL supplementation. 
5Interaction of MET × time. 
6Interaction of CHOL × time. 
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Table 5.4. Performance and immunometabolic status of multiparous Holstein cows during the periparturient period in cows 
supplemented with or without rumen-protected MET and CHOL.  
 MET CHOL  P-value 
Variables With Without With Without SEM1 MET2 CHOL3 Time 
 Prepartum DMI (kg/d) 14.3a 13.2b 14.0 13.5 0.3 0.02 0.28 <0.01 
 Postpartum DMI (kg/d) 19.2a 17.2b 18.1 18.3 0.6 0.02 0.79 <0.01 
 Milk yield (kg/d) 44.2a 40.4b 41.4 43.2 1.2 0.02 0.27 <0.01 
 Milk protein (%) 3.32a 3.14b 3.27 3.19 0.04 <0.01 0.19 <0.01 
 Plasma albumin (g/L) 36.55 35.53 35.87 36.21 0.35 0.04 0.50 0.37 
 Plasma haptoglobin (g/L) 0.35 0.47 0.41 0.41 0.05 0.08 0.94 <0.01 
 Plasma paraoxonase 93.09 84.54 89.18 88.45 3.20 0.07 0.87 <0.01 
 Hepatic glutathione 62.83 23.32 39.61 46.55 10.59 0.01 0.64 <0.01 
Neutrophil phagocytosis (%) 61.05 54.69 58.14 57.60 1.67 0.01 0.81 0.10 
Neutrophil oxidative burst (%) 57.27 49.28 54.34 52.20 2.63 0.03 0.54 0.45 
1Greatest SEM. 
2Overall effect of MET supplementation. 
3Overall effect of CHOL supplementation. 
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Figure 5.2. 
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Figure 5.3. 
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Figure 5.4.
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Figure 5.1. Effects of supplementing multiparous Holstein cows during the periparturient period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or rumen-protected 
choline (CHOL; ReaShure, Balchem Inc.) on circulating methionine concentrations and 
proportion of methionine in total AA (TAA) and essential AA (EAA). Values are means, with 
standard errors represented by vertical bars. 
Figure 5.2. Effects of supplementing multiparous Holstein cows during the periparturient period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) on circulating alanine, 
arginine, cystine, cystathionine, and lysine concentrations. Values are means, with standard 
errors represented by vertical bars. 
Figure 5.3. Effects of supplementing multiparous Holstein cows during the periparturient period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) on circulating sulfur-
containing compound concentrations and proportion of methionine in total sulfur-containing 
compound (TSC). Values are means, with standard errors represented by vertical bars. 
Figure 5.4. Effects of supplementing multiparous Holstein cows during the periparturient period 
with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or rumen-protected 
choline (CHOL; ReaShure, Balchem Inc.) on circulating citrulline and AA derivative 
concentrations. GABA = γ-aminobutyric acid Values are means, with standard errors represented 
by vertical bars.  
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Supplemental Table 5.1. Plasma proteinogenic AA concentrations during the transition period 
in cows supplemented with or without rumen-protected MET and CHOL.  
 Treatments  P-value 
AA (µM) CON1 SMA REA MIX SEM2 M×C3 M×C×T4 
Essential AA        
 Arginine 54.61 61.5 8 54.89 59.31 2.52 0.61 0.31 
 Histidine 52.94 55.17 51.83 53.94 1.69 0.98 0.17 
 Isoleucine 97.84 103.50 93.36 103.72 6.28 0.69 0.99 
 Leucine 151.85 153.56 154.77 170.47 7.55 0.46 0.69 
 Lysine 59.28 67.94 62.74 69.55 3.56 0.75 0.82 
 Methionine 18.88 29.21 18.42 28.68 1.19 0.97 0.46 
 Phenylalanine 47.41b 44.40b 45.87b 49.94a 1.50 0.02 0.56 
 Threonine 75.65 76.20 69.46 81.13 3.56 0.12 0.52 
 Tryptophan 21.56 23.80 22.95 26.28 0.91 0.55 0.49 
 Valine 225.27 233.12 228.27 256.52 13.80 0.45 0.95 
 BCAA 476.13 491.42 477.22 531.31 29.33 0.49 0.91 
 EAA 831.48 866.95 822.75 925.45 35.85 0.08 0.32 
 Met%EAA 2.26 3.30 2.26 3.07 0.14 0.40 0.63 
Non-essential AA        
 Alanine 191.99 204.74 182.78 208.00 7.89 0.43 0.28 
 Asparagine 36.39 39.22 33.46 40.05 2.11 0.33 0.21 
 Aspartate 3.85 4.68 4.62 4.90 0.30 0.26 0.01 
 Cysteine/Cystine* 6.56 8.75 8.54 10.41 0.43 0.70 0.97 
 Glutamate 34.91 38.05 36.99 38.64 1.47 0.58 0.02 
 Glutamine 251.94 263.91 240.5 255.15 9.01 0.88 0.38 
 Glycine 434.39 420.4 419.27 392.03 21.53 0.76 0.95 
 Proline 72.63 75.44 71.97 81.04 2.88 0.29 0.26 
 Serine 90.31 87.02 82.94 90.81 3.23 0.09 0.20 
 Tyrosine 41.82ab 39.75b 39.82b 47.04a 2.17 0.04 0.10 
 NEAA 1141.09 1181.91 1104.44 1140.62 35.63 0.96 0.38 
 TAA 1959.00 2049.14 1910.98 2075.87 60.09 0.51 0.31 
 Met%TAA 0.94 1.39 0.94 1.34 0.06 0.67 0.69 
 Lys%TAA 3.07 3.43 3.34 3.48 0.15 0.13 0.99 
*Significant (P < 0.05) parity effect observed. 
1CON = control; SMA = Smartamine M (0.08% of DM); REA = ReaShure (60 g/d); MIX = 
SMA+REA. 
2Greatest SEM. 
3Interaction of MET × CHOL. 
4Interaction of MET × CHOL × Time. 
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Supplemental Table 5.2. Plasma non-proteinogenic AA and AA derivatives 
concentrations during the transition period in cows supplemented with or without rumen-
protected MET and CHOL.   
 Treatments  P-value 
Parameter (µM) CON1 SMA REA MIX SEM2 M×C3 M×C×T4 
AA and derivatives#        
 1-methyl histidine 16.30 17.29 14.48 15.86 0.82 0.73 0.50 
 3-methyl histidine 6.85 7.09 6.06 5.92 0.42 0.63 0.90 
 α-aminoadipic acid 7.57 8.52 7.18 7.80 0.53 0.78 0.90 
 α-aminobutyric acid 15.99 20.56 15.31 19.04 1.22 0.78 0.61 
 β-alanine 9.08 8.54 9.04 9.19 0.45 0.45 0.71 
 γ-aminobutyric acid 1.86 3.07 2.99 3.91 0.42 0.73 0.59 
 Carnosine* 14.62 18.84 17.25 21.08 1.27 0.78 0.64 
 Citrulline 73.50 85.08 68.96 81.88 4.13 0.79 0.71 
 Glutathione 4.48 5.20 4.88 4.26 0.40 0.09 0.43 
 Hydroxylysine 0.34 0.27 0.30 0.28 0.06 0.62 0.90 
 Hydroxyproline 15.35 15.50 15.04 15.22 0.71 0.98 0.76 
 Ornithine 29.60 31.38 28.69 32.64 1.95 0.56 0.63 
 Phosphoserine 5.91 6.23 6.55 6.13 0.27 0.15 0.19 
 Sarcosine 11.35 11.65 9.95 11.20 0.83 0.54 0.88 
 Urea 4169.91 4483.16 4073.91 4402.78 176.54 0.95 0.73 
Sulfur containing AA and derivatives      
 Cystathionine 1.55 2.12 1.65 2.12 0.10 0.57 0.64 
 Homocystine 4.22 4.85 4.13 5.36 0.45 0.49 0.26 
 Taurine 30.57c 48.29a 35.89b 45.80a 1.81 0.04 0.53 
 TSAA5 63.05 92.02 69.16 93.04 2.63 0.35 0.16 
 Met%TSAA 30.27 31.92 26.61 30.88 1.06 0.21 0.94 
*Significant (P < 0.05) parity effect observed. #β-aminobutyric acid undetectable 
1CON = control; SMA = Smartamine M (0.08% of DM); REA = ReaShure (60 g/d); MIX = 
SMA+REA. 
2Greatest SEM. 
3Interaction of MET × CHOL. 
4Interaction of MET × CHOL × Time. 
5Total sulfur-containing AAs and derivatives (methionine, cystathionine, cystine, homocysteine, 
and taurine). 
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Supplemental Table 5.3. Hepatic short chain acyl coenzyme A (CoA) concentrations and 
relative PC# and PCK1 mRNA expression during the transition period in cows supplemented 
with or without rumen-protected MET and CHOL.    
 Treatments  P-value 
Parameter  CON1 SMA REA MIX SEM2 M×C3 M×C×T4 
CoAs (nmol/g)        
 Acetyl-CoA* 1.46 0.91 0.47 0.45 0.45 0.49 0.34 
 Propionyl-CoA 4.14 1.34 3.02 1.34 0.92 0.46 0.40 
 Succinyl-CoA* 67.68cd 216.24a 121.89b 91.57bc 28.38 <0.01 0.13 
 Total CoA* 95.60b 226.15a 129.12b 94.30b 29.40 <0.01 0.08 
Gene        
 PC 2.13 2.05 2.11 1.99 0.11 0.87 0.77 
 PCK1 2.39 2.39 2.16 2.46 0.14 0.26 0.10 
*Significant (P < 0.05) parity effect observed. #PC=pyruvate carboxylase; 
PCK1=Phosphoenolpyruvate carboxykinase 1. 
1CON = control; SMA = Smartamine M (0.08% of DM); REA = ReaShure (60 g/d); MIX = 
SMA+REA. 
2Greatest SEM. 
3Interaction of MET × CHOL. 
4Interaction of MET × CHOL × Time. 
5Total sulfur-containing AAs and derivatives (methionine, cystathionine, cystine, homocysteine, 
and taurine). 
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Supplemental Figure 5.1 
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Supplemental Figure 5.2 
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Supplemental Figure 5.3 
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Supplemental Figure 5.4
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Supplemental Figure 5.5
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Supplemental Figure 5.6 
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Supplemental Figure 5.7 
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Supplemental Figure 5.8 
Cystathionine
C
ys
ta
th
io
n
in
e
 (
µ
M
)
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
With CHOL
Without CHOL
CHOL P = 0.61
Day     P < 0.01
C × D  P = 0.36
Homocysteine
H
o
m
o
c
ys
te
in
e
 (
µ
M
)
3.0
3.5
4.0
4.5
5.0
5.5
6.0
With CHOL
Without CHOL
CHOL P = 0.65
Day     P < 0.01
C × D  P = 0.28
Taurine
T
a
u
ri
n
e
 (
µ
M
)
20
30
40
50
60 With CHOL
Without CHOL
CHOL P = 0.44
Day     P < 0.01
C × D  P = 0.92
TSAA
Day relative to parturition
-10 4 14 28
T
S
A
A
 (
µ
M
)
70
72
74
76
78
80
82
84
86
88
90
92
With CHOL
Without CHOL
CHOL P = 0.44
Day     P < 0.01
C × D  P = 0.92
Glutathione
G
lu
ta
th
io
n
e
 (
µ
M
)
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0 With MET 
Without MET 
MET    P = 0.89
Day     P < 0.01
M × D  P = 0.50
Glutathione
G
lu
ta
th
io
n
e
 (
µ
M
)
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5 With CHOL
Without CHOL
CHOL P = 0.50
Day     P < 0.01
C × D  P = 0.74
MET%TSAA
Day relative to parturition
-10 4 14 28
M
E
T
%
T
S
A
A
24
26
28
30
32
34
36
With CHOL
Without CHOL
CHOL P = 0.03
Day     P < 0.01
C × D  P = 0.24
G
FE
DC
BA
  
  
187 
 
Supplemental Figure 5.9 
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Supplemental Figure 5.1. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on circulating arginine, lysine, 
histidine, phenylalanine, threonine, and tryptophan. Values are means, with standard errors 
represented by vertical bars. 
Supplemental Figure 5.2. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) on 
circulating valine, leucine, isoleucine, and branch-chained amino acids (BCAA) concentrations. 
Values are means, with standard errors represented by vertical bars. 
Supplemental Figure 5.3. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) on 
circulating alanine, cysteine/cystine, asparagine, aspartate, glutamine, and gluatamate 
concentrations. Values are means, with standard errors represented by vertical bars. 
Supplemental Figure 5.4. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on circulating glycine, proline, 
serine, and tyrosine concentrations. Values are means, with standard errors represented by 
vertical bars.  
Supplemental Figure 5.5. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on circulating essential amino acids 
(EAA), non-essential amino acids (NEAA), total amino acids (TAA) concentrations, and  
percentage of methionine in EAA, percentage of methionine in TAA, and percentage of lysine in 
TAA. Values are means, with standard errors represented by vertical bars.  
Supplemental Figure 5.6. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on circulating α-amino butyric acid, 
β-alanine, carnosine, citrulline, and ornithine concentrations. Values are means, with standard 
errors represented by vertical bars.  
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Supplemental Figure 5.7. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on circulating 1-methyl histidine, 3-
methyl histidine, hydroxylysine, hydroxyproline, phosphoserine, and urea concentrations. Values 
are means, with standard errors represented by vertical bars.  
Supplemental Figure 5.8. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on circulating cystathionine, 
homocystine, glutathione, taurine, total sulfur-containing amino acids (TSAA) concnetrantions, 
and percentage of methionine in TSAA. Values are means, with standard errors represented by 
vertical bars.  
Supplemental Figure 5.9. Effects of supplementing multiparous Holstein cows during the 
peripartal period with rumen-protected methionine (MET; Smartamine M, Adisseo NA) or 
rumen-protected choline (CHOL; ReaShure, Balchem Inc.) on relative mRNA expression of 
pyruvate carboxylase (PC) and phosphoenolpyruvate carboxykinase 1 (PCK1). Values are 
means, with standard errors represented by vertical bars.  
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CHAPTER 6 
DIFFERENCES IN LIVER FUNCTIONALITY INDICES IN PERIPARTAL DAIRY 
COWS SUPPLEMENTED WITH RUMEN-PROTECTED METHIONINE OR CHOLINE 
ARE ASSOCIATED WITH PERFORMANCE, OXIDATIVE STRESS STATUS, AND 
PLASMA AA PROFILES  
-Journal of Dairy Science, 2017, In press 
INTRODUCTION 
Around parturition, the metabolic stress inflicted by negative energy and nutrient balance 
contributes greatly to the occurrence of most metabolic and infectious diseases of dairy cows 
during the first few weeks of lactation (Goff and Horst, 1997). In fact, various diseases 
manifested at later stages of lactation also are related to metabolic insults during the peripartal 
period (Bertoni et al., 2008). It is noteworthy that metabolic stress around parturition may impair 
production and reproduction performance of dairy cows even in the absence of serious infections 
or other pathologies (Bionaz et al., 2007). Hence, assessing metabolic status around parturition 
can help diagnose nutritional management-related issues in dairy farms.  
Although metabolic profiling can be a useful diagnostic tool to prevent metabolic 
disorders, it has not been routinely adopted owing to cost and insensitivity to nutritional 
inadequacies (Bertoni and Trevisi, 2013). In contrast, a composite index such as the liver 
functionality index (LFI) using changes in plasma concentrations of several blood biomarkers 
(i.e. albumin, cholesterol, and bilirubin) has promise for diagnosis and correction of management 
and nutritional problems on dairy farms (Bertoni and Trevisi, 2013). In fact, results from 
previous work have demonstrated the applicability of the LFI to assess immune and 
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inflammatory status as well as metabolic profiles in the periparturient period (Calamari et al., 
2014, Zhou et al., 2016b). For instance, a low LFI (LLFI) is indicative of a pronounced 
inflammatory response and less favorable circulating AA profile, which together is suggestive of 
a more difficult transition from gestation to lactation. In contrast, a high LFI (HLFI) is 
suggestive of a smooth transition (Trevisi et al., 2012). 
It is noteworthy that feed additives such as rumen-protected methionine (MET) and 
choline (CHOL) and ionophores are often supplemented to transition dairy cows in an effort to 
improve not only essential AA and gluconeogenic precursor availability but also hepatic fatty 
acid metabolism. As such, these approaches result in physiologic profiles associated with a 
smoother transition into lactation (Zahra et al., 2006, Swyers et al., 2014, Osorio et al., 2016). 
Although it is possible to assess changes in metabolic and inflammatory status in response to 
feed additive supplementation (Batistel et al., 2016, Osorio et al., 2016, Zhou et al., 2016a, Zhou 
et al., 2016c), the cost and time needed to obtain results make it a less desirable approach for 
evaluating effectiveness of feed additives. In addition, due to differences in nutrition and 
management strategies among farms, variation in effectiveness of such feed additives are 
commonly observed even among research conducted in well-controlled environments (Pinotti et 
al., 2003, Guretzky et al., 2006, Chen et al., 2011, Zom et al., 2011, Osorio et al., 2013, Leiva et 
al., 2015).  
A composite index such as the LFI, which can be determined at lower cost without 
invasive procedures, can potentially help evaluate effectiveness of feed additives within a farm-
specific environment. However, it is unknown whether feed additive-induced changes in 
metabolic and inflammatory profiles of transition dairy cows are manifested in the LFI. Our 
general hypothesis was that favorable changes in response to peripartal MET and CHOL 
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supplementation lead to higher HLFI, indicating a more favorable immunometabolic status 
around parturition. Therefore, the objectives of the present study were to determine 1) if MET 
and/or CHOL alter the LFI response in cows; and 2) if HLFI and LLFI cows have distinct 
oxidative stress status in addition to lactation performance and plasma AA profiles.  
Materials and Methods 
Experimental design and treatments  
All procedures for this study (protocol no. 13023) were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Illinois. Details of the 
experimental design and the feeding regime (nutrient composition and evaluation) have been 
described previously (Zhou et al., 2016c). Briefly, the experiment was conducted as a 
randomized, complete, unbalanced, block design with 2×2 factorial arrangement of MET 
(Smartamine M, Adisseo NA, Alpharetta, GA) and CHOL (ReaShure, Balchem Inc, New 
Hampton, NY) level (with or without) using a total of 81 cows. Cows within each block were 
balanced for parity, previous lactation milk yield, and BCS before the close-up diet groups were 
assigned. Per IACUC guidelines, only half of the cows in each treatment were used for routine 
blood sampling. Thus, for the present study a total of 40 cows were used. Treatments were 
control (CON, n = 10), with no MET or CHOL supplementation; Smartamine (SMA, n = 10), 
CON plus MET at a rate of 0.08% of DM; Reashure (REA, n = 10), CON+CHOL at 60 g/d; or 
Smartamine and Reashure (MIX, n = 10), CON+MET+CHOL. Dosage of MET was based on 
Osorio et al. (2013), whereas CHOL was supplemented following the manufacturer’s 
recommendations. All cows received the same far-off diet from -50 to -22 d before expected 
parturition, close-up diet from -21 d to expected parturition, and lactation diet from parturition 
through 30 days in milk (DIM). The MET and CHOL supplements were both top-dressed from -
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21 ± 2 to 30 DIM once daily at the AM feeding using approximately 50 g of ground corn as 
carrier for all treatments. Supplementation of SMA (0.08% DM of TMR offered) was calculated 
daily for each cow. Smartamine M was supplied as small beads containing a minimum of 75% 
DL-Met, physically protected by a pH sensitive coating, which is considered to have a Met 
bioavailability of 80% (Graulet et al., 2005); therefore, per 10 g of SMA, the cows received 6 g 
of metabolizable Met. With MET supplementation, the amount of Met in prepartal diets 
increased from 1.86% to 2.37% of the MP. Similarly, the amount of Met in postpartal diets also 
increased from 1.79% to 2.30% of the MP. The REA supplement is reported to contain 28.8% 
choline chloride and is protected by microencapsulation. Although the product is considered to 
have CHOL bioavailability of 72% (Benoit, 2009), i.e. per 60 g of REA the cows should have 
received 12.4 g of metabolizable choline chloride, a recent study estimated the relative 
bioavailability (i.e. net absorption of choline in ReaShure from intestine) at 8% (de Veth et al., 
2016). Thus, using that value to calculate the amount of choline that was bioavailable from 
ReaShure in our study gives 1.03 g free choline (60 g/d ReaShure  28.8% choline-chloride (CC) 
content  74.6% choline in CC  8% bioavailability. Clearly, these discrepancies should be taken 
into account when evaluating the present data in the context of choline adequacy. To our 
knowledge, neither SMA nor REA have specific characteristics that may affect palatability of 
diets. 
The LFI was determined for all cows based on plasma concentration of albumin, 
cholesterol and bilirubin as described in Bertoni and Trevisi (2013), and this used to rank the 
cows retrospectively. The LFI calculation was carried out in two steps; the first one considers the 
concentration values (V) of the three parameters detected on d 3 (V3) and changes in 
concentrations between d 3 and 28 (V28). The albumin and cholesterol index was calculated as 
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0.5*V3 + 0.5*(V28-V3), with albumin and cholesterol level on d 3 postpartum representing 50% 
and the reduction between d 3 and 28 the remaining 50% of the partial LFI index. Similarly, the 
bilirubin index was calculated using concentration value as 0.67V3 + 0.33 (V28-V3), with 
bilirubin level on d 3 postpartum representing 67% and the reduction between d 3 and 28 the 
remaining 33% of the partial LFI index. In the second step, the LFI was calculated according to 
the following formula: LFI = [(albumin index - 17.71)/1.08 + (cholesterol index - 2.57)/0.43-
(bilirubin index - 6.08)/2.17] (Zhou et al., 2016b). Cows were ranked retrospectively according 
to LFI and assigned to a low LFI group (LLFI), and a high LFI group (HLFI) regardless of 
MET or CHOL supplementation. Cows with a positive LFI (31 cows, mean ± SEM: 2.04 ± 0.24) 
were considered as the HLFI group and cows with a negative LFI (9 cows, mean ± SEM: -3.63 ± 
0.76) were considered as the LLFI group. 
Animal management 
Full details have been reported previously (Zhou et al., 2016c). Briefly, dry cows were 
housed in a ventilated enclosed barn during the dry period and fed individually once daily at 
0630 h using an individual gate system (American Calan Inc., Northwood, NH). After 
parturition, cows were housed in a tie-stall barn and were fed a common lactation diet once daily. 
Feed offered was adjusted daily to achieve ~10% refusals.  
Feed and Milk Sample Collection and Analyses  
 Full details have been reported previously (Zhou et al., 2016c). Briefly, dry matter intake 
and milk yield were recorded daily. Consecutive morning, midday, and evening milk samples 
were taken weekly until 30 DIM. Composite milk samples were prepared in proportion to milk 
yield at each milking, preserved (800 Broad Spectrum Microtabs II; D & F Control Systems Inc., 
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San Ramon, CA), and analyzed for contents of fat, protein, lactose, SNF, MUN, and SCC by 
mid-infrared procedures in a commercial laboratory (Dairy Lab Services, Dubuque, IA).  
Blood and Liver Sample Collection and Biomarker Analyses 
Full details have been reported previously (Zhou et al., 2016a). Briefly, blood was 
sampled for biomarker analysis from the coccygeal vein on -10 d relative to expected calving 
date and on 4, 8, 20, and 30 d relative to actual calving date before the morning feeding. For 
plasma AA and derivative analyses, blood was sampled from the coccygeal vein on -30 and -10 
d relative to expected parturition date and on 4, 14 and 28 d relative to actual parturition date 
before the morning feeding. Samples were collected into evacuated tubes (BD Vacutainer; BD 
and Co., Franklin Lakes, NJ) containing either clot activator or lithium heparin for serum and 
plasma, respectively.  Liver was sampled via puncture biopsy from cows under local anesthesia 
at approximately 0800 h on d -10, 7, 20, and 30 d relative to parturition (Zhou et al., 2016a). 
Liver was frozen immediately in liquid nitrogen and stored until analysis. 
Plasma was analyzed for creatinine, bilirubin, aspartate aminotransferase (GOT), 
gamma-glutamyl transferase (GGT), cholesterol, paraoxonase (PON), albumin, ceruloplasmin, 
haptoglobin, myeloperoxidase (MPO), reactive oxygen metabolites (ROM), and ferric reducing 
ability of plasma (FRAP) using kits purchased from Instrumentation Laboratory (Lexington, 
MA) following the procedures described previously (Jacometo et al., 2015) using the clinical 
auto-analyzer (ILAB 600, Instrumentation Laboratory). Bovine IL-1β (Cat. No. ESS0027; 
Thermo Scientific, Rockford, IL) plasma concentration was determined using commercial kits. 
Plasma total glutathione (GSH) as well as liver total and reduced GSH were measured using a 
commercial kit (Cat. No. NWH-GSH01; Northwest Life Science Specialties LLC, Vancouver, 
WA). 
  
199 
 
Analyses of Plasma AA and their Derivatives 
Plasma was used to analyze the concentrations of free Arg, His, Ile, Leu, Lys, Met, Phe, 
Thr, Trp, Val, Asn, Asp, Ala, Glu, Gln, Gly, Pro, Ser, Tyr, Cit, carnosine, Orn, Sar, 
cystathionine, cystine, homocystine, taurine, α-aminoadipic acid, α-aminobutyric acid, β-alanine, 
γ-aminobutyric acid (GABA), hydroxylysine, hydroxyproline, phosphoserine, 1-methyl 
histidine, and 3-methyl histidine at the University of Missouri Agriculture Experiment Station 
Chemical Laboratories (Columbia, MO) using high-performance liquid chromatography (Deyl et 
al., 1986, Fekkes, 1996). The essential AA (EAA) pool included Arg + His + Ile + Leu + Lys + 
Met + Phe + Thr + Trp + Val; the non-essential AA (NEAA) pool included Asn + Asp + Ala + 
Gln + Glu + Gly + Pro + Ser + Tyr; total AA (TAA) was the sum of EAA and NEAA; the total 
sulfur-containing compounds (TSC) included Met + cystine + cystathionine + homocystine + 
taurine + GSH. 
Statistical analysis  
Data were assessed for normality of distribution using the Shapiro-Wilk test. When the 
normality assumption was rejected, data were log-transformed before statistical analysis. Back-
transformed data were reported in Tables and Figures for ease of interpretation. Data were 
analyzed using PROC MIXED of SAS (SAS Institute Inc., Cary, NC). The model for data 
analysis contained LFI, day, and their interactions as fixed effects, and cow nested within LFI as 
random effect. For the analysis of all variables, parity was kept in the model as covariate when 
significant. For the analysis of various AA and derivatives, concentrations obtained at -30 d were 
maintained in the model as covariates when significant (P < 0.05). Amino acids and biomarkers 
in plasma and liver were analyzed at various time points that were not equally spaced. Therefore, 
the first order ante-dependence covariance structure ANTE (1) were used for repeated measures. 
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Frequency of MET- and CHOL-supplemented cows in the HLFI or LLFI group and health data 
were analyzed with PROC GLIMMIX (distribution = binary and link = logit) of SAS. Least 
square means separation between time points was performed using the PDIFF statement. 
Statistical differences were declared significant at P ≤ 0.05 and tendencies at P ≤ 0.10.  
RESULTS 
Distribution of MET- and/or CHOL- supplemented cows in LFI groups 
Distribution MET and/or CHOL supplemented cows in LLFI and HLFI groups is 
summarized in Table 6.1. Among the 20 MET-supplemented cows, only 2 cows had an LFI < 0. 
In contrast, 7 cows without MET supplementation during the peripartal period were in the LLFI. 
Hence, although the majority (65%) of cows without MET supplementation ended up with a 
HLFI, a tendency for a greater (P = 0.06) number of MET-supplemented cows in the HLFI was 
observed. In contrast, peripartal CHOL supplementation resulted in a similar number of cows in 
the LLFI (4 vs. 5) and HLFI (15 vs. 16).  
Animal Health and Performance  
Health-related problems that occurred during the experiment and production performance 
are summarized in Table 6.2 and Table 6.3, respectively. As expected, cows with LLFI had 
greater incidence of health-related problems, as indicated by more cases of ketosis (P < 0.01) and 
a tendency for more cases of displaced abomasum (P = 0.06, 1 vs. 0). Both prepartal (P < 0.01; 
Figure 6.1A) and postpartal (P < 0.01; Figure 6.1B) DMI was greater in cows with HLFI. 
Similarly, compared with LLFI cows, overall milk yield (P < 0.01; Figure 6.1C), milk protein 
yield (P < 0.01), and milk fat yield (P = 0.02) were also greater in cows with HLFI.  
Biomarkers of muscle mass, inflammation, liver function, and oxidative stress 
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Effects of LFI on blood and liver biomarkers are summarized in Table 6.4. Although 
plasma BHBA did not differ between LLFI and HLFI cows, a tendency (P = 0.09) for lower fatty 
acid concentrations was observed in HLFI cows. Greater (P = 0.05; Figure 6.2A) circulating 3-
methyl histidine concentration was observed in LLFI cows. In agreement with 3-methyl 
histidine, a tendency for lower (P = 0.06; Figure 6.2B) creatinine concentration was also shown 
in plasma of LLFI cows. As expected, greater albumin (P < 0.01; Figure 6.2C) and cholesterol (P 
< 0.01; Figure 6.2D) as well as lower bilirubin (P = 0.05; Figure 6.2E) were observed in HLFI 
cows. In addition, overall plasma haptoglobin concentration also was lower (P = 0.02; Figure 
6.2F) in HLFI cows.  Although overall circulating concentration did not differ between LLFI and 
HLFI cows, an LFI×day interaction (P < 0.01) was observed for ceruloplasmin, which increased 
to a greater extent in cows with LLFI on d 30 postpartum.  
Among the oxidative stress biomarkers determined in the present study, HLFI cows had 
greater (P < 0.01; Figure 6.2G) overall circulating PON concentrations compared with LLFI 
cows. In agreement with PON, overall hepatic total (P = 0.05) and reduced (P = 0.05; Figure 
6.2H) GSH levels in HLFI cows were doubled compared with cows in the LLFI group. Although 
overall plasma FRAP values did not differ between HLFI and LLFI cows, an LFI×day 
interaction (P < 0.01) was observed due to a greater level in LLFI cows on d 30 postpartum. 
AA and derivatives  
Effects of LFI on plasma AA and derivatives are summarized in Table 6.5 and Table 6.6, 
respectively. Although similar (P > 0.05) levels of circulating EAA were observed in LLFI and 
HLFI cows, HLFI cows had greater circulating His (P = 0.02) and Trp (P = 0.03) as well as a 
tendency (P = 0.06) for greater plasma Ile. Similarly, plasma Met also was greater (P = 0.01; 
Figure 6.3D) in cows with HLFI owing to more (P = 0.06) MET-supplemented cows in this 
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group. Although overall plasma Arg did not differ between HLFI and LLFI cows, an LFI×day 
interaction (P = 0.10) was observed due to greater level of Arg on d 4 in HLFI cows. In contrast, 
an LFI×day interaction (P = 0.02) was observed due to a lower level of Phe on d 28 in HLFI 
cows. 
Unlike EAA, circulating concentrations of most NEAA were either greater (Ala, Asp, 
Gln, Pro, and Ser, P < 0.05) or tended to be greater (Tyr, P = 0.09) in HLFI cows. In fact, despite 
similar circulating levels of EAA between LLFI and HLFI cows, overall circulating TAA was 
greater (P = 0.01; Figure 6.3A) in HLFI cows owing mainly to greater (P = 0.01; Figure 6.3B) 
overall circulating NEAA concentrations in these cows. It is noteworthy that HLFI cows also 
tended to have greater (P = 0.08) overall percentage of Met in the total AA pool (Met%TAA). In 
contrast, an LFI×day interaction was observed due to a lower (P = 0.03) percentage of Lys in the 
total AA pool (Lys%TAA) on d 4 in HLFI cows.  
As expected, greater (P < 0.01; Figure 6.3F) homocystine and a tendency (P = 0.07; 
Figure 6.3E) for greater cystathionine were observed in HLFI cows likely due to more MET-
supplemented cows in this group. Although overall taurine concentration was similar between 
HLFI and LLFI cows, an LFI×day interaction was observed due to a greater (P = 0.03) 
concentration of taurine on d -10 in HLFI cows (Figure 6.4). In addition, the proportion of Met in 
the TSC also was greater (P = 0.05; Figure 6.3C) in the HLFI group due to greater circulating 
Met in these cows. Consequently, overall circulating level of TSC also was greater in HFLI 
compared with LLFI cows.  
Besides taurine, concentration of carnosine, another antioxidant, also was greater (P = 
0.01) in cows with HLFI. Although overall plasma α-aminobutyric acid and γ-aminobutyric acid 
concentrations were similar between LLFI and HLFI cows, an LFI×day interaction was observed 
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due to higher concentrations of α-aminobutyric acid (P = 0.01) and γ-aminobutyric acid (P = 
0.03) on d 14 in HLFI cows. Although a main effect of LFI for Orn was not observed, greater Cit 
(P < 0.01) and an interaction (P = 0.10) for greater circulating urea on 28 d were observed in 
HLFI cows in addition to greater circulating concentration of Arg on 4 d in HFLI cows.  
DISCUSSION 
Health and performance in cows with HLFI and LLFI 
Compared with LLFI (LFI < 0), cows with HLFI (LFI > 0) are considered to be at a 
lesser risk of health problems during the peripartal period (Bertoni and Trevisi, 2013, Zhou et al., 
2016b). The fact that none of the 31 cows in the HLFI group were ketotic or experienced 
displaced abomasum confirmed the usefulness, in the present study, of LFI in identifying cows at 
risk even when metabolically important feed additives such as MET or CHOL are supplemented 
around parturition. Considering MET supplementation led to a lower incidence of ketosis (Zhou 
et al., 2016c), and that more MET-supplemented cows were in the HLFI group, the overall lower 
incidence of ketosis observed in HLFI cows was likely due to MET supplementation. 
In agreement with better lactation performance benefits observed in HLFI cows, recent 
results from our group have demonstrated greater pre- and post-partum DMI, milk fat yield, and 
milk protein yield in response to peripartal MET but not CHOL supplementation (Zhou et al., 
2016c). Considering only a tendency for greater milk yield was detected in a previous LFI study 
that did not involve MET or CHOL supplementation (Zhou et al., 2016b), the differences 
observed between LLFI and HLFI cows were due in large part to peripartal MET 
supplementation. 
Inflammation and oxidative stress in cows with HLFI and LLFI 
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Acute phase proteins (APP) of liver origin serve as useful biomarkers to evaluate chronic 
inflammation mainly due to the decrease of circulating concentrations of negative APP (e.g. 
albumin) and the contemporary increase of positive APP (e.g. haptoglobin) (Bertoni et al., 2008, 
Ceciliani et al., 2012). Therefore, the substantially greater plasma concentration of albumin (2.1 
g/L) and lower haptoglobin (0.12 g/L) in HLFI cows was suggestive of a less pronounced 
inflammatory status around parturition.  
Inflammatory biomarkers in plasma are increased in the circulation of ketotic cows 
around parturition (Abuajamieh et al., 2016). Hence, the fact that none of the cows in the HLFI 
group were ketotic may have greatly contributed to the differences in inflammation status 
observed between the two cohorts of cows. In addition, rodent research revealed that limiting 
MET and CHOL in ketogenic diets increased expression of fatty acid oxidation and 
inflammatory genes, supporting a potential role of MET and CHOL supplementation on ketosis-
related inflammation (Pissios et al., 2013). In agreement with this, MET-supplemented cows 
experienced fewer cases of ketosis and had greater plasma concentrations of albumin, cholesterol 
(index of lipoproteins) and lower haptoglobin  (Zhou et al., 2016a, Zhou et al., 2016c), 
suggesting MET supplementation had direct bearing on the lower inflammatory status in HLFI 
cows. In contrast, CHOL supplementation was not associated with changes in the incidence of 
ketosis or plasma albumin, cholesterol, and haptoglobin concentrations.  
Apart from disease-induced inflammation around parturition, the lack of proper 
antioxidant defenses renders oxidative stress as another significant contributing factor to 
systemic inflammation (Sordillo et al., 2009). The fact that a hepatic intracellular antioxidant 
(GSH), a circulating antioxidant enzyme (PON), FRAP/ROM ratio, and a circulating dipeptide 
(carnosine) with antioxidant properties were all greater in HLFI cows indicated an overall less 
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pronounced state of oxidative stress (Bionaz et al., 2007, Boldyrev et al., 2013). From a 
mechanistic standpoint, the fact that in vivo synthesis of GSH ultimately requires sulfur from 
MET, support the view that the greater hepatic GSH and reduced GSH concentrations in HLFI 
cows were a result of the greater number of MET-supplemented cows in this group. In agreement 
with this, as a non-sulfur-containing compound, peripartal CHOL supplementation did not seem 
to increase hepatic sulfur-containing antioxidant synthesis through the transsulfuration pathway 
(Zhou et al., 2017a). In fact, an increase in plasma cystine in response to peripartal CHOL 
supplementation was likely achieved at the expense of MET (Zhou et al., 2017b). As such, we 
speculate that peripartal MET but not CHOL supplementation led to less pronounced oxidative 
stress status in HLFI cows by enhancing sulfur-containing antioxidant synthesis through the 
transsulfuration pathway. 
It is noteworthy that although differences in plasma bilirubin and cholesterol 
concentrations indicate a less-than-optimal liver function in LLFI cows, the similar plasma GOT 
and GGT concentrations between LLFI and HLFI cows and the fact these values were within the 
range considered normal for healthy cows (Bertoni et al., 2008) are indicative of the absence of 
liver damage. Similarly, although LLFI cows had lower hepatic GSH and plasma PON 
suggesting a less-than-optimal oxidative stress status, the fact that concentrations of FRAP, 
MPO, and ROM in LLFI cows were similar to HLFI cows indicates that they were not suffering 
from severe systemic oxidative stress. Thus, although biomarker analysis in the present study 
indicated that LLFI cows were in a more challenging physiologic state, they were still in better 
overall health than those reported in previous research design to test the validity of the LFI index 
(Bionaz et al., 2007; Bertoni et al., 2008). 
AA profile in cows with HLFI and LLFI 
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Around parturition the decrease in DMI coupled with the increase in AA requirements to 
sustain fetal growth and lactation lead to greater tissue protein mobilization evidenced in part by 
the highest plasma 3-methyl histidine at 4 d regardless of LFI. However, the lower degree of 
tissue catabolism indicated by lower 3-methyl histidine along with the greater muscle mass 
suggested by greater circulating creatinine also revealed a lesser degree of tissue mobilization 
around parturition in HLFI cows. Whether such response was due to a more desirable circulating 
AA profile or an endocrine response induced by differences in AA is unknown. We speculate 
that the greater concentrations of various proteinogenic circulating EAA (His, Ile, Met, and Trp), 
NEAA (Ala, Asn, Gln, Pro, Ser, and Tyr), and non-proteinogenic AA (Cit) in HLFI cows not 
only reflect the greater pre- and post-partum DMI but also less reliance on skeletal muscle to 
provide substrates for milk protein synthesis and gluconeogenesis. It remains to be determined at 
a more mechanistic levels what adaptations might have been induced in the skeletal muscle when 
MET was supplemented. In addition, the fact that concentration of circulating AA was lower in 
LLFI cows supports recent data in sheep demonstrating greater consumption of AA during 
inflammatory events (Hoskin et al., 2016).  
It is noteworthy that the proportion of Met in TAA (Met%TAA) was greater in HLFI 
cows. Concomitantly, the overall greater cystathionine and homocystine in addition to Met were 
largely responsible for the greater circulating total sulfur-containing compounds. Considering 
that an increase in sulfur-containing compounds in a previous LFI study without MET 
supplementation was not observed (Zhou et al., 2016b), and that more cows with MET 
supplementation ended up in the HLFI group, the increase in circulating sulfur-containing 
compounds were likely the result of MET supplementation. Although CHOL could potentially 
achieve similar outcomes by promoting in vivo synthesis of Met, recent data from our group have 
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demonstrated that in vivo CHOL supplementation did not seem to promote MET synthesis in 
liver, a response that could  have been due to a limited level of sulfur-containing substrate 
around parturition (Zhou et al., 2017a).   
CONCLUSIONS 
Overall, the lower incidence of health complications, better lactation performance, and 
more favorable biomarker and plasma AA profiles in HLFI cows indicate a better 
immunometabolic status during the peripartal period. As more MET-supplemented cows were in 
the HLFI group, the differences observed between the two cohorts were due in large part to 
peripartal MET supplementation. Although CHOL supplementation is expected to achieve 
similar benefits as MET in terms of immunometabolic status, the fact that CHOL 
supplementation failed to improve LFI, at least in the present study, did not support this notion. 
However, if as reported recently the choline bioavailability from ReaShure meant that only a 
small fraction of the targeted dose was available to tissues, it is still possible that greater CHOL 
levels are able to impact LFI in a positive fashion. The LFI was able to differentiate effectiveness 
between MET and CHOL feeding, hence, supporting its broader application in the management 
of transition cows. Further studies on the applicability of these biomarkers to monitor transition 
success appears warranted.  
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TABLES AND FIGURES 
Table 6.1. Frequency of peripartal rumen protected methionine (MET) and/or choline (CHOL) 
supplemented multiparous Holstein cows in low and high liver functionality index (LFI) groups. 
 MET CHOL P-value 
LFI +MET -MET +CHOL -CHOL MET CHOL 
Low LFI 2 7 5 4 
0.06 0.71 
High LFI 18 13 15 16 
Low LFI (%) 10 % 35 % 25 % 20 % 
High LFI (%) 90 % 65 % 75 % 80 % 
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Table 6.2. Frequency of occurrence of health problems during the peripartal period in 
multiparous Holstein cows retrospectively grouped into low and high liver functionality index 
(LFI). 
Variable Low LFI High LFI Low LFI (%) High LFI (%) P-value 
  Cows 9 31 - - - 
  Ketosis1 6 0 67 % 0 % < 0.01 
  Displaced abomasum 1 0 11 % 0 % 0.06 
  Retained placenta2 2 2 22 % 7 % 0.17 
  Mastitis 0 1 0 % 3 % 0.59 
1Defined as cows having moderate (~40 mg/dL) or large ketone concentrations (>80 mg/dL) in 
urine and treated by veterinarians with oral propylene glycol or intravenous dextrose. 
2Defined as fetal membranes retained >24 h after calving. 
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Table 6.3. DMI and milk production in peripartal Holstein cows retrospectively grouped into 
low and high liver functionality index (LFI).  
 LFI  P-value 
Parameter (kg/d) LLFI HLFI SEM1 LFI Day LFI×Day 
Prepartum       
  DMI  11.59 14.62 0.74 < 0.01 < 0.01 0.68 
Postpartum       
  DMI 16.14 20.21 0.96 < 0.01 < 0.01 0.21 
  Milk yield 36.24 46.30 2.20 < 0.01 < 0.01 0.07 
  Milk fat yield 1.35 1.59 0.08 0.02 < 0.01 0.34 
  Milk protein yield 1.09 1.48 0.07 < 0.01 < 0.01 0.06 
1Greatest SEM. 
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Table 6.4. Blood and liver biomarkers in peripartal Holstein cows retrospectively grouped into 
low and high liver functionality index (LFI). 
 LFI  P-value 
Parameter LLFI HLFI SEM LFI Day LFI×Day 
Muscle body mass       
  Creatinine (µmol/L) 86.35 91.91 2.42 0.06 < 0.01 0.28 
  3-methyl histidine 7.23 6.25 0.45 0.05 < 0.01 0.71 
Liver function markers       
  Bilirubin (µmol/L) 3.83 2.51 0.71 0.05 < 0.01 0.61 
  AGT (U/L) 97.78 98.91 4.57 0.83 < 0.01 0.36 
  Cholesterol (mmol/L) 2.60 3.35 0.14 < 0.01 < 0.01  < 0.01 
  GGT (U/L) 25.07 22.72 2.34 0.36 < 0.01 0.93 
Inflammation and APP       
  Albumin (g/L) 34.36 36.46 0.48 < 0.01 0.64 < 0.01 
  Ceruloplasmin (µmol/L) 2.71 2.67 0.15 0.84 < 0.01 < 0.01 
  Haptoglobin (g/L) 0.37 0.25 0.05 0.02 < 0.01 0.17 
  IL-1β (pg/mL) 5.49 4.67 1.08 0.48 < 0.01 0.17 
Oxidative stress       
 Ferric reducing ability of plasma (µmol/L) 131.81 132.59 4.28 0.87 0.08 0.05 
 Myeloperoxidase (U/L) 441.57 396.56 28.99 0.16 0.21 0.60 
 Paraoxonase (U/mL) 71.49 90.35 4.32 < 0.01 < 0.01 < 0.01 
 Reactive oxygen metabolites (mg H2O2/100mL) 13.65 12.97 0.67 0.37 < 0.01 0.19 
 Liver total glutathione (µmol/g protein) 12.26 25.11 4.27 0.05 < 0.01 0.97 
 Liver reduced glutathione (µmol/g protein) 11.75 24.35 4.21 0.05 < 0.01 0.98 
a,b,c,d Mean values with different superscripts differ (P < 0.05). 
1Greatest SEM.  
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Table 6.5. Plasma proteinogenic AA concentrations in peripartal Holstein cows retrospectively 
grouped into low and high liver functionality index (LFI). 
 LFI  P-value 
AA (µM) LLFI HLFI SEM1 LFI Day LFI×Day 
Essential AA       
 Arginine 54.95 58.29 2.47 0.26 < 0.01 0.10 
 Histidine 50.93 55.14 1.58 0.02 0.01 0.28 
 Isoleucine 89.39 102.66 5.56 0.06 0.30 0.24 
 Leucine 147.88 160.40 9.20 0.26 0.15 0.52 
 Lysine 62.74 65.34 3.57 0.53 0.03 0.14 
 Methionine 19.28 25.11 1.95 0.01 0.13 0.27 
 Phenylalanine 48.98 46.26 1.63 0.14 < 0.01 0.02 
 Threonine 70.68 77.04 3.73 0.14 0.09 0.88 
 Tryptophan 21.49 24.27 1.05 0.03 < 0.01 0.48 
 Valine 219.67 240.28 12.90 0.19 0.18 0.42 
 BCAA2 458.86 504.08 27.44 0.18 0.13 0.40 
 EAA3 789.06 858.75 36.42 0.12 0.04 0.31 
 Met%EAA 2.42 2.77 0.18 0.11 0.01 0.54 
 Lys%EAA 7.71 8.07 0.28 0.26 0.23 0.11 
Non-essential AA       
 Alanine 177.09 202.63 7.74 0.01 < 0.01 0.62 
 Asparagine 34.28 40.70 1.78 < 0.01 < 0.01 0.59 
 Aspartate 4.41 4.52 0.30 0.75 < 0.01 0.30 
 Glutamate* 36.94 37.17 1.36 0.88 < 0.01 0.11 
 Glutamine 235.01 258.06 9.06 0.03 < 0.01 0.76 
 Glycine 369.88 393.41 19.26 0.30 < 0.01 0.72 
 Proline 69.25 77.02 2.96 0.03 < 0.01 0.99 
 Serine 81.69 89.54 3.24 0.04 < 0.01 0.45 
 Tyrosine 38.47 43.16 2.34 0.09 < 0.01 0.10 
 NEAA4 1076.99 1175.86 31.12 0.01 < 0.01 0.70 
 TAA5 1884.92 2054.00 54.12 0.01 < 0.01 0.86 
 Met%TAA 1.01 1.18 0.08 0.08 < 0.01 0.54 
 Lys%TAA 3.45 3.31 0.16 0.45 < 0.01 0.03 
a,b,c,d Mean values with different superscripts differ (P < 0.05). 
*Significant (P < 0.05) parity effect observed. 
1Greatest SEM. 
2Branched-chain AA 
3Essential AA 
4Non-essential AA 
5Total AA  
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Table 6.6. Plasma amino acid derivative concentrations in peripartal Holstein cows 
retrospectively grouped into low and high liver functionality index (LFI). 
 LFI  P-value 
Parameter (µM) LLFI HLFI SEM LFI Day LFI×Day 
AA and derivatives#       
 1-methyl histidine 15.79 17.10 0.96 0.24 < 0.01 0.86 
 α-amino adipic acid 7.09 7.95 0.48 0.14 < 0.01 0.03 
 α-aminobutyric acid 16.06 18.06 1.20 0.18 < 0.01 0.01 
 β-alanine 8.79 8.71 0.47 0.87 0.94 0.60 
 γ-aminobutyric acid 2.33 3.13 0.49 0.16 < 0.01 0.03 
 Carnosine* 14.36 18.93 1.29 0.01 < 0.01 0.05 
 Citrulline 67.12 80.24 3.43 < 0.01 < 0.01 0.88 
 Hydroxylysine 0.35 0.31 0.04 0.35 0.76 0.75 
 Hydroxyproline 15.87 15.10 0.70 0.34 < 0.01 0.01 
 Ornithine 29.45 30.86 1.87 0.52 < 0.01 0.15 
 Phosphoserine 5.93 6.28 0.27 0.28 0.02 0.80 
 Sarcosine 9.31 9.92 0.74 0.49 < 0.01 0.60 
 Urea 4246.54 4412.14 176.69 0.41 0.01 0.10 
Sulfur-containing compounds       
 Cystathionine 1.64 1.93 0.13 0.07 < 0.01 0.11 
 Cystine 8.18 8.68 0.63 0.49 < 0.01 0.71 
 Glutathione 4.25 4.11 0.38 0.76 0.03 0.56 
 Homocystine 3.77 5.30 0.43 < 0.01 0.02 0.64 
 Taurine 37.07 41.02 2.74 0.21 < 0.01 0.04 
 TSC*2 75.22 86.57 4.92 0.05 0.06 0.29 
 Met%TSC 26.04 28.83 1.21 0.05 0.01 0.01 
a,b,c,d Mean values with different superscripts differ (P < 0.05). 
1Greatest SEM. 
2Total sulfur-containing compounds. TSC included Met + cystine + cystathionine + homocystine 
+ taurine + glutathione. 
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Figure 6.1 
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Figure 6.2
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Figure 6.3 
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Figure 6.1. Dry matter intake and milk yield during the periparturient period in cows 
retrospectively grouped into high (H) and low (L) liver functionality index (LFI; HLFI, LLFI).  
Figure 6.2. Plasma concentrations of 3-methyl histidine, creatinine, albumin, cholesterol, 
bilirubin, haptoglobin, paraoxonase, and hepatic reduced glutathione during the periparturient 
period in cows retrospectively grouped into high (H) and low (L) liver functionality index (LFI; 
HLFI, LLFI). *LSM differ by P < 0.05 (LFIDay). 
Figure 6.3. Plasma concentrations of total AA (TAA), non-essential AA (NEAA), total sulfur-
containing compounds (TSC), Methionine, cystathionine, and homocystine during the 
periparturient period in cows retrospectively grouped into high (H) and low (L) liver 
functionality index (LFI; HLFI, LLFI).  
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